<?xml version="1.0" ?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.3 20210610//EN"  "JATS-archivearticle1-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">elife</journal-id>
<journal-id journal-id-type="publisher-id">eLife</journal-id>
<journal-title-group>
<journal-title>eLife</journal-title>
</journal-title-group>
<issn publication-format="electronic" pub-type="epub">2050-084X</issn>
<publisher>
<publisher-name>eLife Sciences Publications, Ltd</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">96353</article-id>
<article-id pub-id-type="doi">10.7554/eLife.96353</article-id>
<article-id pub-id-type="doi" specific-use="version">10.7554/eLife.96353.3</article-id>
<article-version-alternatives>
<article-version article-version-type="publication-state">reviewed preprint</article-version>
<article-version article-version-type="preprint-version">1.4</article-version>
</article-version-alternatives>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Cell Biology</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Spatiotemporal recruitment of the ubiquitin-specific protease USP8 directs endosome maturation</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-3317-0300</contrib-id>
<name>
<surname>Miao</surname>
<given-names>Yue</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="aff" rid="a2">2</xref>
<xref ref-type="author-notes" rid="n1">#</xref>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Du</surname>
<given-names>Yongtao</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="aff" rid="a2">2</xref>
<xref ref-type="author-notes" rid="n1">#</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Baolei</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="aff" rid="a2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Liang</surname>
<given-names>Jingjing</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Liang</surname>
<given-names>Yu</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="aff" rid="a2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Dang</surname>
<given-names>Song</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Liu</surname>
<given-names>Jiahao</given-names>
</name>
<xref ref-type="aff" rid="a2">2</xref>
<xref ref-type="aff" rid="a3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Li</surname>
<given-names>Dong</given-names>
</name>
<xref ref-type="aff" rid="a2">2</xref>
<xref ref-type="aff" rid="a3">3</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>He</surname>
<given-names>Kangmin</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="aff" rid="a2">2</xref>
<email>kmhe@genetics.ac.cn</email>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Ding</surname>
<given-names>Mei</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="aff" rid="a2">2</xref>
<email>mding@genetics.ac.cn</email>
</contrib>
<aff id="a1"><label>1</label><institution>State Key Laboratory of Molecular Developmental Biology, Institute of Genetics and Developmental Biology, Chinese Academy of Sciences</institution>, <city>Beijing</city>, <country>China</country></aff>
<aff id="a2"><label>2</label><institution>University of Chinese Academy of Sciences</institution>, <city>Beijing</city>, <country>China</country></aff>
<aff id="a3"><label>3</label><institution>National Laboratory of Biomacromolecules, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences</institution>, <city>Beijing</city>, <country>China</country></aff>
</contrib-group>
<contrib-group content-type="section">
<contrib contrib-type="editor">
<name>
<surname>Delgui</surname>
<given-names>Laura Ruth</given-names>
</name>
<role>Reviewing Editor</role>
<aff>
<institution-wrap>
<institution>National Scientific and Technical Research Council</institution>
</institution-wrap>
<city>Mendoza</city>
<country>Argentina</country>
</aff>
</contrib>
<contrib contrib-type="senior_editor">
<name>
<surname>Campelo</surname>
<given-names>Felix</given-names>
</name>
<role>Senior Editor</role>
<aff>
<institution-wrap>
<institution>Institute of Photonic Sciences</institution>
</institution-wrap>
<city>Barcelona</city>
<country>Spain</country>
</aff>
</contrib>
</contrib-group>
<author-notes>
<fn id="n1" fn-type="equal"><label>#</label><p>These authors contributed equally to this work.</p></fn>
</author-notes>
<pub-date date-type="original-publication" iso-8601-date="2024-04-16">
<day>16</day>
<month>04</month>
<year>2024</year>
</pub-date>
<pub-date date-type="update" iso-8601-date="2024-10-18">
<day>18</day>
<month>10</month>
<year>2024</year>
</pub-date>
<volume>13</volume>
<elocation-id>RP96353</elocation-id>
<history>
<date date-type="sent-for-review" iso-8601-date="2024-02-20">
<day>20</day>
<month>02</month>
<year>2024</year>
</date>
</history>
<pub-history>
<event>
<event-desc>Preprint posted</event-desc>
<date date-type="preprint" iso-8601-date="2024-01-11">
<day>11</day>
<month>01</month>
<year>2024</year>
</date>
<self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2024.01.10.575034"/>
</event>
<event>
<event-desc>Reviewed preprint v1</event-desc>
<date date-type="reviewed-preprint" iso-8601-date="2024-04-16">
<day>16</day>
<month>04</month>
<year>2024</year>
</date>
<self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.96353.1"/>
<self-uri content-type="editor-report" xlink:href="https://doi.org/10.7554/eLife.96353.1.sa3">eLife assessment</self-uri>
<self-uri content-type="referee-report" xlink:href="https://doi.org/10.7554/eLife.96353.1.sa2">Reviewer #1 (Public Review):</self-uri>
<self-uri content-type="referee-report" xlink:href="https://doi.org/10.7554/eLife.96353.1.sa1">Reviewer #2 (Public Review):</self-uri>
<self-uri content-type="referee-report" xlink:href="https://doi.org/10.7554/eLife.96353.1.sa0">Reviewer #3 (Public Review):</self-uri>
<self-uri content-type="author-comment" xlink:href="https://doi.org/10.7554/eLife.96353.1.sa4">Author response:</self-uri>
</event>
<event>
<event-desc>Reviewed preprint v2</event-desc>
<date date-type="reviewed-preprint" iso-8601-date="2024-06-14">
<day>14</day>
<month>06</month>
<year>2024</year>
</date>
<self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.96353.2"/>
<self-uri content-type="editor-report" xlink:href="https://doi.org/10.7554/eLife.96353.2.sa3">eLife assessment</self-uri>
<self-uri content-type="referee-report" xlink:href="https://doi.org/10.7554/eLife.96353.2.sa2">Reviewer #1 (Public Review):</self-uri>
<self-uri content-type="referee-report" xlink:href="https://doi.org/10.7554/eLife.96353.2.sa1">Reviewer #2 (Public Review):</self-uri>
<self-uri content-type="referee-report" xlink:href="https://doi.org/10.7554/eLife.96353.2.sa0">Reviewer #3 (Public Review):</self-uri>
<self-uri content-type="author-comment" xlink:href="https://doi.org/10.7554/eLife.96353.2.sa4">Author response:</self-uri>
</event>
</pub-history>
<permissions>
<copyright-statement>© 2024, Miao et al</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Miao et al</copyright-holder>
<ali:free_to_read/>
<license xlink:href="https://creativecommons.org/licenses/by/4.0/">
<ali:license_ref>https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
<license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="elife-preprint-96353-v3.pdf"/>
<abstract>
<title>Abstract</title><p>The spatiotemporal transition of small GTPase Rab5 to Rab7 is crucial for early-to-late endosome maturation, yet the precise mechanism governing Rab5-to-Rab7 switching remains elusive. USP8, a ubiquitin-specific protease, plays a prominent role in the endosomal sorting of a wide range of transmembrane receptors and is a promising target in cancer therapy. Here, we identified that USP8 is recruited to Rab5-positive carriers by Rabex5, a guanine nucleotide exchange factor (GEF) for Rab5. The recruitment of USP8 dissociates Rabex5 from early endosomes (EEs) and meanwhile promotes the recruitment of the Rab7 GEF SAND-1/Mon1. In USP8-deficient cells, the level of active Rab5 is increased, while the Rab7 signal is decreased. As a result, enlarged EEs with abundant intraluminal vesicles accumulate and digestive lysosomes are rudimentary. Together, our results reveal an important and unexpected role of a deubiquitinating enzyme in endosome maturation.</p>
</abstract>
<custom-meta-group>
<custom-meta specific-use="meta-only">
<meta-name>publishing-route</meta-name>
<meta-value>prc</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
<notes>
<notes notes-type="competing-interest-statement">
<title>Competing Interest Statement</title><p>The authors have declared no competing interest.</p></notes>
<fn-group content-type="summary-of-updates">
<title>Summary of Updates:</title>
<fn fn-type="update"><p>Figure 4 revised, and new data is added. Discussion section is updated. Supplemental files updated.</p></fn>
</fn-group>
</notes>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>Endosomes are dynamic and heterogeneous organelles that act as hubs for endocytic trafficking, recycling and degradation. During endocytosis, membrane proteins marked by ubiquitination are incorporated into endocytic vesicles and then transported to early endosomes (EEs). At EEs, membrane proteins are either brought to the recycling endosomes (REs) or incorporated into intraluminal vesicles (ILVs) with the help of ESCRT (Endosomal Sorting Complex Required for Transport) complexes (<xref ref-type="bibr" rid="c63">Sardana and Emr, 2021</xref>). The ILV-containing compartments, often referred to multivesicular bodies (MVBs), are more acidified and upon fusion with lysosomes, can deliver both transmembrane cargos for degradation, as well as fresh supplies of lysosomal hydrolase enzymes required for the turnover of proteins, lipids and other cellular components (<xref ref-type="bibr" rid="c29">Huotari and Helenius, 2011</xref>; <xref ref-type="bibr" rid="c63">Sardana and Emr, 2021</xref>). The EE-to-MVB endosome maturation process is mainly controlled by endosome-specific Rab GTPases and phosphoinositides (<xref ref-type="bibr" rid="c11">Borchers et al., 2021</xref>; <xref ref-type="bibr" rid="c29">Huotari and Helenius, 2011</xref>; <xref ref-type="bibr" rid="c37">Kümmel et al., 2023</xref>; <xref ref-type="bibr" rid="c65">Stenmark, 2009</xref>). Rab GTPases are guanine nucleotide binding proteins that switch between an inactive GDP-bound and an active GTP-bound state. Within the cytosol, the GDP-bound Rab proteins are kept soluble by binding to the GDP dissociation inhibitor (GDI). The GTP-bound Rabs, activated by their corresponding GEF, can associate with cellular membranes and recruit effector proteins.</p>
<p>Rab5, the Rab GTPase critical for early endosome formation and function, can be activated and recruited to EEs by its GEF, Rabex5 (<xref ref-type="bibr" rid="c48">Mattera and Bonifacino, 2008</xref>; <xref ref-type="bibr" rid="c89">Zhu et al., 2007</xref>). The GTP-bound active Rab5 recruits its effectors, for instance, Rabaptin-5. Rabaptin-5 in turn binds to Rabex5 via a coiled-coil region, resulting in a positive feedback loop of Rab5 activation on endosomal membranes (<xref ref-type="bibr" rid="c88">Zhang et al., 2014b</xref>). Isolated Rabex5 appears to have relatively low GEF activity <italic>in vitro</italic> (<xref ref-type="bibr" rid="c19">Delprato and Lambright, 2007</xref>) and binding of Rabaptin-5 to Rabex5 causes a rearrangement in the Rabex5 C-terminus and subsequently enhances nucleotide exchange of Rab5 (<xref ref-type="bibr" rid="c28">Horiuchi et al., 1997</xref>; <xref ref-type="bibr" rid="c39">Lauer et al., 2019</xref>; <xref ref-type="bibr" rid="c42">Lippé et al., 2001</xref>; <xref ref-type="bibr" rid="c88">Zhang et al., 2014b</xref>). Thus, autoinhibition likely serves as a key regulatory mechanism in controlling GEF activity. Other effectors of Rab5 include the phosphatidylinositol-3-phosphate (PI3P) kinase complex II (VPS34/VPS15/Beclin 1/UVRAG) (<xref ref-type="bibr" rid="c74">Tremel et al., 2021</xref>), which promotes the synthesis of phosphatidylinositol-3-phosphate (PI3P) on endosomes, and the class C core vacuole/endosome tethering (CORVET) complex, which promotes membrane homotypic fusion (<xref ref-type="bibr" rid="c1">Abenza et al., 2010</xref>; <xref ref-type="bibr" rid="c6">Balderhaar et al., 2013</xref>; <xref ref-type="bibr" rid="c56">Peplowska et al., 2007</xref>). Rab5 also recruits the early endosomal antigen 1 (EEA1), a tethering protein required for fusion of endocytic vesicles with EEs (<xref ref-type="bibr" rid="c16">Christoforidis et al., 1999</xref>). The phosphorylated head group of PI3P binds to specific domains, such as the FYVE domain in EEA1, allowing for the organelle-specific association of proteins containing this domain (<xref ref-type="bibr" rid="c40">Lawe et al., 2002</xref>; <xref ref-type="bibr" rid="c66">Stenmark et al., 1996</xref>). The fusion of vesicles with organelles depends on tethering complexes as well as soluble <italic>N</italic>-ethylmaleimide-sensitive factor attachment protein receptors (SNAREs). Reconstitution of early endosome fusion revealed that EEA1 functions in the context of multiple additional components, including endosomal SNAREs, during fusion (<xref ref-type="bibr" rid="c54">Ohya et al., 2009</xref>). Rab5 effectors also include the Rab7 GEF Mon1–Ccz1 complex. Rab7 activation by Mon1-Ccz1 complex is essential for the biogenesis and positioning of late endosomes (LEs) and lysosomes, and for the fusion of endosomes and autophagosomes with lysosomes. The Mon1–Ccz1 complex is a heterodimer in yeast, and a heterotrimer in metazoan cells (<xref ref-type="bibr" rid="c18">Dehnen et al., 2020</xref>; <xref ref-type="bibr" rid="c75">Vaites et al., 2018</xref>; <xref ref-type="bibr" rid="c76">van den Boomen et al., 2020</xref>; <xref ref-type="bibr" rid="c77">Wang et al., 2002</xref>). The activation of Mon1-Ccz1 is depended on Rab5 interaction (<xref ref-type="bibr" rid="c10">Borchers et al., 2023</xref>; <xref ref-type="bibr" rid="c38">Langemeyer et al., 2020</xref>) and Mon1 also coordinates endosome maturation together with the Rab5 GAP TBC1D18 (<xref ref-type="bibr" rid="c27">Hiragi et al., 2022</xref>). Additionally, the Mon1-Ccz1 complex is able to interact with Rabex5 (<xref ref-type="bibr" rid="c57">Poteryaev et al., 2010</xref>), causing dissociation of Rabex5 from the membrane, which probably terminates the positive feedback loop of Rab5 activation and then promotes the recruitment and activation of Rab7 on endosomes (<xref ref-type="bibr" rid="c53">Nordmann et al., 2010</xref>; <xref ref-type="bibr" rid="c57">Poteryaev et al., 2010</xref>). All in all, the hierarchy of protein recruitment and their reciprocal regulation ensures the rapid transition from Rab5- to Rab7-positive vesicles which is critical for endosome maturation.</p>
<p>The conserved ESCRT machinery drives endosomal membrane deformation and scission leading to the formation of ILVs within MVBs. On the surface of endosomes, ESCRT-0, -I and -II bind to ubiquitinated membrane proteins, while ESCRT-III and Vps4 bud ILVs into the lumen of the endosomes (<xref ref-type="bibr" rid="c79">Wollert and Hurley, 2010</xref>). The deubiquitinating enzyme (DUB) USP8 belongs to the ubiquitin-specific protease (USP) family and plays a prominent role in the regulation of endosomal sorting of a wide range of transmembrane receptors (<xref ref-type="bibr" rid="c21">Dufner and Knobeloch, 2019</xref>). In addition to direct deubiquitination, USP8 also regulates protein stability through its interactions with various ESCRT components. By binding to STAM and Hrs, USP8 stabilizes the ESCRT-0 complex, which is the crucial element directing ubiquitinated substrates towards MVB/lysosome-mediated degradation (<xref ref-type="bibr" rid="c50">Mizuno et al., 2006</xref>; <xref ref-type="bibr" rid="c62">Row et al., 2006</xref>). The N-terminal microtubule interacting and transport (MIT) domain of USP8 interacts with ESCRT-III proteins, which are thought to be the driving force of several membrane scission events (<xref ref-type="bibr" rid="c61">Row et al., 2007</xref>). In the absence of USP8, EGFR is abnormally accumulated in EEs (<xref ref-type="bibr" rid="c4">Alwan and van Leeuwen, 2007</xref>; <xref ref-type="bibr" rid="c62">Row et al., 2006</xref>). Additionally, the endocytic trafficking of the Frizzled receptor, Smooth, as well as key components of the Wnt and Hedgehog pathways is also affected by <italic>usp8</italic> deficiency (<xref ref-type="bibr" rid="c3">Ali et al., 2013</xref>; <xref ref-type="bibr" rid="c7">Berlin et al., 2010a</xref>; <xref ref-type="bibr" rid="c8">Berlin et al., 2010b</xref>; <xref ref-type="bibr" rid="c17">Crespo-Yàñez et al., 2018</xref>; <xref ref-type="bibr" rid="c32">Jacomin et al., 2015</xref>; <xref ref-type="bibr" rid="c45">MacDonald et al., 2014</xref>). Noticeably, however, the impact of USP8 on protein stability is highly variable and sometimes controversial (<xref ref-type="bibr" rid="c8">Berlin et al., 2010b</xref>; <xref ref-type="bibr" rid="c49">Mizuno et al., 2005</xref>; <xref ref-type="bibr" rid="c52">Niendorf et al., 2007</xref>; <xref ref-type="bibr" rid="c62">Row et al., 2006</xref>).</p>
<p>Here, utilizing both <italic>C. elegans</italic> and cultured mammalian cells as models, we identified that USP8 is recruited to Rab5-positive vesicles through Rabex5 and functions through both the endosomal dissociation of Rabex5 and recruitment of SAND-1/Mon1 to promote endosome maturation. USP8 has recently arisen as a promising therapeutic target in at least two distinct pathological contexts associated with USP8 overexpression or gain-of-function variants (<xref ref-type="bibr" rid="c21">Dufner and Knobeloch, 2019</xref>; <xref ref-type="bibr" rid="c41">Li et al., 2024</xref>; <xref ref-type="bibr" rid="c60">Reincke et al., 2015</xref>). Thus, our data reveal an important and direct role of USP8 in endosome maturation and have clear implications for the therapeutic treatment of USP8-related human diseases.</p>
</sec>
<sec id="s2">
<title>Results</title>
<sec id="s2a">
<title><italic>usp-50</italic> mutation leads to reduction of lysosomal compartments</title>
<p>The epithelial cell hyp7 (hypodermal cell 7) covers most of the worm body and is the largest cell in <italic>C. elegans</italic>. When fused to GFP and driven by the <italic>ced-1</italic> promoter, the transmembrane lysine/arginine transporter LAAT-1 can be used to highlight the lysosome structures in the hyp7 cell (<xref rid="fig1" ref-type="fig">Figure 1A</xref>) (<xref ref-type="bibr" rid="c43">Liu et al., 2012</xref>). In wild type, as worms mature from L4 (larval stage 4) to adult stage, the vesicular and tubular structures of lysosomes become enlarged (<xref rid="fig1" ref-type="fig">Figure 1A</xref>) (<xref ref-type="bibr" rid="c71">Sun et al., 2020</xref>). In <italic>usp-50(xd413)</italic>, a recessive mutation isolated from a genetic screen of worms mutagenized with EMS (ethylmethane sulfonate), lysosomes appear to be greatly reduced in size (<xref rid="fig1" ref-type="fig">Figure 1B and D</xref>). For another <italic>usp-50</italic> allele, <italic>gk632973</italic>, the lysosome distribution and morphology appear normal during L4 stage (<xref rid="fig1" ref-type="fig">Figure 1C</xref>). However, when <italic>usp-50(gk632973)</italic> animals reach adult stage, the individual size and total volume of lysosomes are also reduced (<xref rid="fig1" ref-type="fig">Figure 1C and D</xref>). <italic>nuc-1</italic> encodes a lysosomal deoxyribonuclease (<xref ref-type="bibr" rid="c81">Wu et al., 2000</xref>). In <italic>usp-50(xd413)</italic> animals, the NUC-1 protein is properly targeted to LAAT-1-containing vesicles (<xref rid="fig1" ref-type="fig">Figure 1E and F</xref>; and <xref rid="fig1s1" ref-type="fig">Figure1-figure supplement 1A</xref>), which indicates that the assembly of <italic>de novo</italic> lysosomes is not affected by <italic>usp-50</italic>.</p>
<fig id="fig1" position="float" orientation="portrait" fig-type="figure">
<label>Figure 1.</label>
<caption><title>Abnormal lysosome morphology and enlarged MVB-like structures in <italic>usp-50</italic> mutants.</title>
<p>(A-C) Confocal fluorescence images of hypodermal cell 7 (hyp7) expressing the LAAT-1::GFP marker to highlight lysosome structures in L4 stage, young adult and 3-day-old adult animals. Scale bar, 5 μm. (D) Quantification of the individual volume and total volume of LAAT-1::GFP vesicles in hyp7 of 3-day-old adults. 19 animals for wild-type, 16 animals for <italic>usp-50(xd413)</italic> and 13 animals for <italic>usp-50(gk632973)</italic> were quantified. <italic>P</italic> value ****&lt;0.0001. One-way ANOVA with Tukey’s test. (E and F) The lysosomal membrane marker LAAT-1::GFP co-localizes with the lysosomal hydrolase NUC-1::mCherry in both wild-type (E) and <italic>usp-50(xd413)</italic> (F) animals. Scale bar represents 5 μm for (E-F) and 2 μm for enlarged inserts. (G) Confocal fluorescence images of hypodermis expressing HGRS-1::GFP in L4 stage worms. Compared to wild type, HGRS-1::GFP signal is reduced in <italic>usp-50(gk632973)</italic> and <italic>usp-50(xd413)</italic> animals. Scale bar: 5 μm. (H) Confocal fluorescence images of hypodermis expressing STAM-1::GFP in L4 stage worms. Compared to wild type, STAM-1::GFP signal is reduced in <italic>usp-50(xd413)</italic> animals. Scale bar: 5 μm.</p></caption>
<graphic xlink:href="575034v4_fig1.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
<p><italic>usp-50</italic> encodes the <italic>C. elegans</italic> homolog of <italic>S. cerevisiae</italic> Doa4p and human USP8/UBPY (<xref ref-type="bibr" rid="c12">Bowers et al., 2004</xref>; <xref ref-type="bibr" rid="c30">Huynh et al., 2016</xref>). All the USP8 family members contain a UCH domain which is crucial for the deubiquitination activity (<xref ref-type="bibr" rid="c36">Komander et al., 2009</xref>). The molecular lesions of both <italic>usp-50(xd413)</italic> and <italic>usp-50(gk632973)</italic> occur in the UCH domain, leading to a G541A and A523V substitution respectively.</p>
<p>USP8 was identified as a protein associated with ESCRT components (<xref ref-type="bibr" rid="c35">Kato et al., 2000</xref>; <xref ref-type="bibr" rid="c47">Mathieu et al., 2022</xref>; <xref ref-type="bibr" rid="c61">Row et al., 2007</xref>). The ESCRT machinery drives endosomal membrane deformation and scission, leading to the formation of ILVs within MVBs (<xref ref-type="bibr" rid="c5">Babst, 2011</xref>; <xref ref-type="bibr" rid="c79">Wollert and Hurley, 2010</xref>). In wild type animals, the two ESCRT-0 components, HGRS-1 and STAM-1, are distributed in a distinct punctate pattern (<xref rid="fig1" ref-type="fig">Figure 1G and H</xref>). When <italic>usp-50</italic> is mutated, the punctate HGRS-1::GFP and STAM-1 signals are greatly reduced (<xref rid="fig1" ref-type="fig">Figure 1G and H</xref>; and <xref rid="fig1s1" ref-type="fig">Figure1-figure supplement 1B</xref>), which is consistent with the role of USP8 in stabilizing the ESCRT-0 complex (<xref ref-type="bibr" rid="c35">Kato et al., 2000</xref>; <xref ref-type="bibr" rid="c50">Mizuno et al., 2006</xref>; <xref ref-type="bibr" rid="c52">Niendorf et al., 2007</xref>; <xref ref-type="bibr" rid="c62">Row et al., 2006</xref>; <xref ref-type="bibr" rid="c87">Zhang et al., 2014a</xref>).</p>
</sec>
<sec id="s2b">
<title>Enlarged EEs in <italic>usp-50/usp8</italic> mutant cells</title>
<p>Lysosomes receive and digest materials generated by endocytic pathways. Using YFP-tagged 2xFYVE (YFP::2xFYVE), which specifically labels PI3P, we examined the size and morphology of EEs (<xref rid="fig2" ref-type="fig">Figure 2A</xref>). We found that the size of individual EEs is significantly increased (<xref rid="fig2" ref-type="fig">Figure 2B</xref>). Meanwhile, the total volume of EEs in <italic>usp-50</italic> mutants remains similar to wild type (<xref rid="fig2" ref-type="fig">Figure 2B</xref>), implying that the homotypic fusion of EEs is probably increased. The enlarged EEs in <italic>usp-50(xd413)</italic> are not coated with the lysosome marker LAAT-1::mCherry (<xref rid="fig2" ref-type="fig">Figure 2C and D</xref>; and <xref rid="fig2s1" ref-type="fig">Figure 2-figure supplement 1A</xref>). Hence, the EEs remain differentiated from lysosome structures. The enlarged early endosome defect in <italic>usp-50(xd413)</italic> mutants is rescued by either worm <italic>usp-50</italic> or human USP8 (<xref rid="fig2" ref-type="fig">Figure 2J</xref>; and <xref rid="fig2s1" ref-type="fig">Figure 2-figure supplement 1B</xref>), which suggests that the function of USP-50/USP8 is evolutionarily conserved. Indeed, when we knocked out the expression of USP8 (USP8-KO) in human breast cancer SUM159 cells (<xref rid="fig2s1" ref-type="fig">Figure 2-figure supplement 1C</xref>), the transient expression of EGFP-2xFYVE confirmed that USP8 depletion caused early endosome enlargement (<xref rid="fig2" ref-type="fig">Figure 2K</xref>).</p>
<fig id="fig2" position="float" orientation="portrait" fig-type="figure">
<label>Figure 2.</label>
<caption><title>Enlarged EEs in <italic>usp-50/usp8</italic> mutant cells.</title>
<p>(A) Confocal fluorescence images of hypodermis expressing YFP::2xFYVE to detect EEs in L4 stage animals. Compared to wild-type, EEs are enlarged in <italic>usp-50(gk632973)</italic> and <italic>usp-50(xd413)</italic> mutants. Scale bar: 5 μm. (B) Quantification of the individual vesicle size, total volume, and number of YFP::2xFYVE-marked vesicles in hyp7 in L4 worms (10 animals for wild-type, 11 animals for <italic>usp-50(gk632973)</italic>, 13 animals for <italic>usp-50(xd413)</italic>). Data are presented as mean ± SEM. *<italic>P</italic>&lt;0.05. **<italic>P</italic>&lt;0.01. ***<italic>P</italic>&lt;0.001. ****<italic>P</italic>&lt;0.0001. ns, not significant; one-way ANOVA with Tukey’s test. (C-D) The YFP::2xFYVE marker is not co-localized with LAAT-1::mCherry in wild-type (C) or <italic>usp-50(xd413)</italic> animals (D). Scale bar represents 5 μm for (C-D) and 2 μm for enlarged inserts. (E-J) The YFP::2xFYVE pattern in wild-type (E), <italic>usp-50(xd413)</italic> mutants (F), <italic>usp-50(xd413)</italic> with hypodermis-specific USP-50 expression (G), <italic>usp-50(xd413)</italic> with muscle-specific USP-50 expression (H), <italic>usp-50(xd413)</italic> with gut-specific USP-50 expression (I), and <italic>usp-50(xd413)</italic> with expression of human USP8 driven by the <italic>usp-50</italic> promoter (J). Scale bar: 5 μm. (K) Distribution of transiently expressed EGFP-2xFYVE in wild-type and USP8-KO SUM159 cells. Both wild-type and USP8-KO SUM159 cells were transiently transfected with EGFP-2xFYVE and then imaged by spinning-disk confocal microscopy. The right panel shows quantification of the number of large endosomes marked by EGFP-2xFYVE from 38 cells for wild-type and 49 cells for USP8-KO (****<italic>P</italic>&lt;0.0001 using an unpaired, two-sample Student’s test). Scale bar: 10 μm. (L and L’) High-pressure freezing EM reveals the MVB structure in wild-type animals. The yellow boxed area is enlarged in (L’). (M) Quantification of the abnormal enlarged vesicle in <italic>usp-50(xd413)</italic> animals. For comparative analysis, the quantification of multivesicular body (MVB) structures in wild-type animals was also included. Data are presented as mean ±SEM. ***<italic>P</italic>&lt;0.001. Unpaired Student’s t-test was performed. (N-Q) The enlarged abnormal vesicles in <italic>usp-50(xd413)</italic>, including vesicles containing abundant ILVs (58.7%) (N), vesicles filled with threadlike membrane structures (26.8%) (O), vesicles loaded with electron-dense material (22.4%) (P), and vesicles containing various cellular organelles (4.9%) (Q). Red dashed lines indicate hypodermal cells. Yellow arrows indicate representative vesicles. mito, mitochondrion. Scale bar: 0.5 μm for (L-Q).</p></caption>
<graphic xlink:href="575034v4_fig2.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
<p>Next, we prepared high-pressure frozen samples and performed transmission electron microscopy (TEM) analysis to examine worm epidermal cells. Compared to wild type, many abnormal large vesicles with various intraluminal contents were detected in <italic>usp-50(xd413)</italic> mutants (<xref rid="fig2" ref-type="fig">Figure 2M-Q</xref>). Based upon the vesicular inclusions, we divided those vesicles into four categories. The first class is composed of vesicles containing abundant intraluminal vesicle structures (<xref rid="fig2" ref-type="fig">Figure 2N</xref>). About 58.7% of the abnormal vesicles belong to this category. The second class (26.8%) includes vesicles filled with threadlike membrane structures (<xref rid="fig2" ref-type="fig">Figure 2Q</xref>). Vesicles of the third type (22.4%) are loaded with threadlike membrane structures and electron-dense material (<xref rid="fig2" ref-type="fig">Figure 2P</xref>). The fourth class, which accounts for a relatively small proportion of mutant vesicles (4.9%), contains various cellular organelles, for instance mitochondria (<xref rid="fig2" ref-type="fig">Figure 2Q</xref>). Given the significantly reduced LAAT-1-coated structures and the increased size of FYVE-positive vesicles observed in <italic>usp-50</italic> mutants, it is plausible that these enlarged vesicles represent abnormally expanded early endosomes (EEs).</p>
<p>There was no obvious alteration in the pattern of reporters for Golgi apparatus (MANS::GFP), retromers (VPS-29::GFP), or recycling endosomes (GFP::RME-1) (<xref rid="fig2s2" ref-type="fig">Figure 2-figure supplement 2</xref>). This suggests that the endolysosomal trafficking process is rather specifically affected by <italic>usp-50</italic>.</p>
</sec>
<sec id="s2c">
<title>USP8 is dynamically recruited to Rab5-positive vesicles</title>
<p>How does USP-50/USP8 control the size of EEs? To address this question, we firstly analyzed the subcellular localization of USP-50/USP8. In worm epidermal cells, the GFP-tagged USP-50 protein is co-localized with mCherry::RAB-5 (<xref rid="fig3s1" ref-type="fig">Figure 3-figure supplement 1A</xref>) but not with mCherry::RAB-7 (<xref rid="fig3s1" ref-type="fig">Figure 3-figure supplement 1B</xref>), consistent with the early endosomal localization of USP-50/USP8 (<xref ref-type="bibr" rid="c49">Mizuno et al., 2005</xref>; <xref ref-type="bibr" rid="c62">Row et al., 2006</xref>). The catalytic ubiquitin C-terminal hydrolase (UCH) domain possesses a “cysteine box” containing the active site residues, including Cysteine 492 (C492) (<xref ref-type="bibr" rid="c51">Naviglio et al., 1998</xref>). When we mutated C492 to Alanine, we found that the GFP-tagged USP-50(C492A) protein is still co-localized with mCherry::RAB-5 (<xref rid="fig3s1" ref-type="fig">Figure 3-figure supplement 1C</xref>). Thus, the EE localization of USP-50 is not dependent on its deubiquitination activity. Meanwhile, the mCherry::RAB-5 signal is strongly enhanced by the overexpression of USP-50(C492A) (<xref rid="fig3s1" ref-type="fig">Figure 3-figure supplement 1C</xref>), suggesting that the C492A mutation may have a dominant-negative effect on USP-50 function.</p>
<fig id="fig3" position="float" orientation="portrait" fig-type="figure">
<label>Figure 3.</label>
<caption><title>USP8 is recruited to Rab5-positive vesicles.</title>
<p>(A-C) SUM159 cells genome-edited for USP8-mEGFP<sup>+/+</sup> were transiently transfected with the indicated mScarlet-I-tagged proteins and then imaged by spinning-disk confocal microscopy. The single-frame image in the figure shows the distribution of USP8 with EEA1, RAB7a, or Lamp1. USP8-mEGFP is co-localized with the early endosome marker mScarlet-EEA1 in genome-edited USP8-mEGFP<sup>+/+</sup> SUM159 cells (A). USP8-mEGFP is partly co-localized with the late endosome marker mScarlet-Rab7a (B) or the lysosome marker Lamp1-mScarlet-I (C). Scale bar represents 10 μm for (A-C) and 2 μm for enlarged inserts. (D) USP8-mEGFP localization on enlarged EEs in the genome-edited SUM159 cells. SUM159 cells genome-edited for USP8-mEGFP<sup>+/+</sup> were transiently transfected with mScarlet-I-EEA1 and Halo-Rab5c-Q80L, labeled with the JF<sub>646</sub>-HaloTag ligand, and then imaged by spinning-disk confocal microscopy. Scale bar represents 10 μm for (D) and 2 μm for enlarged inserts. (E) SIM images showing the sub-organelle localization of USP8-mEGFP on EEs marked with mScarlet-EEA1. USP8-mEGFP<sup>+/+</sup> cells were transiently transfected with mScarlet-I-EEA1 and then imaged near the middle plane by SIM. Scale bar represents 2 μm for the left panels and 0.5 μm for the right enlarged panel. (F) SUM159 cells genome-edited for USP8-mEGFP<sup>+/+</sup> were transiently transfected with mScarlet-I-Rab5c and then imaged at two planes (starting from the bottom plane, spaced by 0.5 μm) every 2 s (for 1 min) by spinning-disk confocal microscopy. Shown is the first frame of the maximum intensity projection of the two planes. The boxed region is enlarged and the images at the indicated times are shown on the right. Scale bar represents 10 μm for the left images and 2 μm for the right enlarged images. (G) Kymographs along the line (width 3 pixels) on the first merged image of the montage in (F) showing dynamic recruitment of USP8-mEGFP to the pre-existing mScarlet-Rab5-positive vesicles. (H) The time lapse images in (F) were analyzed by single-particle tracking. The trajectories (longer than 20 s, color-coded based on track lifetime) of Rab5c are plotted on the first frame of mScarlet-I-Rab5c. The boxed region is enlarged and shown on the right. The fluorescence intensity traces for mScarlet-I-Rab5c (red) and USP8-mEGFP (green) of the three tracked events are shown. Scale bar: 2 μm.</p></caption>
<graphic xlink:href="575034v4_fig3.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
<p>To reveal the subcellular localization of USP8 in mammalian cells, we used the CRISPR/Cas9 approach to generate a SUM159 cell line in which the endogenous USP8 was tagged with mEGFP (USP8-mEGFP<sup>+/+</sup>) (<xref rid="fig3s2" ref-type="fig">Figure 3-figure supplement 2</xref>). As shown in <xref rid="fig3" ref-type="fig">Figure 3</xref>, USP8-mEGFP co-localizes well with the EE marker mScarlet-I-EEA1 (<xref rid="fig3" ref-type="fig">Figure 3A</xref>). In contrast, LE or lysosome markers, including mScarlet-I-Rab7a and Lamp1-mScarlet-I, have little overlap with the USP8-mEGFP signal (<xref rid="fig3" ref-type="fig">Figure 3B and C</xref>). Constitutively activated Rab5 GTPase (Rab5c-Q80L) causes enlarged EEs (<xref ref-type="bibr" rid="c67">Stenmark et al., 1994</xref>; <xref ref-type="bibr" rid="c78">Wegner et al., 2010</xref>). Instead of being evenly distributed, USP8-mEGFP formed individual spots located on one side of the enlarged endosomes (<xref rid="fig3" ref-type="fig">Figure 3D</xref>). We further analyzed the sub-organelle distribution of USP8 using structured illumination microscopy (SIM). Consistent with what we observed in enlarged EEs caused by Rab5c-Q80L overexpression, the USP8-mEGFP dots indeed located at subdomains of EEs (<xref rid="fig3" ref-type="fig">Figure 3E</xref>). The uneven distribution of USP8 implies that USP8 may associate dynamically with EEs. To further investigate the dynamic association of USP8 with EEs, we transiently expressed mScarlet-I-Rab5c in the genome-edited USP8-mEGFP<sup>+/+</sup> cells and tracked the recruitment dynamics of USP8-mEGFP to EEs by spinning-disk confocal microscopy (<xref rid="fig3" ref-type="fig">Figure 3F</xref>). We previously reported that Rab5 was recruited to nascent endocytic carriers following the un-coating of clathrin-coated vesicles (<xref ref-type="bibr" rid="c26">He et al., 2017</xref>). This recruitment resulted in the creation of Rab5-positive endocytic carriers, which could subsequently fuse with other Rab5-positive endocytic carriers or EEA1-positive EEs (<xref ref-type="bibr" rid="c26">He et al., 2017</xref>). We found that USP8-mEGFP was recruited to these nascent mScarlet-I-Rab5c-positive vesicles which appeared around the bottom surface of the cells (<xref rid="fig3" ref-type="fig">Figure 3F</xref>). Additionally, we observed the dynamic appearance and disappearance of single USP8-mEGFP spots on these large Rab5c-positive endosomes (<xref rid="fig3" ref-type="fig">Figure 3G-H</xref>).</p>
</sec>
<sec id="s2d">
<title>USP-50/USP8 recruitment dissociates RABX-5 from endosomes</title>
<p>How is the endosomal recruitment of USP8 related to its function in endolysosomal trafficking process? By searching the putative USP-50 binding partners, we found that USP-50 can bind to RABX-5, the worm homolog of Rabex5 protein (<xref rid="fig4" ref-type="fig">Figure 4A and B</xref>). To determine which domain of RABX-5 is required for the interaction with USP-50, we constructed a panel of FLAG-tagged RABX-5 truncation mutants (<xref rid="fig4" ref-type="fig">Figure 4C</xref>) and performed a series of immunoprecipitation tests (<xref rid="fig4" ref-type="fig">Figure 4D</xref>). In general, the C-terminal coiled-coil (CC) and the C-terminal proline-rich (PR) domains are sufficient for RABX-5 to interact with USP-50. Meanwhile, the N-terminal region, including an A20-zinc finger domain (ZF), a motif interacting with ubiquitin (U), the membrane-binding motif (MB) and the downstream helical bundle domain (HB) of RABX-5 could also mediate USP-50 binding. Further including Vps9 domain enhances the molecular interaction between RABX-5 and USP-50 (<xref rid="fig4" ref-type="fig">Figure 4C and D</xref>).</p>
<fig id="fig4" position="float" orientation="portrait" fig-type="figure">
<label>Figure 4.</label>
<caption><title>USP-50 interacts with RABX-5.</title>
<p>(A) The affinity-purified RABX-5::GFP from worm lysates is immuno-precipitated by USP-50::4xFLAG purified from KEK293T cells using anti-FLAG beads. Only the area of the blot containing the USP-50::4xFLAG band is displayed. (B) The affinity-purified USP-50::4xFLAG from KEK293T cells is immuno-precipitated by RABX-5::GFP purified from worm lysates using anti-GFP beads. N2 is wild-type. (C) Schematic drawing of RABX-5 showing the domains that interact with USP-50. (D) Immuno-precipitation tests between USP-50::MYC and FLAG-tagged truncated RABX-5. USP-50::MYC and FLAG-tagged truncated RABX-5 were expressed via co-transfection into HEK293T cells, immunoprecipitated with FLAG beads and immunoblotted with antibodies against MYC and FLAG. (E) Schematic drawing of the RABX-5 protein structure. The molecular lesions of the null mutant is indicated. (F) Confocal fluorescence images of hyp7 expressing USP-50::GFP in wild-type L4 animals (<italic>wt</italic>), <italic>rabx-5(null)</italic> L4 mutants. Scale bar represents 5 μm. (G) Line scan analyses show the fluorescence intensity values along the red solid lines in (F). (H) The EE (labeled by YFP::2xFYVE) enlargement phenotype of <italic>usp-50(xd413)</italic> could be suppressed by <italic>rabx-5(null)</italic> mutation. (I) Quantification of the volume of individual EEs in various genotypes. More than 10 animals were examined in each genotype. Data are presented as mean ± SEM. ****<italic>P</italic>&lt;0.0001. ns, not significant. One-way ANOVA with Tukey’s test.</p></caption>
<graphic xlink:href="575034v4_fig4.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
<p>Does RABX-5 binding affect the endosomal localization of USP-50? To address this question, we created a molecular null of <italic>rabx-5</italic> using the CRISPR/Cas9 technique (<xref ref-type="bibr" rid="c20">Dickinson et al., 2013</xref>) (<xref rid="fig4" ref-type="fig">Figure 4E</xref>). The <italic>rabx-5(null)</italic> animals are healthy and fertile and do not display obvious morphological or behavioral defects. In <italic>rabx-5(null)</italic> mutant animals, the punctate USP-50::GFP signal becomes diffusely distributed (<xref rid="fig4" ref-type="fig">Figure 4F and G</xref>). Thus, <italic>rabx-5</italic> is require for the endosomal localization of USP-50. Does USP-50 regulate endosome maturation via RABX-5? In <italic>rabx-5(null)</italic> mutant animals, early endosomes labeled with 2xFYVE are indistinguishable from those in wild-type controls (<xref rid="fig4" ref-type="fig">Figure 4H and I</xref>). Furthermore, when <italic>rabx-5(null)</italic> was introduced into <italic>usp-50(xd413)</italic> mutant backgrounds, the enlarged early endosome phenotype of <italic>usp-50(xd413)</italic> was efficiently suppressed (<xref rid="fig4" ref-type="fig">Figure 4H and I</xref>). These findings suggest that USP-50 likely exerts its regulatory effects on early endosome size through RABX-5.</p>
<p>In wild-type animals, the fluorescence signal of RABX-5::GFP in hyp7 is rather dim (<xref rid="fig5" ref-type="fig">Figure 5A</xref>). When <italic>usp-50</italic> is mutated, the RABX-5::GFP KI signal is greatly enhanced (<xref rid="fig5" ref-type="fig">Figure 5B</xref>). USP8-KO also caused a significant increase in the number of enlarged endosomes in Rabex5-mEGFP<sup>+/+</sup> SUM159 cells (<xref rid="fig5s1" ref-type="fig">Figure 5-figure supplement 1A-C</xref> and E). Rabex5-mEGFP signals were enriched and co-localized well with the mScarlet-I-Rab5c signal on the enlarged endosomes (<xref rid="fig5s1" ref-type="fig">Figure 5-figure supplement 1A</xref>). Antibody staining of endogenous EEA1 further showed that the enlarged EEs in USP8-KO cells were coated with both Rabex5 and EEA1 (<xref rid="fig5s1" ref-type="fig">Figure 5-figure supplement 1D</xref>). The increased endosomal RABX-5/Rabex5 may lead to Rab5 signal enhancement. Indeed, in <italic>usp-50</italic> mutants, the GFP::RAB-5 KI-labeled vesicles are significantly enlarged (<xref rid="fig5s2" ref-type="fig">Figure 5-figure supplement 2A-C</xref>) and the proportion of membrane-associated GFP::RAB-5 KI is also increased (<xref rid="fig5s2" ref-type="fig">Figure 5-figure supplement 2D</xref>). The GTP-bound activated RAB-5 protein binds to its downstream effector EEA1 via the N-terminal domain of EEA1 (EEA1-NT). We utilized EEA1-NT (<xref rid="fig5s2" ref-type="fig">Figure 5-figure supplement 2E</xref>) to show that loss of <italic>usp-50</italic> indeed led to more activated RAB-5 <italic>in vivo</italic> (<xref rid="fig5s2" ref-type="fig">Figure 5-figure supplement 2F</xref>). In addition, the total RAB-5 protein level is increased by <italic>usp-50</italic> mutation (<xref rid="fig5s2" ref-type="fig">Figure 5-figure supplement 2G</xref> and H), which implies that RAB-5 activation may stabilize RAB-5 protein. To explore the relationship between Rab5 and USP8 in SUM159 cells, we knocked down the expression of USP8 by siRNA (USP8-KD) in the clonal genome-edited EGFP-Rab5c<sup>+/+</sup> cells. We found that EEs, labeled by Rab5, are significantly enlarged (<xref rid="fig5s2" ref-type="fig">Figure 5-figure supplement 2I</xref> and J). Taken together, these results indicate that USP-50/USP8 recruitment dissociates RABX-5 from endosomes, and subsequently diminish Rab5 signaling.</p>
<fig id="fig5" position="float" orientation="portrait" fig-type="figure">
<label>Figure 5.</label>
<caption><title>USP-50 dissociates RABX-5 from endosomes</title>
<p>(A-D) The punctate distribution of RABX-5::GFP KI (knock-in) in wild type (A) and <italic>usp-50(xd413)</italic> (B). The increased RABX-5::GFP KI signal in <italic>usp-50(xd413)</italic> is rescued by expressing wild-type (C) but not C492A mutant <italic>usp-50</italic> (D). (E and F) The <italic>usp-50(xd413)</italic> mutation increases the GFP intensity of RABX-5(K88R)::GFP KI. (G and H) The <italic>usp-50(xd413)</italic> mutation does not alter the GFP intensity of RABX-5(K323R)::GFP KI. (I) Line scan analyses show the fluorescence intensity values along the red solid lines in (A-H). (J and K) Both the enlarged early endosome (YFP::2xFYVE) and the diminished late endosome (NUC-1::mCherry) phenotypes of <italic>usp-50(xd413)</italic> can be suppressed by <italic>rabx-5(k323R)</italic>. (L-M) Quantification of the volume of individual EEs (labeled by YFP::2xFYVE) and LEs (labeled by NUC-1::mCherry) in various genotypes. Data are presented as mean ± SEM. ****<italic>P</italic>&lt;0.0001. ns, not significant; one-way ANOVA with Tukey’s test. Scale bar represents 10 μm for (A-H), 5 μm for (J and K).</p></caption>
<graphic xlink:href="575034v4_fig5.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
</sec>
<sec id="s2e">
<title>USP-50 acts on K323 de-ubiquitination to regulate RABX-5 localization</title>
<p>The enzyme-inactive USP-50(C492A) cannot rescue the enhanced endosomal RABX-5 signal in <italic>usp-50</italic> mutant animals (<xref rid="fig5" ref-type="fig">Figure 5C and D</xref>). This suggests that USP-50 acts through its de-ubiquitination activity to dissociate RABX-5 from endosomes. To further dissect how the USP-50-mediated de-ubiquitination might contribute to RABX-5 localization, we precipitated the FLAG-tagged RABX-5 from overexpressed 293T cells and performed ubiquitination proteomics analysis. We found that the K88 and K323 residues of RABX-5 are modified by ubiquitin <italic>in vivo</italic> (<xref rid="fig5s3" ref-type="fig">Figure 5-figure supplement 3A</xref> and B). K88 is located in the membrane-binding motif, while K323 resides in the conserved Vps9 domain of RABX-5 (<xref rid="fig5s3" ref-type="fig">Figure 5-figure supplement 3B</xref>). To understand whether and how these two ubiquitin modification sites are involved in USP-50-mediated deubiquitination, we generated non-ubiquitinated mutations at K88 and K323 (K88R and K323R, respectively). In wild-type animals, the RABX-5::GFP KI intensity is rather dim (<xref rid="fig5" ref-type="fig">Figure 5A</xref>). When <italic>usp-50</italic> is mutated, the RABX-5::GFP KI intensity is strongly enhanced and displays the typical punctate pattern (<xref rid="fig5" ref-type="fig">Figure 5B and I</xref>). On a wild-type background, both RABX-5(K88R)::GFP KI and RABX-5(K323R)::GFP KI display weak signals (<xref rid="fig5" ref-type="fig">Figure 5E and G</xref>) similar to wild-type RABX-5::GFP KI (<xref rid="fig5" ref-type="fig">Figure 5A</xref>). When <italic>usp-50</italic> is mutated, the RABX-5(K88R)::GFP KI signal is greatly enhanced and displays an apparent punctate pattern (<xref rid="fig5" ref-type="fig">Figure 5F and I</xref>), which is similar to what we observed with the wild-type RABX-5::GFP KI line. In contrast, when K323 is mutated, the signal from RABX-5(K323A)::GFP KI remains dim in both wild-type and <italic>usp-50</italic> mutant animals (<xref rid="fig5" ref-type="fig">Figure 5G-I</xref>). These observations suggest that USP-50 cannot regulate the endosomal localization of RABX-5 when K323 is mutated. Furthermore, the <italic>rabx-5(K323R)</italic> mutation successfully suppressed both the enlarged early endosome and diminished late endosome phenotypes of <italic>usp-50</italic> (<xref rid="fig5" ref-type="fig">Figure 5J-M</xref>). Taken together, USP-50 recruitment to EEs relies on RABX-5, and through its deubiquitination action on the Vps9 domain of RABX-5, USP-50 dissociates RABX-5 from EEs, thereby terminating Rab5 signaling to promote endosome maturation.</p>
</sec>
<sec id="s2f">
<title>USP-50/USP8 is required for SAND-1/Mon1 recruitment</title>
<p>SAND-1/Mon1-Ccz1 binds to RABX-5, and by displacing RABX-5 from the endosomal membrane, functions as a GEF of Rab7 to recruit and activate Rab7 GTPase (<xref ref-type="bibr" rid="c53">Nordmann et al., 2010</xref>; <xref ref-type="bibr" rid="c57">Poteryaev et al., 2010</xref>). In the absence of RABX-5 <italic>(rabx-5 null</italic>), the GFP::SAND-1 puncta are diminished (<xref rid="fig6" ref-type="fig">Figure 6A</xref>, B and D) and the LAAT-1::GFP-labeled lysosome structures are also reduced (<xref rid="fig6" ref-type="fig">Figure 6E and F</xref>; and <xref rid="fig6s1" ref-type="fig">Figure 6-figure supplement 1A</xref>). In <italic>usp-50</italic> mutants, the RABX-5 signal is enhanced, while the lysosome structures are reduced. Intriguingly, when we introduced the GFP::SAND-1 marker into <italic>usp-50</italic> mutants, we found that the punctate distribution of GFP::SAND-1 is lost (<xref rid="fig6" ref-type="fig">Figure 6A</xref>, C and D). Mon1a and Mon1b are mammalian homologs of worm SAND-1. In SUM159 cells, mEGFP-tagged endogenous Mon1a (<xref rid="fig6s1" ref-type="fig">Figure 6-figure supplement 1B</xref>) is localized on both Rab5-positive EEs and Rab7-positive late endosomes (<xref rid="fig6s1" ref-type="fig">Figure 6-figure supplement 1C</xref> and D). In contrast, endogenous Mon1b (<xref rid="fig6s1" ref-type="fig">Figure 6-figure supplement 1E</xref>) is more localized on late endosomes (<xref rid="fig6s1" ref-type="fig">Figure 6-figure supplement 1F</xref> and G). When the expression of USP8 in the mEGFP-Mon1a<sup>+/+</sup> or mEGFP-Mon1b<sup>+/+</sup> cells was knocked down by siRNA, we found that the number of vesicles positive for mEGFP-Mon1a or mEGFP-Mon1b was greatly reduced (<xref rid="fig6s1" ref-type="fig">Figure 6-figure supplement 1H</xref> and I). Taken together, these results indicate that the function of USP8/USP-50 in endosomal localization of SAND-1/Mon1-Ccz1 is evolutionarily conserved. We noticed that when <italic>sand-1</italic> is mutated, the EEs are enlarged (<xref rid="fig6" ref-type="fig">Figure 6J-L</xref> and <xref rid="fig6s1" ref-type="fig">Figure 6-figure supplement 1H</xref>) and late endosomes/lysosomes become smaller (<xref rid="fig6" ref-type="fig">Figure 6M-O</xref> and <xref rid="fig6s1" ref-type="fig">Figure 6-figure supplement 1I</xref>), which is highly similar to <italic>usp-50</italic> mutants. Furthermore, co-IP experiments indicated that the USP-50 protein is able to bind to SAND-1 (<xref rid="fig6" ref-type="fig">Figure 6P</xref>), which is consistent with the role of USP-50 in endosomal localization of SAND-1.</p>
<fig id="fig6" position="float" orientation="portrait" fig-type="figure">
<label>Figure 6.</label>
<caption><title>Loss of <italic>usp-50/usp8</italic> disrupts SAND-1/Mon1 localization</title>
<p>(A-C) The reduction of punctate GFP::SAND-1 signals in <italic>rabx-5(null)</italic> and <italic>usp-50(xd413)</italic> mutant animals. (D) Line scan analyses for (A-C). (E-G) The reduced lysosomes (labeled by LAAT-1::GFP) in <italic>rabx-5(null)</italic> and <italic>usp-50(xd413)</italic> mutant animals. (H-I) SUM159 cells genome-edited for mEGFP-Mon1a<sup>+/+</sup> (H) or mEGFP-Mon1b<sup>+/+</sup> (I) were treated with control siRNA or siRNA targeting USP8 and then imaged by spinning-disk confocal microscopy (starting from the bottom plane, spaced by 0.35 μm). The single frame image shows the distribution and area of Mon1a- or Mon1b-labeled endosomes near the middle plane. Quantification is shown on the right (Data are presented as mean ± SEM. ****<italic>P</italic>&lt;0.0001; unpaired Student’s t-test). Scale bar: 10 μm. (J-L) EEs (labeled by YFP::2xFYVE) are enlarged in <italic>sand-1(or552)</italic> mutants. (M-O) Late endosomes/lysosomes (labeled by LAAT-1::GFP) are smaller in <italic>sand-1(or552)</italic> mutants. (P) USP-50::MYC and SAND-1::4xFLAG were expressed in HEK293T cells via co-transfection, then immunoprecipitated with anti-FLAG beads and immunoblotted with antibodies against MYC and FLAG. (Q-S) The reduction of punctate GFP::RAB-7 signals in <italic>sand-1(or522)</italic> and <italic>usp-50(xd413)</italic> animals. (T) Line scan analyses for (Q-S). (U-W) Overexpressing <italic>rab-7</italic> suppresses the enlarged early endosome phenotype of <italic>usp-50</italic> mutants. EEs were detected with YFP::2xFYVE. (X) Quantification of the individual volume of YFP::2xFYVE vesicles in hypodermal cell 7 (hyp7) of L4 stage from 10 animals for wild-type, 13 animals for <italic>usp-50(xd413)</italic>, and 10 animals for the <italic>rab-7-</italic>expressing line (Data are presented as mean ± SEM. ****<italic>P</italic>&lt;0.0001; one-way ANOVA with Tukey’s test). (Y) Working models showing the role of USP-50 in endosome maturation. RABX-5-depdendent recruitment of USP-50 promotes the dissociation of RABX-5 from EEs and enhances the recruitment of SAND-1, thereby promoting the endosome maturation process. Scale bar represents 5 μm for (A-C, E-G, J-L, M-O, Q-S, U-W), 10 μm for (H and I).</p></caption>
<graphic xlink:href="575034v4_fig6.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
<p>SAND-1/Mon1 is a GEF for Rab7, and therefore a reduced level of SAND-1/Mon1 may decrease the endosomal distribution of Rab7 (<xref ref-type="bibr" rid="c27">Hiragi et al., 2022</xref>; <xref ref-type="bibr" rid="c53">Nordmann et al., 2010</xref>; <xref ref-type="bibr" rid="c85">Yong et al., 2023</xref>). Indeed, with the GFP::RAB-7 KI line, we found that the punctate RAB-7 signal was greatly reduced by loss of function of <italic>sand-1</italic> (<xref rid="fig6" ref-type="fig">Figure 6Q and R</xref>). In <italic>usp-50</italic> mutants, the punctate GFP::RAB-7 KI signal is also reduced (<xref rid="fig6" ref-type="fig">Figure 6S and T</xref>). Given the coupled phenotype of enlarged EEs and smaller late endosomes/lysosomes in both <italic>usp-50</italic> and <italic>sand-1</italic> mutants, we wondered whether increasing Rab7 would enhance the endosome maturation process, thus overriding the early endosome enlargement defect in <italic>usp-50</italic> mutants. Therefore, we overexpressed the wild-type <italic>rab-7</italic> gene and found that the early endosome enlargement phenotype of <italic>usp-50</italic> mutants was greatly suppressed (<xref rid="fig6" ref-type="fig">Figure 6U-X</xref>). In conclusion, we propose that the recruitment of USP-50/USP8, dependent on Rabex5, dissociates Rabex5 from EEs. Concurrently, this recruitment promotes the enrollment of SAND-1/Mon1-Ccz1, thereby facilitating the maturation of endosomes (<xref rid="fig6" ref-type="fig">Figure 6Y</xref>).</p>
</sec>
</sec>
<sec id="s3">
<title>Discussion</title>
<p>In this study, we identified that the recruitment of ubiquitin-specific protease USP-50/USP8 to EEs requires Rabex5. Instead of stabilizing Rabex5, the USP-50/USP8 recruitment dissociates Rabex5 from endosomes and meanwhile enrolls the Rab7 GEF SAND-1/Mon1. In <italic>usp-50/usp8</italic> loss-of-function cells, the RABX-5/Rabex5 signal is enhanced and the SAND-1/Mon1 protein fails to be localized onto endosomes. As a result, abnormal enlarged EEs are accumulated and the lysosomal structures become rudimentary.</p>
<p>Most studies of USP8 focus on endosomal trafficking of growth factor receptor tyrosine kinases (RTKs) in cultured vertebrate cells. In some cases, reduced USP8 activity results in accumulation of ubiquitinated cargos (<xref ref-type="bibr" rid="c4">Alwan and van Leeuwen, 2007</xref>; <xref ref-type="bibr" rid="c13">Bowers et al., 2006</xref>; <xref ref-type="bibr" rid="c50">Mizuno et al., 2006</xref>; <xref ref-type="bibr" rid="c62">Row et al., 2006</xref>). USP8 can also promote RTK stability (<xref ref-type="bibr" rid="c8">Berlin et al., 2010b</xref>; <xref ref-type="bibr" rid="c49">Mizuno et al., 2005</xref>; <xref ref-type="bibr" rid="c52">Niendorf et al., 2007</xref>). It is thought that USP8 promotes the recycling of cell surface receptors back to the plasma membrane or enhances their degradation depending on when and where it deubiquitinates its substrate along the recycling pathway (<xref ref-type="bibr" rid="c49">Mizuno et al., 2005</xref>; <xref ref-type="bibr" rid="c52">Niendorf et al., 2007</xref>; <xref ref-type="bibr" rid="c80">Wright et al., 2011</xref>). Besides EGFR, USP8 regulates the endocytic trafficking and/or stability of many other transmembrane proteins (<xref ref-type="bibr" rid="c46">Martín-Rodríguez et al., 2020</xref>; <xref ref-type="bibr" rid="c55">Peng et al., 2020</xref>; <xref ref-type="bibr" rid="c70">Sun et al., 2018</xref>; <xref ref-type="bibr" rid="c82">Xie et al., 2022</xref>; <xref ref-type="bibr" rid="c83">Xiong et al., 2022</xref>), but conclusions about the impact of USP8 on protein stability are highly diverse. The conflicting results may be caused by massive global ubiquitination and proteolytic stress triggered by depletion of USP8 or overexpression of a catalytically inactive enzyme.</p>
<p>Endosome maturation controls the sorting, processing, recycling, and degradation of incoming substances and receptors, and is thus responsible for regulation and fine-tuning of numerous pathways in cells. The Rab5 GEF Rabex5 can be recruited to EEs through an early endosomal targeting (EET) domain or by binding with ubiquitinated cargoes through its UBD region (<xref ref-type="bibr" rid="c48">Mattera and Bonifacino, 2008</xref>; <xref ref-type="bibr" rid="c89">Zhu et al., 2007</xref>). Notably, complex intramolecular interactions are extensively involved in Rabex5 function and dynamic localization (<xref ref-type="bibr" rid="c39">Lauer et al., 2019</xref>). Here, RABX-5 associates with USP-50 through multiple domains. Thus, in the context of <italic>usp8/usp-50</italic> deletion, the enhanced endosomal localization of Rabex5/RABX-5 may be caused by alterations in multiple inter- and intramolecular interactions. The GTP-bound active Rab5 recruits Rabaptin-5 resulting in a positive feedback loop of Rab5 activation on endosomal membranes (<xref ref-type="bibr" rid="c88">Zhang et al., 2014b</xref>). How is this positive feedback loop terminated? The role of Rabex5 in recruiting Rab7 GEF SAND-1/Mon1-Ccz1 is well established. Here, we further showed that the endosomal localization of USP-50 is also dependent on RABX-5. Thus, Rabex5 may recruit multifaceted negative regulators, which work subsequently or collaboratively to regulate endosome maturation. Late endosomes transport new lysosomal hydrolases and membrane proteins to lysosomes for the maintenance and amplification of the degradative compartment (<xref ref-type="bibr" rid="c84">Yang and Wang, 2021</xref>). Loss of worm <italic>usp-50</italic> results in reduced lysosome size. Previous studies also observed lysosome formation deficiency in fly <italic>ubpy/usp8</italic> knock-down fat cells (<xref ref-type="bibr" rid="c32">Jacomin et al., 2015</xref>; <xref ref-type="bibr" rid="c33">Jacomin et al., 2016</xref>). Removal of Rab5 and its replacement with Rab7 is an essential step in late endosome formation and in the transport of cargo to lysosomes (<xref ref-type="bibr" rid="c11">Borchers et al., 2021</xref>; <xref ref-type="bibr" rid="c86">Zeigerer et al., 2012</xref>). In the absence of USP8/USP-50, the RABX-5/Rabex5 signal is enhanced, but the endosomal localization of SAND-1/Mon1 is reduced, suggesting that in addition to Rabex5, USP8 is further needed to engage Rab7 GEF. The Mon1-Ccz1 complex can be recruited to various organelles through a variety of binding partners (<xref ref-type="bibr" rid="c25">Gao et al., 2018</xref>). Thus, recruited by Rabex5, USP8 may serve a linker specifically bridging endosomes to the Rab7 GEF. <italic>sand-1</italic> mutants display an almost identical phenotype to <italic>usp-50</italic> mutants, including enlarged EEs and much smaller late endosomes/lysosomes, implying that USP8/USP-50 functions similarly to SAND-1/Mon1-Ccz1. In <italic>usp-50</italic> mutants, the great reduction of RAB-7 signal is accompanied by a dramatically increased RAB-5 signal. Therefore, we suspect that the extended Rab5 activation in <italic>usp-50</italic> mutants actually prevents the Rab5-to-Rab7 conversion from occurring. Of course, we cannot rule out the possibility that the remaining SAND-1 is able to convert some of the Rab5 to Rab7, thus forming late endosomes to some degree. However, due to the quick conversion of late endosomes to lysosomes for degradation, most of the EEs remain clearly differentiated from late endosomes/lysosomes (<xref rid="fig2" ref-type="fig">Figure 2C and D</xref>; and <xref rid="fig2s1" ref-type="fig">Figure 2-figure supplement 1A</xref>). Overexpression of RAB-7 rescued the enlarged early endosome phenotype of <italic>usp-50</italic> mutants (<xref rid="fig6" ref-type="fig">Figure 6U-X</xref>), further supporting the idea that USP-50/USP8 downregulates Rab5 signaling and meanwhile promotes Rab7 activation, thus facilitating the EE-to-LE conversion. Together, we propose a working model, in which Rab5-coated vesicles recruit USP8, possibly through RABX-5-USP-50 interactions. Subsequently, USP8 dissociates Rabex5 from endosomes, meanwhile facilitating the recruitment of SAND-1/Mon1-Ccz1 complex to initiate LE formation (<xref rid="fig6" ref-type="fig">Figure 6Y</xref>).</p>
<p>Formation of ILVs is a hallmark of MVBs, which constitute morphologically distinct late endosomal structures that receive cargo in transit to the lysosomes. USP8 is important for the stability and ubiquitination status of various ESCRT components (<xref ref-type="bibr" rid="c2">Adoro et al., 2017</xref>; <xref ref-type="bibr" rid="c17">Crespo-Yàñez et al., 2018</xref>; <xref ref-type="bibr" rid="c47">Mathieu et al., 2022</xref>; <xref ref-type="bibr" rid="c50">Mizuno et al., 2006</xref>; <xref ref-type="bibr" rid="c52">Niendorf et al., 2007</xref>; <xref ref-type="bibr" rid="c87">Zhang et al., 2014a</xref>). Indeed, the punctate distribution of ESCRT-0 components is reduced significantly in <italic>usp-50</italic> worms (<xref rid="fig1" ref-type="fig">Figure 1G-H</xref>; and <xref rid="fig1s1" ref-type="fig">Figure 1-figure supplement 1B</xref>). By EM ultrastructural analysis, we found that a large number of abnormal vesicular structures accumulate in <italic>usp-50</italic> mutants and a large portion of them contain various intraluminal structures (<xref rid="fig2" ref-type="fig">Figure 2L-Q</xref>). In wild-type animals, MVBs are rarely observed, indicating that once formed, they rapidly fuse with lysosomes and are subsequently degraded. The loss of USP-50 results in the upregulation of Rab5 signaling, which may enhance the homophilic fusion of early endosomes (EEs). Given the substantial reduction in Rab7 levels and the marked diminution in lysosomal structures, it is likely that the aberrantly enlarged vesicles in <italic>usp-50</italic> mutants represent excessively enlarged EEs.</p>
<p>USP8 deubiquitinates numerous plasma membrane receptors, making this enzyme a promising target in cancer therapy to overcome chemoresistance associated with RTK stabilization (<xref ref-type="bibr" rid="c15">Byun et al., 2013</xref>; <xref ref-type="bibr" rid="c31">Islam et al., 2021</xref>). Gain-of-function mutations of USP8 have been found in microadenomas of patients with Cushing’s disease, a rare disease where the secretion of large amounts of adrenocorticotrophic hormone (ACTH) by pituitary corticotroph adenomas results in an excess of glucocorticoids and hypercortisolism, putatively due to defective EGFR sorting (<xref ref-type="bibr" rid="c44">Ma et al., 2015</xref>; <xref ref-type="bibr" rid="c60">Reincke et al., 2015</xref>). The role of USP8 in directing endosomal trafficking revealed here should shed new light on understanding its contribution to membrane receptor trafficking, resistance to chemotherapy, or EGFR stabilization in Cushing’s disease.</p>
</sec>
<sec id="s4">
<title>Materials and methods</title>
<sec id="s4a">
<title><italic>C. elegans</italic> genetics</title>
<p>Strain maintenance and genetic manipulations were performed as described(<xref ref-type="bibr" rid="c14">Brenner, 1974</xref>). The following strains were used in this study: linkage group (LG) I: <italic>stam-1(ok406)</italic>; LG III: <italic>rabx-5(xd548)</italic>; LG IV: <italic>sand-1(or552)</italic>; LG V: <italic>usp-50(gk632973)</italic>, <italic>usp-50(xd413)</italic>. Mutants and GFP knock-in strains for <italic>rabx-5</italic> are: <italic>xdKi58</italic> (<italic>rabx-5::gfp</italic> knock-in); <italic>xd571</italic> (<italic>rabx-5(K88R)::gfp</italic> knock-in), <italic>xd572</italic> (<italic>rabx-5(K323R)::gfp</italic> knock-in). Additional knock-in strains are: <italic>xdKi22</italic> (<italic>gfp::rab-5</italic> knock-in), <italic>xdKi18</italic> (<italic>gfp::rab-7</italic> knock-in). The reporter strains used in this work are listed as follows: <italic>xdEx2766</italic> (<italic>Psemo-1</italic>::GFP::RAB-5), <italic>xdEx2857</italic> (<italic>Psemo-1</italic>::mCherry::RAB-5), <italic>xdEx2860</italic> (<italic>Psemo-1</italic>::USP-50::GFP), <italic>xdEx2863</italic> (<italic>Psemo-1</italic>::mCherry::RAB-7), <italic>xdEx2991</italic> (<italic>Psemo-1</italic>::USP-50(C492A)::GFP), <italic>xdEx2949</italic> (<italic>Psemo-1</italic>::GFP::SAND-1), <italic>qxIs354</italic> (<italic>Pced-1</italic>::LAAT-1::GFP), <italic>qxIs257</italic> (<italic>Pced-1</italic>::NUC-1::nmCherry), <italic>qxIs352</italic> (<italic>Pced-1</italic>::LAAT-1::nmCherry), <italic>qxIs439</italic> (<italic>Psemo-1</italic>::GFP::TRAM), <italic>qxEx3928</italic> (<italic>Psemo-1</italic>::MANS::GFP), <italic>yqIs75</italic> (<italic>Pvps-29</italic>::VPS-29::GFP), <italic>bIs46 (Pvit-2::GFP::RME-1)</italic>, <italic>opIs334 (Pced-1::YFP::2xFYVE)</italic>, and <italic>Phgrs-1</italic>::HGRS-1::GFP. The CRISPR/Cas9-mediated genome editing strains were generated by Sunny Biotech and were verified with DNA sequencing. All strains were outcrossed with wild type twice before use.</p>
</sec>
<sec id="s4b">
<title><italic>C. elegans</italic> gene expression constructs</title>
<p>The complete <italic>usp-50</italic> cDNA was provided by Yuji Kohara (National Institute of Genetics, Japan). The full-length wild-type and C492A mutant <italic>usp-50</italic> cDNAs were cloned into dpSM vector. The P<italic>usp-50,</italic> P<italic>semo-1</italic>, P<italic>myo-3</italic>, and P<italic>vha-6</italic> promoters were cloned into dpSM upstream of the <italic>usp-50</italic> cDNA. The human <italic>usp8</italic> cDNA was cloned into dpSM vector after the P<italic>usp-50</italic> promoter. To express USP-50, SAND-1, RAB-5 or RAB-7 in hyp7, the P<italic>semo-1</italic> promoter was cloned into dpSM vector, followed by GFP, mCherry, or corresponding cDNAs. The full-length and truncated forms of <italic>rabx-5, sand-1</italic> or <italic>usp-50</italic> cDNAs were cloned into pcDNA3.0 with MYC tag, or pCS2 with 4xFLAG tag. The N-terminus of EEA1 was cloned into pGEX4T-1 vector. All constructs were confirmed by DNA sequencing.</p>
</sec>
<sec id="s4c">
<title><italic>C. elegans</italic> imaging analysis</title>
<p>Images of LAAT-1::GFP with NUC-1::mCherry were collected from 3-day-old adults. Images of YFP::2xFYVE with LAAT-1::mCherry were collected from L4 worms. Images were captured by spinning-disk microscopy (Observer Z1; Carl Zeiss). The co-localization analysis was performed with ImageJ software with Pearson correlation coefficient. At least 10 worms were examined. Fluorescence images of worms expressing LAAT-1::GFP, NUC-1::mCherry at adult day 3 and YFP::2xFYVE, HGRS-1::GFP, GFP::RAB-5 at the L4 stage were captured by spinning-disk microscopy (Observer Z1, Carl Zeiss) in 10-20 z-series (0.3μm/section). A 3D view was reconstituted from the serial optical sections and the number and volume of endosomes and lysosomes were measured using Volocity software (PerkinElmer). At least 10 worms were examined for every genotype at each given developmental stage.</p>
<p>To quantify the fluorescence intensity of USP-50::GFP, RABX-5::GFP, GFP::SAND-1 and GFP::RAB-7, images of strains for comparison were captured with a 63x objective. Mean fluorescence intensity was determined by ImageJ software (National Institute of Health). For line scan analyses, fluorescence intensity values along the solid lines of a given image were extracted with ImageJ software and plotted using Graphpad Prism 8.</p>
</sec>
<sec id="s4d">
<title><italic>C. elegans</italic> high-pressure freezing electron microscopy</title>
<p>Young adult worms were cryofixed on a Leica Microsystems HPM 100 and frozen in liquid nitrogen. After high-pressure freezing, the samples were washed four times in acetone and stained with 1% uranyl acetate for 1 hour. The infiltration was performed by increasing the concentration of SPI-PON 812. Samples were placed in fresh resin in an embedding mold and polymerized in 60°C oven for 3 days. Thin sections (60 nm) were produced with a diamond knife (Diatome) on an ultramicrotome (Ultracut UC7; Leica Microsystems). Sections were pictured with a JEM-1400 TEM (Hitachi HT7700), operating at 80 kV. Pictures were recorded on a Gatan832 4 k × 2.7 k CCD camera. The sizes of vesicles detected in EM were evaluated by NIH ImageJ.</p>
</sec>
<sec id="s4e">
<title><italic>C. elegans</italic> protein expression and protein-protein interactions</title>
<p>HEK293T cells were cultured at 37°C with 5% CO<sub>2</sub> in DMEM supplemented with 10% FBS (Hyclone). Transfections were performed with Lipofectamine 3000 (Invitrogen) according to the manufacturer’s instructions. Cultured cells were harvested 24-48 hours after transfection. For immunoprecipitation (IP), whole-cell extracts were collected 24-48 hours after transfection and lysed in RIPA buffer (1% [vol:vol] Triton X-100, 100 mM Tris-HCl, 50 mM EDTA, 150 mM NaCl, 1% deoxycholate, 0.1% SDS with protease inhibitor cocktail (Roche, 04693132001). Worms were lysed with 1% Nonidet P-40 worm lysis buffer (40 mM Tris-HCl, 150 mM NaCl, 1% NP-40) and homogenized with a Dounce homogenizer (Cheng-He Company, Zhuhai, China) on ice for 10 min. Both cell lysates and worm lysates were centrifuged at 12,000 rpm for 15 min at 4°C and the protein supernatants were incubated with anti-FLAG M2 affinity gel or GFP Nanoab-Agarose. After 8 hours of incubation, the agarose beads were washed with lysis buffer. For protein purification, the immunoprecipitated samples were eluted with 3xFLAG peptide or glycine (pH 2.5) neutralized with Tris buffer (pH 10.4). Immunoprecipitated samples or whole cell lysates were resolved by SDS-PAGE, then transferred to nitrocellulose membranes (Pall Life Sciences). Membranes were blocked with 5% dried milk and signals were visualized with Pierce<sup>TM</sup> ECL western blotting substrate (Thermo Fisher Scientific, 34095).</p>
</sec>
<sec id="s4f">
<title><italic>C. elegans</italic> GTP-RAB-5 pull-down assay</title>
<p>GST or the GST-EEA1-NT fusion protein was expressed in <italic>E. coli</italic> BL21 (DE3) and induced with 0.2 mM IPTG for 12 hours at 25°C. Bacterial pellets were lysed by sonication in PBS buffer containing 1% Triton X-100, 1 mM phenylmethylsulphonyl fluoride, and protease inhibitor cocktail. GST or the GST fusion protein was purified using a glutathione Sepharose 4B column (GE Healthcare). GFP::RAB-5 protein from wild-type or <italic>usp-50(xd413)</italic> mutant GFP::RAB-5 KI worms was collected and washed with M9 buffer. Worm lysis buffer containing 1% Nonidet P-40 was then added and samples were disrupted with a Dounce homogenizer on ice for 10 minutes. Debris was removed by centrifuging at 12,000 rpm for 15 minutes at 4°C. The GFP::RAB-5 input in each experiment was equalized before the pull-down assay. The worm lysates were incubated with GST or GST-EEA1-NT coupled to glutathione Sepharose 4B for 4 hours at 4°C. After washing five times, the GFP::RAB-5 protein was analyzed by 12% SDS-PAGE followed by standard western blotting with anti-GFP antibody.</p>
</sec>
<sec id="s4g">
<title><italic>C. elegans</italic> membrane/cytoplasm ratio of GFP::RAB-5</title>
<p>Images of GFP::RAB-5 KI worms were collected at the L4 stage using spinning-disk microscopy (Observer Z1, Carl Zeiss). The total fluorescence intensity and membranous fluorescence intensity were measured using Volocity software (PerkinElmer). The cytosol fluorescence intensity was measured as total fluorescence intensity minus the membranous fluorescence intensity. Then the membrane/cytoplasm fluorescence intensity ratio was measured. At least 10 worms were examined for each genotype.</p>
</sec>
<sec id="s4h">
<title><italic>C. elegans</italic> antibodies and reagents</title>
<p>The primary antibodies used were: anti-GFP (Abcam, ab290), anti-FLAG (Sigma-Aldrich, F1804), anti-tubulin (Sigma-Aldrich, T5168), anti-myc (Santa Cruz Biotechnology, sc-40). The secondary antibodies used were: goat anti-rabbit IgG-HRP (Santa Cruz Biotechnology, sc-2004) and goat anti-mouse IgG-HRP (Santa Cruz Biotechnology, sc-2005). Anti-FLAG M2 Agarose Affinity Gel (A2220) and 3xFLAG Peptide (F4799) were from Sigma-Aldrich. GFP-Nanoab-Agarose was from Lablead (GNA-50-1000) and Glutathione Sepharose 4B was from GE Healthcare (17075601).</p>
</sec>
<sec id="s4i">
<title><italic>C. elegans</italic> statistical analysis</title>
<p>For each western blot, at least three replications were chosen for quantitative analysis with NIH ImageJ following the published protocol (<xref ref-type="bibr" rid="c24">Gallo-Oller et al., 2018</xref>). All graphical data are presented as mean ±SEM. Two-tailed unpaired Student’s t-tests were performed for comparison between two groups of samples. To compare multiple groups, one-way analysis of variance (ANOVA) followed by Tukey’s post-test was performed. The P values are represented as follows: *P&lt; 0.05, **P&lt; 0.01, ***P&lt; 0.001, ****P&lt; 0.0001 and NS (not significant, *P&gt;0.05).</p>
</sec>
<sec id="s4j">
<title>Cell culture</title>
<p>The human breast cancer SUM159 cells, kindly provided by J. Brugge (Harvard Medical School, Boston, MA), were confirmed by STR genotyping and verified to be mycoplasma-free using the TransDetect PCR Mycoplasma Detection Kit (TransGen Biotech). SUM159 cells were cultured at 37°C and 5% CO<sub>2</sub> in DMEM/F-12 (Corning), supplemented with 5% FBS (Gibco), 100 U/ml penicillin, streptomycin (Corning), 1 μg/ml hydrocortisone (Sigma-Aldrich), 5 μg/ml insulin (Sigma-Aldrich), and 20 mM HEPES (Corning), pH 7.4.</p>
</sec>
<sec id="s4k">
<title>Plasmids and transfection</title>
<p>The cDNA sequence of human Rabex5 was amplified from SUM159 cDNA and inserted into a vector containing mEGFP or mScarlet-I to generate the plasmids Rabex5-mEGFP and Rabex5-mScarlet-I using the Gibson assembly method (pEASY-Uni Seamless Cloning and Assembly Kit, TransGen Biotech). The cDNA sequences of human Rab7a, Lamp1, EEA1, Rab5c were amplified from the related cDNA clones and inserted into the mScarlet-I-, mEGFP-, or Halo-containing vectors to generate the plasmids mScarlet-I-Rab7A, Lamp1-mScarlet-I, mScarlet-I-EEA1, mScarlet-I-Rab5c, mEGFP-Rab5c, or Halo-Rab5c using the Gibson assembly method. Transfections were performed using Lipofectamine 3000 Transfection Reagent (Invitrogen) according to the manufacturer’s instructions. Cells expressing fluorescently-tagged proteins at relatively low levels were imaged 16–20 hours after transfection.</p>
</sec>
<sec id="s4l">
<title>Genome editing of SUM159 cells to generate mEGFP-USP8<sup>+/+</sup>, mEGFP-Mon1a<sup>+/+</sup> or mEGFP-Mon1b<sup>+/+</sup> cells using the CRISPR/Cas9 approach</title>
<p>SUM159 cells were genome-edited to incorporate mEGFP at the N-terminus of USP8, Mon1a, and Mon1b using the CRISPR/Cas9 approach as described (<xref ref-type="bibr" rid="c26">He et al., 2017</xref>; <xref ref-type="bibr" rid="c59">Ran et al., 2013</xref>). The single-guide RNAs (sgRNA) targeting human USP8 (5’-ATGCAGATTAGATCGTGATG-3’), human Mon1a (5’-GGATGGCTACTGACATGCAG-3’), or human Mon1b (5’-GATGTGCAGATGGAGGTCGG-3’) were cloned into pSpCas9(BB)-2A-Puro (PX459) (Addgene #48139). The donor constructs used for homologous recombination were generated by cloning into the pUC19 vector with two ∼600-800-nucleotide fragments of genomic DNA upstream and downstream of the start codon of human USP8, Mon1a, and Mon1b, and the open reading frame of mEGFP using the pEASY-Uni Seamless Cloning and Assembly Kit (TransGen Biotech). A flexible (GGS)<sub>3</sub> linker was inserted between the start or stop codon of the gene and the open reading frame of mEGFP. 4-5 days after transfection with the donor plasmid and PX459 plasmid containing sgRNA targeting sequence, SUM159 cells expressing mEGFP were enriched by fluorescence-activated cell sorting (FACSAria Fusion, BD Biosciences). The sorted positive cells were expanded and then subjected to single-cell sorting into 96-well plates. The genome-edited monoclonal cell populations were identified by PCR (GoTaq Polymerase, Promega) and then verified by western blot analysis and imaging.</p>
</sec>
<sec id="s4m">
<title>Genome editing of SUM159 cells to generate CLTA-miRFP670nano<sup>+/+</sup> cells using the TALEN-based approach</title>
<p>SUM159 cells were genome-edited to incorporate miRFP670nano into the C terminus of clathrin light chain A (CLTA) using a TALEN-based protocol as described (<xref ref-type="bibr" rid="c26">He et al., 2017</xref>; <xref ref-type="bibr" rid="c59">Ran et al., 2013</xref>). SUM159 cells were transfected with 800 ng each of the upstream and downstream TALEN targeting sequences and the donor construct using Lipofectamine 3000 (Invitrogen) according to the manufacturer’s instructions. The monoclonal cell line with both alleles edited for CLTA-miRFP670nano was generated as described above.</p>
</sec>
<sec id="s4n">
<title>Knockout of USP8 using the CRISPR/Cas9 approach</title>
<p>Knockout of USP8 in SUM159 cells was performed using the CRISPR/Cas9 approach as described (<xref ref-type="bibr" rid="c26">He et al., 2017</xref>; <xref ref-type="bibr" rid="c59">Ran et al., 2013</xref>). The sgRNA targeting the human USP8 gene (5’-ATGCAGATTAGATCGTGATG-3’) was cloned into pSpCas9(BB)-2A-Halo. pSpCas9(BB)-2A-Halo was generated by replacing GFP with HaloTag in pSpCas9(BB)-2A-GFP (PX458) (Addgene #488138). SUM159 cells were transfected with 1000 ng of the plasmid containing the sgRNA targeting sequence using Lipofectamine 3000. 24 hours after transfection, the cells expressing HaloTag were subjected to single-cell sorting into 96-well plates (FACSAria Fusion, BD Biosciences). The monoclonal cell populations with frameshift deletions in both alleles of <italic>USP8</italic> were identified by sequencing and confirmed by western blot analysis.</p>
</sec>
<sec id="s4o">
<title>Knock-down of USP8 expression by siRNA</title>
<p>The siRNA (GenePharma) used to knock down the expression of USP8 was transfected into cells by using Lipofectamine RNAiMAX (Invitrogen) according to the manufacturer’s instructions. The siRNA sequence targeting human <italic>USP8</italic> was 5’-CCAAAGAGAAAGGAGCAAT-3’(<xref ref-type="bibr" rid="c34">Jing et al., 2020</xref>). The non-targeting siRNA mixture (5’-ATGTATTGGCCTGTATTAG-3’, 5’-GCGACGATCTGCCTAAGAT-3’, and 5’-TTTCCGCACTGTGATTCGG-3’) was used as a control. Knock-down of USP8 by siRNA was achieved by two sequential transfections on day 1 and day 3 (cells plated on day 0), followed by analysis on day 5.</p>
</sec>
<sec id="s4p">
<title>Live-cell imaging by spinning-disk confocal microscopy and imaging analysis</title>
<p>The spinning-disk confocal microscope was built on the Nikon TiE microscope as described (<xref ref-type="bibr" rid="c9">Bi et al., 2021</xref>). Briefly, the microscope was equipped with a CFI Apochromat SD 100X objective (1.46 NA, Nikon), a Motorized XY stage (Prior Scientific), a fully enclosed and environmentally controlled cage incubator (Okolab), OBIS 488, 561 and 647 nm lasers (Coherent), a CSU-X1 spinning-disk confocal unit (Yokogawa) and an EMCCD camera (iXon Ultra 897, Andor Technology). Images were acquired using Micro-Manager 2.0 (<xref ref-type="bibr" rid="c22">Edelstein et al., 2010</xref>).</p>
<p>SUM159 cells were plated on single-well confocal dishes (Cellvis) approximately 6-8 hours after transfection. Cells expressing relatively low levels of the endosome makers were imaged from the bottom surface (Z = 1) to the middle plane (spaced 0.35 μm) in phenol-free DMEM/F12 (Corning) containing 5% FBS and 20 mM HEPES. Single frames or merge images were generated in Fiji (<xref ref-type="bibr" rid="c64">Schindelin et al., 2012</xref>). To quantify the areas and numbers of the fluorescently labeled Rab5c, Rabex5, or EEA1 spots per cell, the cell boundary was firstly manually segmented based on the fluorescence of the cell in Fiji (<xref ref-type="bibr" rid="c64">Schindelin et al., 2012</xref>). The raw image and the segmented cell boundary were then loaded into Cellprofiler 4 (<xref ref-type="bibr" rid="c68">Stirling et al., 2021</xref>) (<ext-link ext-link-type="uri" xlink:href="http://www.cellprofiler.org">http://www.cellprofiler.org</ext-link>) to detect the numbers and areas of spots in the middle plane of the cell (optical section Z = 4). Finally, these results were exported from Cellprofiler 4 and further analyzed and plotted using GraphPad Prism 9.</p>
<p>For live-cell imaging and tracking of USP8 recruitment to Rab5-positive carriers, USP8-mEGFP<sup>+/+</sup> cells were transiently transfected with mScarlet-I-Rab5c, and then imaged at two planes (the bottom plane and the plane 0.5 μm above the bottom plane) every 2 seconds for 60 seconds by spinning-disk confocal microscopy. The maximum fluorescence intensity projection of the two imaging planes was generated using Fiji and was used for further imaging analysis. The detection and tracking of Rab5-positive carriers in the time-lapse series were performed using the TrackMate 7 plugin in Fiji (<xref ref-type="bibr" rid="c23">Ershov et al., 2022</xref>; <xref ref-type="bibr" rid="c73">Tinevez et al., 2017</xref>). The mScarlet-I-Rab5c channel was used for spot detection and tracking. Then the fluorescence intensities of mScarlet-I-Rab5c and USP8-mEGFP were extracted and plotted. Montages were generated using the Multi Kymograph plugin in Fiji.</p>
</sec>
<sec id="s4q">
<title>Imaging by SIM</title>
<p>Imaging of the sub-organelle distribution of USP8 on EEs was performed on the multi-SIM system as described (<xref ref-type="bibr" rid="c58">Qiao et al., 2022</xref>). The mEGFP-USP8<sup>+/+</sup> cells transiently expressed relatively low levels of mScarlet-I-EEA1 and the images were acquired with a CFI SR HP Apo TIRF 100X objective (1.49 NA, Nikon) and a sCMOS camera (Kinetix, TELEDYNE PHOTOMETRICS).</p>
</sec>
<sec id="s4r">
<title>Western blot analysis</title>
<p>SUM159 cells were lysed at 4°C for 20 minutes with RIPA lysis buffer (Sigma-Aldrich) containing a protease inhibitor cocktail (Thermo Scientific), and then pelleted at 12,000 g for 15 minutes at 4°C. The supernatant was mixed with 5× sample buffer (MB01015, GenScript), heated to 100°C for 8-10 minutes, and then fractionated by SDS–PAGE (TGX FastCast AcrylamideKit, 10%, Bio-Rad) and transferred to nitrocellulose membranes (PALL). The membranes were incubated in TBST buffer containing 5% skim milk for 1 hour at room temperature, followed by overnight incubation at 4°C with the specific primary antibodies. After three washes in TBST (5 min each), the membranes were incubated with the appropriate HRP-conjugated secondary antibody (Beyotime, 1:1,000) at room temperature for 1 hour. The membrane was incubated with the SignalFire<sup>TM</sup> ECL Reagent (Cell Signaling) or BeyoECL Moon (Beyotime) and imaged by the Tanon-5200 Chemiluminescent Imaging System (Tanon). The primary antibodies used in this study were: USP8 (sc-376130, 1:500, Santa Cruz), GFP (14-6674-82, 1:1,000, Invitrogen), EEA1 (610456, 1:1,000, BD Biosciences), GAPDH (60004-1-Ig, 1:50,000, Proteintech).</p>
</sec>
<sec id="s4s">
<title>Immunofluorescence</title>
<p>For immunofluorescence staining, cells were cultured on small coverslips (801010, NEST) coated with PDL. Cells were washed with PBS once, and then fixed using 4% PFA (157-8, Electron Microscopy Sciences) for 20 minutes at room temperature. After washing with PBS for three times, the samples were incubated with 0.5% Triton X-100 in PBS for 15 minutes at room temperature. Then the samples were incubated in the blocking buffer (1% BSA in PBS) for 60 minutes at room temperature. Afterwards, the samples were incubated with the primary antibody against EEA1 (1:200 in 1% BSA) overnight at 4°C. After washing with PBS for five times, the samples were incubated with the Alexa Fluor 488- or 555-conjugated secondary antibodies (1:500 in 1% BSA, Thermo Fisher) for 60 minutes at room temperature. After washing with PBS for five times and ddH<sub>2</sub>O once, the coverslip was mounted on a slide with the FluorSave<sup>TM</sup>Reagent (Merck, 345789-20ML). The prepared samples were imaged by the spinning-disk confocal microscope described above.</p>
</sec>
</sec>
</body>
<back>
<ack>
<title>Acknowledgments</title>
<p>We thank Drs. Xiaochen Wang, Chonglin Yang, Qi Xie, Hong Zhang, Yuji Kohara, Xun Huang, Luke D. Lavis, Tom Kirchhausen, Joan Brugge, the Million Mutation Project, and the Caenorhabditis Genetics Center for providing reagents, strains, and technical support. This work was supported by the National Key R&amp;D Program of China (2021YFA0805802 to M.D. and 2022YFA1304500 and 2021YFA0804802 to K.H.) and the National Natural Science Foundation of China (32070810 and 31921002 to M.D. and 32321004 and 92354305 to K.H.).</p>
</ack>
<sec id="s5">
<title>Figure supplements</title>
<fig id="fig1s1" position="float" orientation="portrait" fig-type="figure">
<label>Figure 1-figure supplement 1.</label>
<caption><title>ESCRT-0 components are stabilized by <italic>usp-50</italic>.</title>
<p>(A) Pearson’s correlation coefficient for co-localization of the lysosome membrane protein LAAT-1 (LAAT-1::GFP) and the lysosomal nuclease NUC-1 (NUC-1::mCherry) in wild-type and <italic>usp-50(xd413)</italic> animals. ns, not significant. Unpaired Student’s t-test was performed. (B) Quantification of the individual volume, total volume, and number of HGRS-1::GFP puncta in hypodermal cell 7 (hyp7) of L4 stage from 10 animals for wild-type, <italic>usp-50(gk632973)</italic> and <italic>usp-50(xd413)</italic> respectively. (Data are presented as mean ± SEM. ****<italic>P</italic>&lt;0.0001; one-way ANOVA with Tukey’s test).</p></caption>
<graphic xlink:href="575034v4_fig1s1.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
<fig id="fig2s1" position="float" orientation="portrait" fig-type="figure">
<label>Figure 2-figure supplement 1.</label>
<caption><title><italic>usp-50</italic> functions cell-autonomously.</title><p>(A) Pearson’s correlation coefficient for co-localization of EEs (labeled with YFP::2xFYVE) and lysosomes (labeled with LAAT-1:: mCherry) in wild-type and <italic>usp-50(xd413)</italic> animals. ns, not significant. Unpaired Student’s t-test was performed. (B) Quantification of the volume of individual EEs in various genotypes. Data are presented as mean ± SEM. ****<italic>P</italic>&lt;0.0001. ns, not significant; one-way ANOVA with Tukey’s test. (C) The CRISPR/Cas9 genome-editing tool was used to knock out the expression of USP8 (USP8-KO) in SUM159 cells. Knockout of USP8 was confirmed by western blot analysis using antibodies against USP8 and GAPDH.</p></caption>
<graphic xlink:href="575034v4_fig2s1.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
<fig id="fig2s2" position="float" orientation="portrait" fig-type="figure">
<label>Figure 2-figure supplement 2.</label>
<caption><title>Mutation of <italic>usp-50</italic> does not affect other organelles.</title>
<p>(A-C) In <italic>usp-50</italic> mutant animals, no obvious alterations are detected in Golgi apparatus (MANS::GFP) (A), recycling endosomes (GFP::RME-1) (B) or retromers (VPS-29::GFP) (C). Confocal fluorescence images of the hypodermis were captured at L4 stage. Scale bars represent 5 μm.</p></caption>
<graphic xlink:href="575034v4_fig2s2.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
<fig id="fig3s1" position="float" orientation="portrait" fig-type="figure">
<label>Figure 3-figure supplement 1.</label>
<caption><title>The EE localization of USP-50 and USP8.</title>
<p>(A) USP-50::GFP is co-localized with mCherry::RAB-5 in hypodermal cell 7 (hyp7) of wild-type animals at L4 stage. (B) USP-50::GFP is not co-localized with mCherry::RAB-7 in hypodermal cell 7 (hyp7) of wild-type animals at L4 stage. (C) USP-50::GFP(C492A) is co-localized with mCherry::RAB-5 in hypodermal cell 7 (hyp7) and causes enlarged EEs. Scale bar represents 5 μm for (A-C) and 10 μm for enlarged inserts.</p></caption>
<graphic xlink:href="575034v4_fig3s1.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
<fig id="fig3s2" position="float" orientation="portrait" fig-type="figure">
<label>Figure 3-figure supplement 2.</label>
<caption><title>The generation of endogenous tagged USP8.</title>
<p>(A) CRISPR/Cas9 genome-editing strategy used to incorporate mEGFP at the C-terminus of USP8 in SUM159 cells. The target sequence at the genomic <italic>USP8</italic> locus recognized by the single-guide RNA is highlighted by the blue nucleotides. The stop codon TAA (red) and the site of mEGFP incorporation upon homologous recombination are highlighted. (B) Genomic PCR analysis showing biallelic integration of mEGFP into the <italic>USP8</italic> genomic locus to generate the clonal gene-edited cell line USP8-mEGFP<sup>+/+</sup>. (C) Western blot analysis of cell lysates probed with antibodies for USP8 and GAPDH. The endogenous and mEGFP-tagged USP8 are indicated by arrows.</p></caption>
<graphic xlink:href="575034v4_fig3s2.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
<fig id="fig5s1" position="float" orientation="portrait" fig-type="figure">
<label>Figure 5-figure supplement 1.</label>
<caption><title>USP8 inhibits the EE localization of Rabex5.</title>
<p>(A) USP8-KO leads to enlarged EEs and enhanced Rabex5 (Rabex5-mEGFP<sup>+/+</sup>) and Rab5 (mScarlet-I-Rab5c) signals. Rabex5-mEGFP<sup>+/+</sup> SUM159 cells with or without USP8 expression were transiently transfected with mScarlet-I-Rab5c and then imaged by spinning-disk confocal microscopy. Images show the intracellular distribution of Rabex5-mEGFP and mScarlet-I-Rab5c. Scale bar: 10 μm. (B) Quantification of the number of Rabex5-mEGFP spots in Rabex5-mEGFP<sup>+/+</sup> cells. 30 wild-type and 30 USP8-KO cells were scored (*<italic>P</italic>&lt;0.05 using an unpaired, two-sample Student’s test). (C) Quantification of the number of large Rabex5-mEGFP spots (diameter &gt; 0.5 μm) in Rabex5-mEGFP<sup>+/+</sup> cells. 30 wild-type and 30 USP8-KO cells were scored (****<italic>P</italic>&lt;0.0001 using an unpaired, two-sample Student’s test). (D) Enlarged EEs in USP8-KO SUM159 cells contain both Rabex5 (detected via knock-in of Rabex5-mEGFP) and EEA1 (detected by anti-EEA1). The wild-type and USP8-KO Rabex5-mEGFP<sup>+/+</sup> cells were transiently immuno-stained by anti-EEA1 antibody, and then imaged by spinning-disk confocal microscopy. Scale bar: 10 μm. Enlarged inserts: 2 μm. (E) The CRISPR/Cas9 genome-editing tool was used to knock out of USP8 expression (USP8-KO) in Rabex5-mEGFP<sup>+/+</sup> SUM159 cells. Knockout of USP8 was confirmed by western blot analysis using antibodies against USP8 and GAPDH.</p></caption>
<graphic xlink:href="575034v4_fig5s1.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
<fig id="fig5s2" position="float" orientation="portrait" fig-type="figure">
<label>Figure 5-figure supplement 2.</label>
<caption><title>Loss of <italic>usp-50/USP8</italic> leads to more activated RAB-5.</title>
<p>(A-B) The GFP::RAB-5 KI signal in wild type (A) and <italic>usp-50(xd413)</italic> (B). Scale bar: 5 μm. (C) Quantification of the volume of individual RAB-5::GFP KI vesicles in L4 animals (10 animals for wild-type and 11 animals for <italic>usp-50(xd413)</italic>). Data are presented as mean ± SEM. ****<italic>P</italic>&lt;0.0001. unpaired Student’s t-test. (D) Quantification of the relative GFP::RAB-5 KI signal on membrane vs. cytosol in hypodermal cell 7 (hyp7) of L4 animals. 10 animals for wild-type, 10 animals for <italic>usp-50(xd413)</italic>. ***<italic>P</italic>&lt;0.001; unpaired Student’s t-test. (E) Coomassie blue staining of purified GST-EEA1-NT protein. (F) More GFP::RAB-5 is pulled down by GST-EEA1-NT protein in <italic>usp-50(xd413)</italic> mutants. (G) The GFP::RAB-5 protein level is increased in <italic>usp-50(xd413)</italic> mutants. (H) Quantification of GFP::RAB-5 protein level in wild-type and <italic>usp-50(xd413)</italic> mutant animals from three independent experiments. ****<italic>P</italic>&lt;0.0001; unpaired Student’s t-test. (I) Knockdown of USP8 (USP8-KD) leads to enlarged EEs in genome-edited SUM159 cells expressing EGFP-Rab5c<sup>+/+</sup>. EGFP-Rab5c<sup>+/+</sup> cells were treated with control siRNA (NC) or siRNA targeting USP8, and then imaged by spinning-disk confocal microscopy. Scale bar: 10 μm. Enlarged insertions: 2 μm. (J) The numbers of Rab5c-positive endosomes in (I) with diameters greater than 1.5 μm were quantified in 30 cells of each genotype. Data are presented as mean ± SEM. ****<italic>P</italic>&lt;0.0001; unpaired Student’s t-test.</p></caption>
<graphic xlink:href="575034v4_fig5s2.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
<fig id="fig5s3" position="float" orientation="portrait" fig-type="figure">
<label>Figure 5-figure supplement 3.</label>
<caption><title>The ubiquitin modification sites on RABX-5</title>
<p>(A) Peptide sequences identified from the ubiquitination proteomics analysis. (B) The ubiquitinated sites of RABX-5 detected by ubiquitination proteomics analysis.</p></caption>
<graphic xlink:href="575034v4_fig5s3.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
<fig id="fig6s1" position="float" orientation="portrait" fig-type="figure">
<label>Figure 6-figure supplement 1.</label>
<caption><title>The distribution of endogenous Mon1a and Mon1b proteins.</title>
<p>(A) Quantification of the individual volume of LAAT-1::GFP vesicles in hyp7 of 3-day-old adults. Data are presented as mean ± SEM. ****<italic>P</italic>&lt;0.0001; one-way ANOVA with Tukey’s test. (B) Western blotting analysis of SUM159 cells genome-edited to express mEGFP-Mon1a<sup>+/+</sup> using antibodies against GFP and GAPDH. (C and D) Genome-edited mEGFP-Mon1a<sup>+/+</sup> SUM159 cells were transiently transfected with mScarlet-I-Rab5c (C) and mScarlet-I-Rab7a (D), and then imaged by spinning-disk confocal microscopy. mEGFP-Mon1a localizes to both EEs (mScarlet-I-Rab5c) and late endosomes (mScarlet-I-Rab7a). (E) Western blotting analysis of genome-edited mEGFP-Mon1b<sup>+/+</sup> SUM159 cells using antibodies against GFP and GAPDH. (F and G) mEGFP-Mon1b is not localized on EEs (E) but is localized on late endosomes (G). Genome-edited mEGFP-Mon1b<sup>+/+</sup> SUM159 cells were transiently transfected with mScarlet-I-Rab5c (F) and mScarlet-I-Rab7a (G), and then imaged by spinning-disk confocal microscopy. Scale bar represents 10 μm. (H) Quantification of the individual volume of YFP::2xFYVE vesicles in hypodermal cell 7 (hyp7) of L4 worms. 10 animals for wild-type, 13 animals for <italic>usp-50(xd413)</italic>, and 18 animals for <italic>sand-1(or552)</italic>. Data are presented as mean ± SEM. ****<italic>P</italic>&lt;0.0001; one-way ANOVA with Tukey’s test. (I) Quantification of the individual volume of LAAT-1::GFP vesicles in hyp7 of 3-day-old adults (19 animals for wild-type, 16 animals for <italic>usp-50(xd413)</italic>, and 13 animals for <italic>sand-1(or552)</italic>). Data are presented as mean ± SEM. ****<italic>P</italic>&lt;0.0001; one-way ANOVA with Tukey’s test.</p></caption>
<graphic xlink:href="575034v4_fig6s1.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
</sec>
<ref-list>
<title>References</title>
<ref id="c1"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Abenza</surname>, <given-names>J.F.</given-names></string-name>, <string-name><given-names>A.</given-names> <surname>Galindo</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Pantazopoulou</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Gil</surname></string-name>, <string-name><given-names>V.</given-names> <surname>de los Rios</surname></string-name>, and <string-name><given-names>M.A.</given-names> <surname>Penalva</surname></string-name></person-group>. <year>2010</year>. <article-title>Aspergillus RabB Rab5 integrates acquisition of degradative identity with the long distance movement of early endosomes</article-title>. <source>Mol. Biol. Cell</source>. <volume>21</volume>:<fpage>2756</fpage>–<lpage>2769</lpage>. <pub-id pub-id-type="doi">10.1091/mbc.e10-02-0119</pub-id></mixed-citation></ref>
<ref id="c2"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Adoro</surname>, <given-names>S.</given-names></string-name>, <string-name><given-names>K.H.</given-names> <surname>Park</surname></string-name>, <string-name><given-names>S.E.</given-names> <surname>Bettigole</surname></string-name>, <string-name><given-names>R.</given-names> <surname>Lis</surname></string-name>, <string-name><given-names>H.R.</given-names> <surname>Shin</surname></string-name>, <string-name><given-names>H.</given-names> <surname>Seo</surname></string-name>, <string-name><given-names>J.H.</given-names> <surname>Kim</surname></string-name>, <string-name><given-names>K.P.</given-names> <surname>Knobeloch</surname></string-name>, <string-name><given-names>J.H.</given-names> <surname>Shim</surname></string-name>, and <string-name><given-names>L.H.</given-names> <surname>Glimcher</surname></string-name></person-group>. <year>2017</year>. <article-title>Post-translational control of T cell development by the ESCRT protein CHMP5</article-title>. <source>Nat. Immunol</source>. <volume>18</volume>:<fpage>780</fpage>–<lpage>790</lpage>. <pub-id pub-id-type="doi">10.1038/ni.3764</pub-id></mixed-citation></ref>
<ref id="c3"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ali</surname>, <given-names>N.</given-names></string-name>, <string-name><given-names>L.</given-names> <surname>Zhang</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Taylor</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Mironov</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Urbé</surname></string-name>, and <string-name><given-names>P.</given-names> <surname>Woodman</surname></string-name></person-group>. <year>2013</year>. <article-title>Recruitment of UBPY and ESCRT exchange drive HD-PTP-dependent sorting of EGFR to the MVB</article-title>. <source>Curr. Biol</source>. <volume>23</volume>:<fpage>453</fpage>–<lpage>461</lpage>. <pub-id pub-id-type="doi">10.1016/j.cub.2013.02.033</pub-id></mixed-citation></ref>
<ref id="c4"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Alwan</surname>, <given-names>H.A.</given-names></string-name>, and <string-name><given-names>J.E.</given-names> <surname>van Leeuwen</surname></string-name></person-group>. <year>2007</year>. <article-title>UBPY-mediated epidermal growth factor receptor (EGFR) de-ubiquitination promotes EGFR degradation</article-title>. <source>J. Biol. Chem</source>. <volume>282</volume>:<fpage>1658</fpage>–<lpage>1669</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M604711200</pub-id></mixed-citation></ref>
<ref id="c5"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Babst</surname>, <given-names>M</given-names></string-name></person-group>. <year>2011</year>. <article-title>MVB vesicle formation: ESCRT-dependent, ESCRT-independent and everything in between</article-title>. <source>Curr. Opin. Cell Biol</source>. <volume>23</volume>:<fpage>452</fpage>–<lpage>457</lpage>. <pub-id pub-id-type="doi">10.1016/j.ceb.2011.04.008</pub-id></mixed-citation></ref>
<ref id="c6"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Balderhaar</surname>, <given-names>H.J.</given-names></string-name>, <string-name><given-names>J.</given-names> <surname>Lachmann</surname></string-name>, <string-name><given-names>E.</given-names> <surname>Yavavli</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Bröcker</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Lürick</surname></string-name>, and <string-name><given-names>C.</given-names> <surname>Ungermann</surname></string-name></person-group>. <year>2013</year>. <article-title>The CORVET complex promotes tethering and fusion of Rab5/Vps21-positive membranes</article-title>. <source>Proc. Natl. Acad. Sci. USA</source>. <volume>110</volume>:<fpage>3823</fpage>–<lpage>3828</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1221785110</pub-id></mixed-citation></ref>
<ref id="c7"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Berlin</surname>, <given-names>I.</given-names></string-name>, <string-name><given-names>K.M.</given-names> <surname>Higginbotham</surname></string-name>, <string-name><given-names>R.S.</given-names> <surname>Dise</surname></string-name>, <string-name><given-names>M.I.</given-names> <surname>Sierra</surname></string-name>, and <string-name><given-names>P.D.</given-names> <surname>Nash</surname></string-name></person-group>. <year>2010a</year>. <article-title>The deubiquitinating enzyme USP8 promotes trafficking and degradation of the chemokine receptor 4 at the sorting endosome</article-title>. <source>J. Biol. Chem</source>. <volume>285</volume>:<fpage>37895</fpage>–<lpage>37908</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M110.129411</pub-id></mixed-citation></ref>
<ref id="c8"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Berlin</surname>, <given-names>I.</given-names></string-name>, <string-name><given-names>H.</given-names> <surname>Schwartz</surname></string-name>, and <string-name><given-names>P.D.</given-names> <surname>Nash</surname></string-name></person-group>. <year>2010b</year>. <article-title>Regulation of epidermal growth factor receptor ubiquitination and trafficking by the USP8·STAM complex</article-title>. <source>J. Biol. Chem</source>. <volume>285</volume>:<fpage>34909</fpage>–<lpage>34921</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M109.016287</pub-id></mixed-citation></ref>
<ref id="c9"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bi</surname>, <given-names>G.</given-names></string-name>, <string-name><given-names>M.</given-names> <surname>Su</surname></string-name>, <string-name><given-names>N.</given-names> <surname>Li</surname></string-name>, <string-name><given-names>Y.</given-names> <surname>Liang</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Dang</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Xu</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Hu</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Wang</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Zou</surname></string-name>, <string-name><given-names>Y.</given-names> <surname>Deng</surname></string-name>, <string-name><given-names>Q.</given-names> <surname>Li</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Huang</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Li</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Chai</surname></string-name>, <string-name><given-names>K.</given-names> <surname>He</surname></string-name>, <string-name><given-names>Y.H.</given-names> <surname>Chen</surname></string-name>, and <string-name><given-names>J.M.</given-names> <surname>Zhou</surname></string-name></person-group>. <year>2021</year>. <article-title>The ZAR1 resistosome is a calcium-permeable channel triggering plant immune signaling</article-title>. <source>Cell</source>. <volume>184</volume>:<fpage>3528</fpage>–<lpage>3541.e3512.</lpage> <pub-id pub-id-type="doi">10.1016/j.cell.2021.05.003</pub-id></mixed-citation></ref>
<ref id="c10"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Borchers</surname>, <given-names>A.C.</given-names></string-name>, <string-name><given-names>M.</given-names> <surname>Janz</surname></string-name>, <string-name><given-names>J.H.</given-names> <surname>Schäfer</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Moeller</surname></string-name>, <string-name><given-names>D.</given-names> <surname>Kümmel</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Paululat</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Ungermann</surname></string-name>, and <string-name><given-names>L.</given-names> <surname>Langemeyer</surname></string-name></person-group>. <year>2023</year>. <article-title>Regulatory sites in the Mon1-Ccz1 complex control Rab5 to Rab7 transition and endosome maturation</article-title>. <source>Proc. Natl. Acad. Sci. USA</source>. <volume>120</volume>:<fpage>e2303750120</fpage>. <pub-id pub-id-type="doi">10.1073/pnas.2303750120</pub-id></mixed-citation></ref>
<ref id="c11"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Borchers</surname>, <given-names>A.C.</given-names></string-name>, <string-name><given-names>L.</given-names> <surname>Langemeyer</surname></string-name>, and <string-name><given-names>C.</given-names> <surname>Ungermann</surname></string-name></person-group>. <year>2021</year>. <article-title>Who’s in control? Principles of Rab GTPase activation in endolysosomal membrane trafficking and beyond</article-title>. <source>J. Cell Biol</source>. <volume>220</volume>:<fpage>e202105120</fpage>. <pub-id pub-id-type="doi">10.1083/jcb.202105120</pub-id></mixed-citation></ref>
<ref id="c12"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bowers</surname>, <given-names>K.</given-names></string-name>, <string-name><given-names>J.</given-names> <surname>Lottridge</surname></string-name>, <string-name><given-names>S.B.</given-names> <surname>Helliwell</surname></string-name>, <string-name><given-names>L.M.</given-names> <surname>Goldthwaite</surname></string-name>, <string-name><given-names>J.P.</given-names> <surname>Luzio</surname></string-name>, and <string-name><given-names>T.H.</given-names> <surname>Stevens</surname></string-name></person-group>. <year>2004</year>. <article-title>Protein-protein interactions of ESCRT complexes in the yeast <italic>Saccharomyces cerevisiae</italic></article-title>. <source>Traffic</source>. <volume>5</volume>:<fpage>194</fpage>–<lpage>210</lpage>. <pub-id pub-id-type="doi">10.1111/j.1600-0854.2004.00169.x</pub-id></mixed-citation></ref>
<ref id="c13"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bowers</surname>, <given-names>K.</given-names></string-name>, <string-name><given-names>S.C.</given-names> <surname>Piper</surname></string-name>, <string-name><given-names>M.A.</given-names> <surname>Edeling</surname></string-name>, <string-name><given-names>S.R.</given-names> <surname>Gray</surname></string-name>, <string-name><given-names>D.J.</given-names> <surname>Owen</surname></string-name>, <string-name><given-names>P.J.</given-names> <surname>Lehner</surname></string-name>, and <string-name><given-names>J.P.</given-names> <surname>Luzio</surname></string-name></person-group>. <year>2006</year>. <article-title>Degradation of endocytosed epidermal growth factor and virally ubiquitinated major histocompatibility complex class I is independent of mammalian ESCRTII</article-title>. <source>J. Biol. Chem</source>. <volume>281</volume>:<fpage>5094</fpage>–<lpage>5105</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M508632200</pub-id></mixed-citation></ref>
<ref id="c14"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Brenner</surname>, <given-names>S</given-names></string-name></person-group>. <year>1974</year>. <article-title>The genetics of <italic>Caenorhabditis elegans</italic></article-title>. <source>Genetics</source>. <volume>77</volume>:<fpage>71</fpage>–<lpage>94</lpage>. <pub-id pub-id-type="doi">10.1093/genetics/77.1.71</pub-id></mixed-citation></ref>
<ref id="c15"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Byun</surname>, <given-names>S.</given-names></string-name>, <string-name><given-names>S.Y.</given-names> <surname>Lee</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Lee</surname></string-name>, <string-name><given-names>C.H.</given-names> <surname>Jeong</surname></string-name>, <string-name><given-names>L.</given-names> <surname>Farrand</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Lim</surname></string-name>, <string-name><given-names>K.</given-names> <surname>Reddy</surname></string-name>, <string-name><given-names>J.Y.</given-names> <surname>Kim</surname></string-name>, <string-name><given-names>M.H.</given-names> <surname>Lee</surname></string-name>, <string-name><given-names>H.J.</given-names> <surname>Lee</surname></string-name>, <string-name><given-names>A.M.</given-names> <surname>Bode</surname></string-name>, <string-name><given-names>K.</given-names> <surname>Won Lee</surname></string-name>, and <string-name><given-names>Z.</given-names> <surname>Dong</surname></string-name></person-group>. <year>2013</year>. <article-title>USP8 is a novel target for overcoming gefitinib resistance in lung cancer</article-title>. <source>Clin. Cancer Res</source>. <volume>19</volume>:<fpage>3894</fpage>–<lpage>3904</lpage>. <pub-id pub-id-type="doi">10.1158/1078-0432.ccr-12-3696</pub-id></mixed-citation></ref>
<ref id="c16"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Christoforidis</surname>, <given-names>S.</given-names></string-name>, <string-name><given-names>H.M.</given-names> <surname>McBride</surname></string-name>, <string-name><given-names>R.D.</given-names> <surname>Burgoyne</surname></string-name>, and <string-name><given-names>M.</given-names> <surname>Zerial</surname></string-name></person-group>. <year>1999</year>. <article-title>The Rab5 effector EEA1 is a core component of endosome docking</article-title>. <source>Nature</source>. <volume>397</volume>:<fpage>621</fpage>–<lpage>625</lpage>. <pub-id pub-id-type="doi">10.1038/17618</pub-id></mixed-citation></ref>
<ref id="c17"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Crespo-Yàñez</surname>, <given-names>X.</given-names></string-name>, <string-name><given-names>C.</given-names> <surname>Aguilar-Gurrieri</surname></string-name>, <string-name><given-names>A.C.</given-names> <surname>Jacomin</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Journet</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Mortier</surname></string-name>, <string-name><given-names>E.</given-names> <surname>Taillebourg</surname></string-name>, <string-name><given-names>E.</given-names> <surname>Soleilhac</surname></string-name>, <string-name><given-names>W.</given-names> <surname>Weissenhorn</surname></string-name>, and <string-name><given-names>M.O.</given-names> <surname>Fauvarque</surname></string-name></person-group>. <year>2018</year>. <article-title>CHMP1B is a target of USP8/UBPY regulated by ubiquitin during endocytosis</article-title>. <source>PLoS Genet</source>. <volume>14</volume>:<fpage>e1007456</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pgen.1007456</pub-id></mixed-citation></ref>
<ref id="c18"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Dehnen</surname>, <given-names>L.</given-names></string-name>, <string-name><given-names>M.</given-names> <surname>Janz</surname></string-name>, <string-name><given-names>J.K.</given-names> <surname>Verma</surname></string-name>, <string-name><given-names>O.E.</given-names> <surname>Psathaki</surname></string-name>, <string-name><given-names>L.</given-names> <surname>Langemeyer</surname></string-name>, <string-name><given-names>F.</given-names> <surname>Fröhlich</surname></string-name>, <string-name><given-names>J.J.</given-names> <surname>Heinisch</surname></string-name>, <string-name><given-names>H.</given-names> <surname>Meyer</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Ungermann</surname></string-name>, and <string-name><given-names>A.</given-names> <surname>Paululat</surname></string-name></person-group>. <year>2020</year>. <article-title>A trimeric metazoan Rab7 GEF complex is crucial for endocytosis and scavenger function</article-title>. <source>J. Cell Sci</source>. <volume>133</volume>. <pub-id pub-id-type="doi">10.1242/jcs.247080</pub-id></mixed-citation></ref>
<ref id="c19"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Delprato</surname>, <given-names>A.</given-names></string-name>, and <string-name><given-names>D.G.</given-names> <surname>Lambright</surname></string-name></person-group>. <year>2007</year>. <article-title>Structural basis for Rab GTPase activation by VPS9 domain exchange factors</article-title>. <source>Nat. Struct. Mol. Biol</source>. <volume>14</volume>:<fpage>406</fpage>–<lpage>412</lpage>. <pub-id pub-id-type="doi">10.1038/nsmb1232</pub-id></mixed-citation></ref>
<ref id="c20"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Dickinson</surname>, <given-names>D.J.</given-names></string-name>, <string-name><given-names>J.D.</given-names> <surname>Ward</surname></string-name>, <string-name><given-names>D.J.</given-names> <surname>Reiner</surname></string-name>, and <string-name><given-names>B.</given-names> <surname>Goldstein</surname></string-name></person-group>. <year>2013</year>. <article-title>Engineering the Caenorhabditis elegans genome using Cas9-triggered homologous recombination</article-title>. <source>Nat. Methods</source>. <volume>10</volume>:<fpage>1028</fpage>–<lpage>1034</lpage>. <pub-id pub-id-type="doi">10.1038/nmeth.2641</pub-id></mixed-citation></ref>
<ref id="c21"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Dufner</surname>, <given-names>A.</given-names></string-name>, and <string-name><given-names>K.P.</given-names> <surname>Knobeloch</surname></string-name></person-group>. <year>2019</year>. <article-title>Ubiquitin-specific protease 8 (USP8/UBPy): a prototypic multidomain deubiquitinating enzyme with pleiotropic functions</article-title>. <source>Biochem. Soc. Trans</source>. <volume>47</volume>:<fpage>1867</fpage>–<lpage>1879</lpage>. <pub-id pub-id-type="doi">10.1042/BST20190527</pub-id></mixed-citation></ref>
<ref id="c22"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Edelstein</surname>, <given-names>A.</given-names></string-name>, <string-name><given-names>N.</given-names> <surname>Amodaj</surname></string-name>, <string-name><given-names>K.</given-names> <surname>Hoover</surname></string-name>, <string-name><given-names>R.</given-names> <surname>Vale</surname></string-name>, and <string-name><given-names>N.</given-names> <surname>Stuurman</surname></string-name></person-group>. <year>2010</year>. <article-title>Computer control of microscopes using µManager</article-title>. <source>Curr. Protoc. Mol. Biol.</source> <volume>92</volume>:<fpage>14.20.1</fpage>-<lpage>14.20.17</lpage>. <pub-id pub-id-type="doi">10.1002/0471142727.mb1420s92</pub-id></mixed-citation></ref>
<ref id="c23"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ershov</surname>, <given-names>D.</given-names></string-name>, <string-name><given-names>M.S.</given-names> <surname>Phan</surname></string-name>, <string-name><given-names>J.W.</given-names> <surname>Pylvänäinen</surname></string-name>, <string-name><given-names>S.U.</given-names> <surname>Rigaud</surname></string-name>, <string-name><given-names>L.</given-names> <surname>Le Blanc</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Charles-Orszag</surname></string-name>, <string-name><given-names>J.R.W.</given-names> <surname>Conway</surname></string-name>, <string-name><given-names>R.F.</given-names> <surname>Laine</surname></string-name>, <string-name><given-names>N.H.</given-names> <surname>Roy</surname></string-name>, <string-name><given-names>D.</given-names> <surname>Bonazzi</surname></string-name>, <string-name><given-names>G.</given-names> <surname>Duménil</surname></string-name>, <string-name><given-names>G.</given-names> <surname>Jacquemet</surname></string-name>, and <string-name><given-names>J.Y.</given-names> <surname>Tinevez</surname></string-name></person-group>. <year>2022</year>. <article-title>TrackMate 7: integrating state-of-the-art segmentation algorithms into tracking pipelines</article-title>. <source>Nat. Methods</source>. <volume>19</volume>:<fpage>829</fpage>–<lpage>832</lpage>. <pub-id pub-id-type="doi">10.1038/s41592-022-01507-1</pub-id></mixed-citation></ref>
<ref id="c24"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gallo-Oller</surname>, <given-names>G.</given-names></string-name>, <string-name><given-names>R.</given-names> <surname>Ordoñez</surname></string-name>, and <string-name><given-names>J.</given-names> <surname>Dotor</surname></string-name></person-group>. <year>2018</year>. <article-title>A new background subtraction method for Western blot densitometry band quantification through image analysis software</article-title>. <source>J. Immunol. Methods</source>. <volume>457</volume>:<fpage>1</fpage>–<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1016/j.jim.2018.03.004</pub-id></mixed-citation></ref>
<ref id="c25"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gao</surname>, <given-names>J.</given-names></string-name>, <string-name><given-names>L.</given-names> <surname>Langemeyer</surname></string-name>, <string-name><given-names>D.</given-names> <surname>Kümmel</surname></string-name>, <string-name><given-names>F.</given-names> <surname>Reggiori</surname></string-name>, and <string-name><given-names>C.</given-names> <surname>Ungermann</surname></string-name></person-group>. <year>2018</year>. <article-title>Molecular mechanism to target the endosomal Mon1-Ccz1 GEF complex to the pre-autophagosomal structure</article-title>. <source>eLife</source>. <volume>7</volume>:<fpage>e31145</fpage>. <pub-id pub-id-type="doi">10.7554/eLife.31145</pub-id></mixed-citation></ref>
<ref id="c26"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>He</surname>, <given-names>K.</given-names></string-name>, <string-name><given-names>R.</given-names> <surname>Marsland</surname>, <suffix>III</suffix></string-name>, <string-name><given-names>S.</given-names> <surname>Upadhyayula</surname></string-name>, <string-name><given-names>E.</given-names> <surname>Song</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Dang</surname></string-name>, <string-name><given-names>B.R.</given-names> <surname>Capraro</surname></string-name>, <string-name><given-names>W.</given-names> <surname>Wang</surname></string-name>, <string-name><given-names>W.</given-names> <surname>Skillern</surname></string-name>, <string-name><given-names>R.</given-names> <surname>Gaudin</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Ma</surname></string-name>, and <string-name><given-names>T.</given-names> <surname>Kirchhausen</surname></string-name></person-group>. <year>2017</year>. <article-title>Dynamics of phosphoinositide conversion in clathrin-mediated endocytic traffic</article-title>. <source>Nature</source>. <volume>552</volume>:<fpage>410</fpage>–<lpage>414</lpage>. <pub-id pub-id-type="doi">10.1038/nature25146</pub-id></mixed-citation></ref>
<ref id="c27"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hiragi</surname>, <given-names>S.</given-names></string-name>, <string-name><given-names>T.</given-names> <surname>Matsui</surname></string-name>, <string-name><given-names>Y.</given-names> <surname>Sakamaki</surname></string-name>, and <string-name><given-names>M.</given-names> <surname>Fukuda</surname></string-name></person-group>. <year>2022</year>. <article-title>TBC1D18 is a Rab5-GAP that coordinates endosome maturation together with Mon1</article-title>. <source>J. Cell Biol</source>. <volume>221</volume>:<fpage>e202201114</fpage>. <pub-id pub-id-type="doi">10.1083/jcb.202201114</pub-id></mixed-citation></ref>
<ref id="c28"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Horiuchi</surname>, <given-names>H.</given-names></string-name>, <string-name><given-names>R.</given-names> <surname>Lippé</surname></string-name>, <string-name><given-names>H.M.</given-names> <surname>McBride</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Rubino</surname></string-name>, <string-name><given-names>P.</given-names> <surname>Woodman</surname></string-name>, <string-name><given-names>H.</given-names> <surname>Stenmark</surname></string-name>, <string-name><given-names>V.</given-names> <surname>Rybin</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Wilm</surname></string-name>, <string-name><given-names>K.</given-names> <surname>Ashman</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Mann</surname></string-name>, and <string-name><given-names>M.</given-names> <surname>Zerial</surname></string-name></person-group>. <year>1997</year>. <article-title>A novel Rab5 GDP/GTP exchange factor complexed to Rabaptin-5 links nucleotide exchange to effector recruitment and function</article-title>. <source>Cell</source>. <volume>90</volume>:<fpage>1149</fpage>–<lpage>1159</lpage>. <pub-id pub-id-type="doi">10.1016/s0092-8674(00)80380-3</pub-id></mixed-citation></ref>
<ref id="c29"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Huotari</surname>, <given-names>J.</given-names></string-name>, and <string-name><given-names>A.</given-names> <surname>Helenius</surname></string-name></person-group>. <year>2011</year>. <article-title>Endosome maturation</article-title>. <source>EMBO J</source>. <volume>30</volume>:<fpage>3481</fpage>–<lpage>3500</lpage>. <pub-id pub-id-type="doi">10.1038/emboj.2011.286</pub-id></mixed-citation></ref>
<ref id="c30"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Huynh</surname>, <given-names>J.M.</given-names></string-name>, <string-name><given-names>H.</given-names> <surname>Dang</surname></string-name>, <string-name><given-names>I.A.</given-names> <surname>Munoz-Tucker</surname></string-name>, <string-name><given-names>M.</given-names> <surname>O’Ketch</surname></string-name>, <string-name><given-names>I.T.</given-names> <surname>Liu</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Perno</surname></string-name>, <string-name><given-names>N.</given-names> <surname>Bhuyan</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Crain</surname></string-name>, <string-name><given-names>I.</given-names> <surname>Borbon</surname></string-name>, and <string-name><given-names>H.</given-names> <surname>Fares</surname></string-name></person-group>. <year>2016</year>. <article-title>ESCRT-dependent cell death in a <italic>Caenorhabditis elegans</italic> model of the lysosomal storage disorder mucolipidosis type IV</article-title>. <source>Genetics</source>. <volume>202</volume>:<fpage>619</fpage>–<lpage>638</lpage>. <pub-id pub-id-type="doi">10.1534/genetics.115.182485</pub-id></mixed-citation></ref>
<ref id="c31"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Islam</surname>, <given-names>M.T.</given-names></string-name>, <string-name><given-names>F.</given-names> <surname>Chen</surname></string-name>, and <string-name><given-names>H.</given-names> <surname>Chen</surname></string-name></person-group>. <year>2021</year>. <article-title>The oncogenic role of ubiquitin specific peptidase (USP8) and its signaling pathways targeting for cancer therapeutics</article-title>. <source>Arch. Biochem. Biophys</source>. <volume>701</volume>:<fpage>108811</fpage>. <pub-id pub-id-type="doi">10.1016/j.abb.2021.108811</pub-id></mixed-citation></ref>
<ref id="c32"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Jacomin</surname>, <given-names>A.C.</given-names></string-name>, <string-name><given-names>A.</given-names> <surname>Bescond</surname></string-name>, <string-name><given-names>E.</given-names> <surname>Soleilhac</surname></string-name>, <string-name><given-names>B.</given-names> <surname>Gallet</surname></string-name>, <string-name><given-names>G.</given-names> <surname>Schoehn</surname></string-name>, <string-name><given-names>M.O.</given-names> <surname>Fauvarque</surname></string-name>, and <string-name><given-names>E.</given-names> <surname>Taillebourg</surname></string-name></person-group>. <year>2015</year>. <article-title>The deubiquitinating enzyme UBPY is required for lysosomal biogenesis and productive autophagy in <italic>Drosophila</italic></article-title>. <source>PLoS One</source>. <volume>10</volume>:<fpage>e0143078</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0143078</pub-id></mixed-citation></ref>
<ref id="c33"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Jacomin</surname>, <given-names>A.C.</given-names></string-name>, <string-name><given-names>M.O.</given-names> <surname>Fauvarque</surname></string-name>, and <string-name><given-names>E.</given-names> <surname>Taillebourg</surname></string-name></person-group>. <year>2016</year>. <article-title>A functional endosomal pathway is necessary for lysosome biogenesis in Drosophila</article-title>. <source>BMC Cell Biol</source>. <volume>17</volume>:<fpage>36</fpage>. <pub-id pub-id-type="doi">10.1186/s12860-016-0115-7</pub-id></mixed-citation></ref>
<ref id="c34"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Jing</surname>, <given-names>X.</given-names></string-name>, <string-name><given-names>Y.</given-names> <surname>Chen</surname></string-name>, <string-name><given-names>Y.</given-names> <surname>Chen</surname></string-name>, <string-name><given-names>G.</given-names> <surname>Shi</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Lv</surname></string-name>, <string-name><given-names>N.</given-names> <surname>Cheng</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Feng</surname></string-name>, <string-name><given-names>Z.</given-names> <surname>Xin</surname></string-name>, <string-name><given-names>L.</given-names> <surname>Zhang</surname></string-name>, and <string-name><given-names>J.</given-names> <surname>Wu</surname></string-name></person-group>. <year>2020</year>. <article-title>Down-regulation of USP8 Inhibits Cholangiocarcinoma Cell Proliferation and Invasion</article-title>. <source>Cancer Manag. Res</source>. <volume>12</volume>:<fpage>2185</fpage>–<lpage>2194</lpage>. <pub-id pub-id-type="doi">10.2147/cmar.s234586</pub-id></mixed-citation></ref>
<ref id="c35"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kato</surname>, <given-names>M.</given-names></string-name>, <string-name><given-names>K.</given-names> <surname>Miyazawa</surname></string-name>, and <string-name><given-names>N.</given-names> <surname>Kitamura</surname></string-name></person-group>. <year>2000</year>. <article-title>A deubiquitinating enzyme UBPY interacts with the Src homology 3 domain of Hrs-binding protein via a novel binding motif PX(V/I)(D/N)RXXKP</article-title>. <source>J. Biol. Chem</source>. <volume>275</volume>:<fpage>37481</fpage>–<lpage>37487</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M007251200</pub-id></mixed-citation></ref>
<ref id="c36"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Komander</surname>, <given-names>D.</given-names></string-name>, <string-name><given-names>M.J.</given-names> <surname>Clague</surname></string-name>, and <string-name><given-names>S.</given-names> <surname>Urbé</surname></string-name></person-group>. <year>2009</year>. <article-title>Breaking the chains: structure and function of the deubiquitinases</article-title>. <source>Nat. Rev. Mol. Cell Biol</source>. <volume>10</volume>:<fpage>550</fpage>–<lpage>563</lpage>. <pub-id pub-id-type="doi">10.1038/nrm2731</pub-id></mixed-citation></ref>
<ref id="c37"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kümmel</surname>, <given-names>D.</given-names></string-name>, <string-name><given-names>E.</given-names> <surname>Herrmann</surname></string-name>, <string-name><given-names>L.</given-names> <surname>Langemeyer</surname></string-name>, and <string-name><given-names>C.</given-names> <surname>Ungermann</surname></string-name></person-group>. <year>2023</year>. <article-title>Molecular insights into endolysosomal microcompartment formation and maintenance</article-title>. <source>Biol. Chem</source>. <volume>404</volume>:<fpage>441</fpage>–<lpage>454</lpage>. <pub-id pub-id-type="doi">10.1515/hsz-2022-0294</pub-id></mixed-citation></ref>
<ref id="c38"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Langemeyer</surname>, <given-names>L.</given-names></string-name>, <string-name><given-names>A.C.</given-names> <surname>Borchers</surname></string-name>, <string-name><given-names>E.</given-names> <surname>Herrmann</surname></string-name>, <string-name><given-names>N.</given-names> <surname>Füllbrunn</surname></string-name>, <string-name><given-names>Y.</given-names> <surname>Han</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Perz</surname></string-name>, <string-name><given-names>K.</given-names> <surname>Auffarth</surname></string-name>, <string-name><given-names>D.</given-names> <surname>Kümmel</surname></string-name>, and <string-name><given-names>C.</given-names> <surname>Ungermann</surname></string-name></person-group>. <year>2020</year>. <article-title>A conserved and regulated mechanism drives endosomal Rab transition</article-title>. <source>eLife</source>. <volume>9</volume>:<fpage>e56090</fpage>. <pub-id pub-id-type="doi">10.7554/eLife.56090</pub-id></mixed-citation></ref>
<ref id="c39"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lauer</surname>, <given-names>J.</given-names></string-name>, <string-name><given-names>S.</given-names> <surname>Segeletz</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Cezanne</surname></string-name>, <string-name><given-names>G.</given-names> <surname>Guaitoli</surname></string-name>, <string-name><given-names>F.</given-names> <surname>Raimondi</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Gentzel</surname></string-name>, <string-name><given-names>V.</given-names> <surname>Alva</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Habeck</surname></string-name>, <string-name><given-names>Y.</given-names> <surname>Kalaidzidis</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Ueffing</surname></string-name>, <string-name><given-names>A.N.</given-names> <surname>Lupas</surname></string-name>, <string-name><given-names>C.J.</given-names> <surname>Gloeckner</surname></string-name>, and <string-name><given-names>M.</given-names> <surname>Zerial</surname></string-name></person-group>. <year>2019</year>. <article-title>Auto-regulation of Rab5 GEF activity in Rabex5 by allosteric structural changes, catalytic core dynamics and ubiquitin binding</article-title>. <source>eLife</source>. <volume>8</volume>:<fpage>e46302</fpage>. <pub-id pub-id-type="doi">10.7554/eLife.46302</pub-id></mixed-citation></ref>
<ref id="c40"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lawe</surname>, <given-names>D.C.</given-names></string-name>, <string-name><given-names>A.</given-names> <surname>Chawla</surname></string-name>, <string-name><given-names>E.</given-names> <surname>Merithew</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Dumas</surname></string-name>, <string-name><given-names>W.</given-names> <surname>Carrington</surname></string-name>, <string-name><given-names>K.</given-names> <surname>Fogarty</surname></string-name>, <string-name><given-names>L.</given-names> <surname>Lifshitz</surname></string-name>, <string-name><given-names>R.</given-names> <surname>Tuft</surname></string-name>, <string-name><given-names>D.</given-names> <surname>Lambright</surname></string-name>, and <string-name><given-names>S.</given-names> <surname>Corvera</surname></string-name></person-group>. <year>2002</year>. <article-title>Sequential Roles for Phosphatidylinositol 3-Phosphate and Rab5 in Tethering and Fusion of Early Endosomes via Their Interaction with EEA1</article-title>. <source>J. Biol. Chem</source>. <volume>277</volume>:<fpage>8611</fpage>–<lpage>8617</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M109239200</pub-id></mixed-citation></ref>
<ref id="c41"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Li</surname>, <given-names>H.</given-names></string-name>, <string-name><given-names>Y.</given-names> <surname>Sun</surname></string-name>, <string-name><given-names>Y.</given-names> <surname>Yao</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Ke</surname></string-name>, <string-name><given-names>N.</given-names> <surname>Zhang</surname></string-name>, <string-name><given-names>W.</given-names> <surname>Xiong</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Shi</surname></string-name>, <string-name><given-names>C.</given-names> <surname>He</surname></string-name>, <string-name><given-names>X.</given-names> <surname>Xiao</surname></string-name>, <string-name><given-names>H.</given-names> <surname>Yu</surname></string-name>, <string-name><given-names>P.</given-names> <surname>Dai</surname></string-name>, <string-name><given-names>B.</given-names> <surname>Xiang</surname></string-name>, <string-name><given-names>X.</given-names> <surname>Xing</surname></string-name>, <string-name><given-names>G.</given-names> <surname>Xu</surname></string-name>, <string-name><given-names>W.</given-names> <surname>Song</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Song</surname></string-name>, and <string-name><given-names>J.</given-names> <surname>Zhang</surname></string-name></person-group>. <year>2024</year>. <article-title>USP8-governed GPX4 homeostasis orchestrates ferroptosis and cancer immunotherapy</article-title>. <source>Proc Natl Acad Sci U S A</source>. <volume>121</volume>:<fpage>e2315541121</fpage>. <pub-id pub-id-type="doi">10.1073/pnas.2315541121</pub-id></mixed-citation></ref>
<ref id="c42"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lippé</surname>, <given-names>R.</given-names></string-name>, <string-name><given-names>M.</given-names> <surname>Miaczynska</surname></string-name>, <string-name><given-names>V.</given-names> <surname>Rybin</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Runge</surname></string-name>, and <string-name><given-names>M.</given-names> <surname>Zerial</surname></string-name></person-group>. <year>2001</year>. <article-title>Functional synergy between Rab5 effector Rabaptin-5 and exchange factor Rabex-5 when physically associated in a complex</article-title>. <source>Mol. Biol. Cell</source>. <volume>12</volume>:<fpage>2219</fpage>–<lpage>2228</lpage>. <pub-id pub-id-type="doi">10.1091/mbc.12.7.2219</pub-id></mixed-citation></ref>
<ref id="c43"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Liu</surname>, <given-names>B.</given-names></string-name>, <string-name><given-names>H.W.</given-names> <surname>Du</surname></string-name>, <string-name><given-names>R.</given-names> <surname>Rutkowski</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Gartner</surname></string-name>, and <string-name><given-names>X.C.</given-names> <surname>Wang</surname></string-name></person-group>. <year>2012</year>. <article-title>LAAT-1 is the lysosomal lysine/arginine transporter that maintains amino acid homeostasis</article-title>. <source>Science</source>. <volume>337</volume>:<fpage>351</fpage>–<lpage>354</lpage>. <pub-id pub-id-type="doi">10.1126/science.1220281</pub-id></mixed-citation></ref>
<ref id="c44"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ma</surname>, <given-names>Z.Y.</given-names></string-name>, <string-name><given-names>Z.J.</given-names> <surname>Song</surname></string-name>, <string-name><given-names>J.H.</given-names> <surname>Chen</surname></string-name>, <string-name><given-names>Y.F.</given-names> <surname>Wang</surname></string-name>, <string-name><given-names>S.Q.</given-names> <surname>Li</surname></string-name>, <string-name><given-names>L.F.</given-names> <surname>Zhou</surname></string-name>, <string-name><given-names>Y.</given-names> <surname>Mao</surname></string-name>, <string-name><given-names>Y.M.</given-names> <surname>Li</surname></string-name>, <string-name><given-names>R.G.</given-names> <surname>Hu</surname></string-name>, <string-name><given-names>Z.Y.</given-names> <surname>Zhang</surname></string-name>, <string-name><given-names>H.Y.</given-names> <surname>Ye</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Shen</surname></string-name>, <string-name><given-names>X.F.</given-names> <surname>Shou</surname></string-name>, <string-name><given-names>Z.Q.</given-names> <surname>Li</surname></string-name>, <string-name><given-names>H.</given-names> <surname>Peng</surname></string-name>, <string-name><given-names>Q.Z.</given-names> <surname>Wang</surname></string-name>, <string-name><given-names>D.Z.</given-names> <surname>Zhou</surname></string-name>, <string-name><given-names>X.L.</given-names> <surname>Qin</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Ji</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Zheng</surname></string-name>, <string-name><given-names>H.</given-names> <surname>Chen</surname></string-name>, <string-name><given-names>Y.</given-names> <surname>Wang</surname></string-name>, <string-name><given-names>D.Y.</given-names> <surname>Geng</surname></string-name>, <string-name><given-names>W.J.</given-names> <surname>Tang</surname></string-name>, <string-name><given-names>C.W.</given-names> <surname>Fu</surname></string-name>, <string-name><given-names>Z.F.</given-names> <surname>Shi</surname></string-name>, <string-name><given-names>Y.C.</given-names> <surname>Zhang</surname></string-name>, <string-name><given-names>Z.</given-names> <surname>Ye</surname></string-name>, <string-name><given-names>W.Q.</given-names> <surname>He</surname></string-name>, <string-name><given-names>Q.L.</given-names> <surname>Zhang</surname></string-name>, <string-name><given-names>Q.S.</given-names> <surname>Tang</surname></string-name>, <string-name><given-names>R.</given-names> <surname>Xie</surname></string-name>, <string-name><given-names>J.W.</given-names> <surname>Shen</surname></string-name>, <string-name><given-names>Z.J.</given-names> <surname>Wen</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Zhou</surname></string-name>, <string-name><given-names>T.</given-names> <surname>Wang</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Huang</surname></string-name>, <string-name><given-names>H.J.</given-names> <surname>Qiu</surname></string-name>, <string-name><given-names>N.D.</given-names> <surname>Qiao</surname></string-name>, <string-name><given-names>Y.</given-names> <surname>Zhang</surname></string-name>, <string-name><given-names>L.</given-names> <surname>Pan</surname></string-name>, <string-name><given-names>W.M.</given-names> <surname>Bao</surname></string-name>, <string-name><given-names>Y.C.</given-names> <surname>Liu</surname></string-name>, <string-name><given-names>C.X.</given-names> <surname>Huang</surname></string-name>, <string-name><given-names>Y.Y.</given-names> <surname>Shi</surname></string-name>, and <string-name><given-names>Y.</given-names> <surname>Zhao</surname></string-name></person-group>. <year>2015</year>. <article-title>Recurrent gain-of-function USP8 mutations in Cushing’s disease</article-title>. <source>Cell Res</source>. <volume>25</volume>:<fpage>306</fpage>–<lpage>317</lpage>. <pub-id pub-id-type="doi">10.1038/cr.2015.20</pub-id></mixed-citation></ref>
<ref id="c45"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>MacDonald</surname>, <given-names>E.</given-names></string-name>, <string-name><given-names>S.</given-names> <surname>Urbé</surname></string-name>, and <string-name><given-names>M.J.</given-names> <surname>Clague</surname></string-name></person-group>. <year>2014</year>. <article-title>USP8 controls the trafficking and sorting of lysosomal enzymes</article-title>. <source>Traffic</source>. <volume>15</volume>:<fpage>879</fpage>–<lpage>888</lpage>. <pub-id pub-id-type="doi">10.1111/tra.12180</pub-id></mixed-citation></ref>
<ref id="c46"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Martín-Rodríguez</surname>, <given-names>C.</given-names></string-name>, <string-name><given-names>M.</given-names> <surname>Song</surname></string-name>, <string-name><given-names>B.</given-names> <surname>Anta</surname></string-name>, <string-name><given-names>F.J.</given-names> <surname>González-Calvo</surname></string-name>, <string-name><given-names>R.</given-names> <surname>Deogracias</surname></string-name>, <string-name><given-names>D.</given-names> <surname>Jing</surname></string-name>, <string-name><given-names>F.S.</given-names> <surname>Lee</surname></string-name>, and <string-name><given-names>J.C.</given-names> <surname>Arevalo</surname></string-name></person-group>. <year>2020</year>. <article-title>TrkB deubiquitylation by USP8 regulates receptor levels and BDNF-dependent neuronal differentiation</article-title>. <source>J. Cell Sci</source>. <volume>133</volume>:<fpage>jcs247841</fpage>. <pub-id pub-id-type="doi">10.1242/jcs.247841</pub-id></mixed-citation></ref>
<ref id="c47"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mathieu</surname>, <given-names>J.</given-names></string-name>, <string-name><given-names>P.</given-names> <surname>Michel-Hissier</surname></string-name>, <string-name><given-names>V.</given-names> <surname>Boucherit</surname></string-name>, and <string-name><given-names>J.R.</given-names> <surname>Huynh</surname></string-name></person-group>. <year>2022</year>. <article-title>The deubiquitinase USP8 targets ESCRT-III to promote incomplete cell division</article-title>. <source>Science</source>. <volume>376</volume>:<fpage>818</fpage>–<lpage>823</lpage>. <pub-id pub-id-type="doi">10.1126/science.abg2653</pub-id></mixed-citation></ref>
<ref id="c48"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mattera</surname>, <given-names>R.</given-names></string-name>, and <string-name><given-names>J.S.</given-names> <surname>Bonifacino</surname></string-name></person-group>. <year>2008</year>. <article-title>Ubiquitin binding and conjugation regulate the recruitment of Rabex-5 to early endosomes</article-title>. <source>EMBO J</source>. <volume>27</volume>:<fpage>2484</fpage>–<lpage>2494</lpage>. <pub-id pub-id-type="doi">10.1038/emboj.2008.177</pub-id></mixed-citation></ref>
<ref id="c49"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mizuno</surname>, <given-names>E.</given-names></string-name>, <string-name><given-names>T.</given-names> <surname>Iura</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Mukai</surname></string-name>, <string-name><given-names>T.</given-names> <surname>Yoshimori</surname></string-name>, <string-name><given-names>N.</given-names> <surname>Kitamura</surname></string-name>, and <string-name><given-names>M.</given-names> <surname>Komada</surname></string-name></person-group>. <year>2005</year>. <article-title>Regulation of epidermal growth factor receptor down-regulation by UBPY-mediated deubiquitination at endosomes</article-title>. <source>Mol. Biol. Cell</source>. <volume>16</volume>:<fpage>5163</fpage>–<lpage>5174</lpage>. <pub-id pub-id-type="doi">10.1091/mbc.e05-06-0560</pub-id></mixed-citation></ref>
<ref id="c50"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mizuno</surname>, <given-names>E.</given-names></string-name>, <string-name><given-names>K.</given-names> <surname>Kobayashi</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Yamamoto</surname></string-name>, <string-name><given-names>N.</given-names> <surname>Kitamura</surname></string-name>, and <string-name><given-names>M.</given-names> <surname>Komada</surname></string-name></person-group>. <year>2006</year>. <article-title>A deubiquitinating enzyme UBPY regulates the level of protein ubiquitination on endosomes</article-title>. <source>Traffic</source>. <volume>7</volume>:<fpage>1017</fpage>–<lpage>1031</lpage>. <pub-id pub-id-type="doi">10.1111/j.1600-0854.2006.00452.x</pub-id></mixed-citation></ref>
<ref id="c51"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Naviglio</surname>, <given-names>S.</given-names></string-name>, <string-name><given-names>C.</given-names> <surname>Mattecucci</surname></string-name>, <string-name><given-names>B.</given-names> <surname>Matoskova</surname></string-name>, <string-name><given-names>T.</given-names> <surname>Nagase</surname></string-name>, <string-name><given-names>N.</given-names> <surname>Nomura</surname></string-name>, <string-name><given-names>P.P.</given-names> <surname>Di Fiore</surname></string-name>, and <string-name><given-names>G.F.</given-names> <surname>Draetta</surname></string-name></person-group>. <year>1998</year>. <article-title>UBPY: a growth-regulated human ubiquitin isopeptidase</article-title>. <source>EMBO J</source>. <volume>17</volume>:<fpage>3241</fpage>–<lpage>3250</lpage>. <pub-id pub-id-type="doi">10.1093/emboj/17.12.3241</pub-id></mixed-citation></ref>
<ref id="c52"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Niendorf</surname>, <given-names>S.</given-names></string-name>, <string-name><given-names>A.</given-names> <surname>Oksche</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Kisser</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Lohler</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Prinz</surname></string-name>, <string-name><given-names>H.</given-names> <surname>Schorle</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Feller</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Lewitzky</surname></string-name>, <string-name><given-names>I.</given-names> <surname>Horak</surname></string-name>, and <string-name><given-names>K.P.</given-names> <surname>Knobeloch</surname></string-name></person-group>. <year>2007</year>. <article-title>Essential role of ubiquitin-specific protease 8 for receptor tyrosine kinase stability and endocytic trafficking in vivo</article-title>. <source>Mol. Cell Biol</source>. <volume>27</volume>:<fpage>5029</fpage>–<lpage>5039</lpage>. <pub-id pub-id-type="doi">10.1128/MCB.01566-06</pub-id></mixed-citation></ref>
<ref id="c53"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Nordmann</surname>, <given-names>M.</given-names></string-name>, <string-name><given-names>M.</given-names> <surname>Cabrera</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Perz</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Bröcker</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Ostrowicz</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Engelbrecht-Vandré</surname></string-name>, and <string-name><given-names>C.</given-names> <surname>Ungermann</surname></string-name></person-group>. <year>2010</year>. <article-title>The Mon1-Ccz1 complex is the GEF of the late endosomal Rab7 homolog Ypt7</article-title>. <source>Curr. Biol</source>. <volume>20</volume>:<fpage>1654</fpage>–<lpage>1659</lpage>. <pub-id pub-id-type="doi">10.1016/j.cub.2010.08.002</pub-id></mixed-citation></ref>
<ref id="c54"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ohya</surname>, <given-names>T.</given-names></string-name>, <string-name><given-names>M.</given-names> <surname>Miaczynska</surname></string-name>, <string-name><given-names>U.</given-names> <surname>Coskun</surname></string-name>, <string-name><given-names>B.</given-names> <surname>Lommer</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Runge</surname></string-name>, <string-name><given-names>D.</given-names> <surname>Drechsel</surname></string-name>, <string-name><given-names>Y.</given-names> <surname>Kalaidzidis</surname></string-name>, and <string-name><given-names>M.</given-names> <surname>Zerial</surname></string-name></person-group>. <year>2009</year>. <article-title>Reconstitution of Rab- and SNARE-dependent membrane fusion by synthetic endosomes</article-title>. <source>Nature</source>. <volume>459</volume>:<fpage>1091</fpage>–<lpage>1097</lpage>. <pub-id pub-id-type="doi">10.1038/nature08107</pub-id></mixed-citation></ref>
<ref id="c55"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Peng</surname>, <given-names>H.</given-names></string-name>, <string-name><given-names>F.</given-names> <surname>Yang</surname></string-name>, <string-name><given-names>Q.</given-names> <surname>Hu</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Sun</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Peng</surname></string-name>, <string-name><given-names>Y.</given-names> <surname>Zhao</surname></string-name>, and <string-name><given-names>C.</given-names> <surname>Huang</surname></string-name></person-group>. <year>2020</year>. <article-title>The ubiquitin-specific protease USP8 directly deubiquitinates SQSTM1/p62 to suppress its autophagic activity</article-title>. <source>Autophagy</source>. <volume>16</volume>:<fpage>698</fpage>–<lpage>708</lpage>. <pub-id pub-id-type="doi">10.1080/15548627.2019.1635381</pub-id></mixed-citation></ref>
<ref id="c56"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Peplowska</surname>, <given-names>K.</given-names></string-name>, <string-name><given-names>D.F.</given-names> <surname>Markgraf</surname></string-name>, <string-name><given-names>C.W.</given-names> <surname>Ostrowicz</surname></string-name>, <string-name><given-names>G.</given-names> <surname>Bange</surname></string-name>, and <string-name><given-names>C.</given-names> <surname>Ungermann</surname></string-name></person-group>. <year>2007</year>. <article-title>The CORVET tethering complex interacts with the yeast Rab5 homolog Vps21 and is involved in endo-lysosomal biogenesis</article-title>. <source>Dev. Cell</source>. <volume>12</volume>:<fpage>739</fpage>–<lpage>750</lpage>. <pub-id pub-id-type="doi">10.1016/j.devcel.2007.03.006</pub-id></mixed-citation></ref>
<ref id="c57"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Poteryaev</surname>, <given-names>D.</given-names></string-name>, <string-name><given-names>S.</given-names> <surname>Datta</surname></string-name>, <string-name><given-names>K.</given-names> <surname>Ackema</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Zerial</surname></string-name>, and <string-name><given-names>A.</given-names> <surname>Spang</surname></string-name></person-group>. <year>2010</year>. <article-title>Identification of the switch in early-to-late endosome transition</article-title>. <source>Cell</source>. <volume>141</volume>:<fpage>497</fpage>–<lpage>508</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2010.03.011</pub-id></mixed-citation></ref>
<ref id="c58"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Qiao</surname>, <given-names>C.</given-names></string-name>, <string-name><given-names>D.</given-names> <surname>Li</surname></string-name>, <string-name><given-names>Y.</given-names> <surname>Liu</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Zhang</surname></string-name>, <string-name><given-names>K.</given-names> <surname>Liu</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Liu</surname></string-name>, <string-name><given-names>Y.</given-names> <surname>Guo</surname></string-name>, <string-name><given-names>T.</given-names> <surname>Jiang</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Fang</surname></string-name>, <string-name><given-names>N.</given-names> <surname>Li</surname></string-name>, <string-name><given-names>Y.</given-names> <surname>Zeng</surname></string-name>, <string-name><given-names>K.</given-names> <surname>He</surname></string-name>, <string-name><given-names>X.</given-names> <surname>Zhu</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Lippincott-Schwartz</surname></string-name>, <string-name><given-names>Q.</given-names> <surname>Dai</surname></string-name>, and <string-name><given-names>D.</given-names> <surname>Li</surname></string-name></person-group>. <year>2022</year>. <article-title>Rationalized deep learning super-resolution microscopy for sustained live imaging of rapid subcellular processes</article-title>. <source>Nat. Biotechnol</source>. <pub-id pub-id-type="doi">10.1038/s41587-022-01471-3</pub-id></mixed-citation></ref>
<ref id="c59"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ran</surname>, <given-names>F.A.</given-names></string-name>, <string-name><given-names>P.D.</given-names> <surname>Hsu</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Wright</surname></string-name>, <string-name><given-names>V.</given-names> <surname>Agarwala</surname></string-name>, <string-name><given-names>D.A.</given-names> <surname>Scott</surname></string-name>, and <string-name><given-names>F.</given-names> <surname>Zhang</surname></string-name></person-group>. <year>2013</year>. <article-title>Genome engineering using the CRISPR-Cas9 system</article-title>. <source>Nat. Protoc</source>. <volume>8</volume>:<fpage>2281</fpage>–<lpage>2308</lpage>. <pub-id pub-id-type="doi">10.1038/nprot.2013.143</pub-id></mixed-citation></ref>
<ref id="c60"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Reincke</surname>, <given-names>M.</given-names></string-name>, <string-name><given-names>S.</given-names> <surname>Sbiera</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Hayakawa</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Theodoropoulou</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Osswald</surname></string-name>, <string-name><given-names>F.</given-names> <surname>Beuschlein</surname></string-name>, <string-name><given-names>T.</given-names> <surname>Meitinger</surname></string-name>, <string-name><given-names>E.</given-names> <surname>Mizuno-Yamasaki</surname></string-name>, <string-name><given-names>K.</given-names> <surname>Kawaguchi</surname></string-name>, <string-name><given-names>Y.</given-names> <surname>Saeki</surname></string-name>, <string-name><given-names>K.</given-names> <surname>Tanaka</surname></string-name>, <string-name><given-names>T.</given-names> <surname>Wieland</surname></string-name>, <string-name><given-names>E.</given-names> <surname>Graf</surname></string-name>, <string-name><given-names>W.</given-names> <surname>Saeger</surname></string-name>, <string-name><given-names>C.L.</given-names> <surname>Ronchi</surname></string-name>, <string-name><given-names>B.</given-names> <surname>Allolio</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Buchfelder</surname></string-name>, <string-name><given-names>T.M.</given-names> <surname>Strom</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Fassnacht</surname></string-name>, and <string-name><given-names>M.</given-names> <surname>Komada</surname></string-name></person-group>. <year>2015</year>. <article-title>Mutations in the deubiquitinase gene USP8 cause Cushing’s disease</article-title>. <source>Nat. Genet</source>. <volume>47</volume>:<fpage>31</fpage>–<lpage>38</lpage>. <pub-id pub-id-type="doi">10.1038/ng.3166</pub-id></mixed-citation></ref>
<ref id="c61"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Row</surname>, <given-names>P.E.</given-names></string-name>, <string-name><given-names>H.</given-names> <surname>Liu</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Hayes</surname></string-name>, <string-name><given-names>R.</given-names> <surname>Welchman</surname></string-name>, <string-name><given-names>P.</given-names> <surname>Charalabous</surname></string-name>, <string-name><given-names>K.</given-names> <surname>Hofmann</surname></string-name>, <string-name><given-names>M.J.</given-names> <surname>Clague</surname></string-name>, <string-name><given-names>C.M.</given-names> <surname>Sanderson</surname></string-name>, and <string-name><given-names>S.</given-names> <surname>Urbé</surname></string-name></person-group>. <year>2007</year>. <article-title>The MIT domain of UBPY constitutes a CHMP binding and endosomal localization signal required for efficient epidermal growth factor receptor degradation</article-title>. <source>J. Biol. Chem</source>. <volume>282</volume>:<fpage>30929</fpage>–<lpage>30937</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M704009200</pub-id></mixed-citation></ref>
<ref id="c62"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Row</surname>, <given-names>P.E.</given-names></string-name>, <string-name><given-names>I.A.</given-names> <surname>Prior</surname></string-name>, <string-name><given-names>J.</given-names> <surname>McCullough</surname></string-name>, <string-name><given-names>M.J.</given-names> <surname>Clague</surname></string-name>, and <string-name><given-names>S.</given-names> <surname>Urbe</surname></string-name></person-group>. <year>2006</year>. <article-title>The ubiquitin isopeptidase UBPY regulates endosomal ubiquitin dynamics and is essential for receptor down-regulation</article-title>. <source>J. Biol. Chem</source>. <volume>281</volume>:<fpage>12618</fpage>–<lpage>12624</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M512615200</pub-id></mixed-citation></ref>
<ref id="c63"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sardana</surname>, <given-names>R.</given-names></string-name>, and <string-name><given-names>S.D.</given-names> <surname>Emr</surname></string-name></person-group>. <year>2021</year>. <article-title>Membrane Protein Quality Control Mechanisms in the Endo-Lysosome System</article-title>. <source>Trends Cell Biol</source>. <volume>31</volume>:<fpage>269</fpage>–<lpage>283</lpage>. <pub-id pub-id-type="doi">10.1016/j.tcb.2020.11.011</pub-id></mixed-citation></ref>
<ref id="c64"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Schindelin</surname>, <given-names>J.</given-names></string-name>, <string-name><given-names>I.</given-names> <surname>Arganda-Carreras</surname></string-name>, <string-name><given-names>E.</given-names> <surname>Frise</surname></string-name>, <string-name><given-names>V.</given-names> <surname>Kaynig</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Longair</surname></string-name>, <string-name><given-names>T.</given-names> <surname>Pietzsch</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Preibisch</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Rueden</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Saalfeld</surname></string-name>, <string-name><given-names>B.</given-names> <surname>Schmid</surname></string-name>, <string-name><given-names>J.Y.</given-names> <surname>Tinevez</surname></string-name>, <string-name><given-names>D.J.</given-names> <surname>White</surname></string-name>, <string-name><given-names>V.</given-names> <surname>Hartenstein</surname></string-name>, <string-name><given-names>K.</given-names> <surname>Eliceiri</surname></string-name>, <string-name><given-names>P.</given-names> <surname>Tomancak</surname></string-name>, and <string-name><given-names>A.</given-names> <surname>Cardona</surname></string-name></person-group>. <year>2012</year>. <article-title>Fiji: an open-source platform for biological-image analysis</article-title>. <source>Nat. Methods</source>. <volume>9</volume>:<fpage>676</fpage>–<lpage>682</lpage>. <pub-id pub-id-type="doi">10.1038/nmeth.2019</pub-id></mixed-citation></ref>
<ref id="c65"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Stenmark</surname>, <given-names>H</given-names></string-name></person-group>. <year>2009</year>. <article-title>Rab GTPases as coordinators of vesicle traffic</article-title>. <source>Nat. Rev. Mol. Cell Biol</source>. <volume>10</volume>:<fpage>513</fpage>–<lpage>525</lpage>. <pub-id pub-id-type="doi">10.1038/nrm2728</pub-id></mixed-citation></ref>
<ref id="c66"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Stenmark</surname>, <given-names>H.</given-names></string-name>, <string-name><given-names>R.</given-names> <surname>Aasland</surname></string-name>, <string-name><given-names>B.-H.</given-names> <surname>Toh</surname></string-name>, and <string-name><given-names>A.</given-names> <surname>D’Arrigo</surname></string-name></person-group>. <year>1996</year>. <article-title>Endosomal Localization of the Autoantigen EEA1 Is Mediated by a Zinc-binding FYVE Finger</article-title>. <source>J. Biol. Chem</source>. <volume>271</volume>:<fpage>24048</fpage>–<lpage>24054</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.271.39.24048</pub-id></mixed-citation></ref>
<ref id="c67"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Stenmark</surname>, <given-names>H.</given-names></string-name>, <string-name><given-names>R.G.</given-names> <surname>Parton</surname></string-name>, <string-name><given-names>O.</given-names> <surname>Steele-Mortimer</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Lutcke</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Gruenberg</surname></string-name>, and <string-name><given-names>M.</given-names> <surname>Zerial</surname></string-name></person-group>. <year>1994</year>. <article-title>Inhibition of rab5 GTPase activity stimulates membrane fusion in endocytosis</article-title>. <source>EMBO J</source>. <volume>13</volume>:<fpage>1287</fpage>–<lpage>1296</lpage>. <pub-id pub-id-type="doi">10.1002/j.1460-2075.1994.tb06381.x</pub-id></mixed-citation></ref>
<ref id="c68"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Stirling</surname>, <given-names>D.R.</given-names></string-name>, <string-name><given-names>M.J.</given-names> <surname>Swain-Bowden</surname></string-name>, <string-name><given-names>A.M.</given-names> <surname>Lucas</surname></string-name>, <string-name><given-names>A.E.</given-names> <surname>Carpenter</surname></string-name>, <string-name><given-names>B.A.</given-names> <surname>Cimini</surname></string-name>, and <string-name><given-names>A.</given-names> <surname>Goodman</surname></string-name></person-group>. <year>2021</year>. <article-title>CellProfiler 4: improvements in speed, utility and usability</article-title>. <source>BMC Bioinformatics</source>. <volume>22</volume>:<fpage>433</fpage>. <pub-id pub-id-type="doi">10.1186/s12859-021-04344-9</pub-id></mixed-citation></ref>
<ref id="c69"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Stuffers</surname>, <given-names>S.</given-names></string-name>, <string-name><given-names>C.</given-names> <surname>Sem Wegner</surname></string-name>, <string-name><given-names>H.</given-names> <surname>Stenmark</surname></string-name>, and <string-name><given-names>A.</given-names> <surname>Brech</surname></string-name></person-group>. <year>2009</year>. <article-title>Multivesicular endosome biogenesis in the absence of ESCRTs</article-title>. <source>Traffic</source>. <volume>10</volume>:<fpage>925</fpage>–<lpage>937</lpage>. <pub-id pub-id-type="doi">10.1111/j.1600-0854.2009.00920.x</pub-id></mixed-citation></ref>
<ref id="c70"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sun</surname>, <given-names>J.</given-names></string-name>, <string-name><given-names>Q.</given-names> <surname>Hu</surname></string-name>, <string-name><given-names>H.</given-names> <surname>Peng</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Peng</surname></string-name>, <string-name><given-names>L.</given-names> <surname>Zhou</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Lu</surname></string-name>, and <string-name><given-names>C.</given-names> <surname>Huang</surname></string-name></person-group>. <year>2018</year>. <article-title>The ubiquitin-specific protease USP8 deubiquitinates and stabilizes Cx43</article-title>. <source>J. Biol. Chem</source>. <volume>293</volume>:<fpage>8275</fpage>–<lpage>8284</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.RA117.001315</pub-id></mixed-citation></ref>
<ref id="c71"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sun</surname>, <given-names>Y.</given-names></string-name>, <string-name><given-names>M.</given-names> <surname>Li</surname></string-name>, <string-name><given-names>D.</given-names> <surname>Zhao</surname></string-name>, <string-name><given-names>X.</given-names> <surname>Li</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Yang</surname></string-name>, and <string-name><given-names>X.</given-names> <surname>Wang</surname></string-name></person-group>. <year>2020</year>. <article-title>Lysosome activity is modulated by multiple longevity pathways and is important for lifespan extension in <italic>C. elegans</italic></article-title>. <source>eLife</source>. <volume>9</volume>:<fpage>e55745</fpage>. <pub-id pub-id-type="doi">10.7554/eLife.55745</pub-id></mixed-citation></ref>
<ref id="c72"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Theos</surname>, <given-names>A.C.</given-names></string-name>, <string-name><given-names>S.T.</given-names> <surname>Truschel</surname></string-name>, <string-name><given-names>D.</given-names> <surname>Tenza</surname></string-name>, <string-name><given-names>I.</given-names> <surname>Hurbain</surname></string-name>, <string-name><given-names>D.C.</given-names> <surname>Harper</surname></string-name>, <string-name><given-names>J.F.</given-names> <surname>Berson</surname></string-name>, <string-name><given-names>P.C.</given-names> <surname>Thomas</surname></string-name>, <string-name><given-names>G.</given-names> <surname>Raposo</surname></string-name>, and <string-name><given-names>M.S.</given-names> <surname>Marks</surname></string-name></person-group>. <year>2006</year>. <article-title>A lumenal domain-dependent pathway for sorting to intralumenal vesicles of multivesicular endosomes involved in organelle morphogenesis</article-title>. <source>Dev. Cell</source>. <volume>10</volume>:<fpage>343</fpage>–<lpage>354</lpage>. <pub-id pub-id-type="doi">10.1016/j.devcel.2006.01.012</pub-id></mixed-citation></ref>
<ref id="c73"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tinevez</surname>, <given-names>J.Y.</given-names></string-name>, <string-name><given-names>N.</given-names> <surname>Perry</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Schindelin</surname></string-name>, <string-name><given-names>G.M.</given-names> <surname>Hoopes</surname></string-name>, <string-name><given-names>G.D.</given-names> <surname>Reynolds</surname></string-name>, <string-name><given-names>E.</given-names> <surname>Laplantine</surname></string-name>, <string-name><given-names>S.Y.</given-names> <surname>Bednarek</surname></string-name>, <string-name><given-names>S.L.</given-names> <surname>Shorte</surname></string-name>, and <string-name><given-names>K.W.</given-names> <surname>Eliceiri</surname></string-name></person-group>. <year>2017</year>. <article-title>TrackMate: An open and extensible platform for single-particle tracking</article-title>. <source>Methods</source>. <volume>115</volume>:<fpage>80</fpage>–<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1016/j.ymeth.2016.09.016</pub-id></mixed-citation></ref>
<ref id="c74"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tremel</surname>, <given-names>S.</given-names></string-name>, <string-name><given-names>Y.</given-names> <surname>Ohashi</surname></string-name>, <string-name><given-names>D.R.</given-names> <surname>Morado</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Bertram</surname></string-name>, <string-name><given-names>O.</given-names> <surname>Perisic</surname></string-name>, <string-name><given-names>L.T.L.</given-names> <surname>Brandt</surname></string-name>, <string-name><given-names>M.K.</given-names> <surname>von Wrisberg</surname></string-name>, <string-name><given-names>Z.A.</given-names> <surname>Chen</surname></string-name>, <string-name><given-names>S.L.</given-names> <surname>Maslen</surname></string-name>, <string-name><given-names>O.</given-names> <surname>Kovtun</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Skehel</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Rappsilber</surname></string-name>, <string-name><given-names>K.</given-names> <surname>Lang</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Munro</surname></string-name>, <string-name><given-names>J.A.G.</given-names> <surname>Briggs</surname></string-name>, and <string-name><given-names>R.L.</given-names> <surname>Williams</surname></string-name></person-group>. <year>2021</year>. <article-title>Structural basis for VPS34 kinase activation by Rab1 and Rab5 on membranes</article-title>. <source>Nat. Commun</source>. <volume>12</volume>:<fpage>1564</fpage>. <pub-id pub-id-type="doi">10.1038/s41467-021-21695-2</pub-id></mixed-citation></ref>
<ref id="c75"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Vaites</surname>, <given-names>L.P.</given-names></string-name>, <string-name><given-names>J.A.</given-names> <surname>Paulo</surname></string-name>, <string-name><given-names>E.L.</given-names> <surname>Huttlin</surname></string-name>, and <string-name><given-names>J.W.</given-names> <surname>Harper</surname></string-name></person-group>. <year>2018</year>. <article-title>Systematic Analysis of Human Cells Lacking ATG8 Proteins Uncovers Roles for GABARAPs and the CCZ1/MON1 Regulator C18orf8/RMC1 in Macroautophagic and Selective Autophagic Flux</article-title>. <source>Mol. Cell Biol</source>. <volume>38</volume>. <pub-id pub-id-type="doi">10.1128/mcb.00392-17</pub-id></mixed-citation></ref>
<ref id="c76"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>van den Boomen</surname>, <given-names>D.J.H.</given-names></string-name>, <string-name><given-names>A.</given-names> <surname>Sienkiewicz</surname></string-name>, <string-name><given-names>I.</given-names> <surname>Berlin</surname></string-name>, <string-name><given-names>M.L.M.</given-names> <surname>Jongsma</surname></string-name>, <string-name><given-names>D.M.</given-names> <surname>van Elsland</surname></string-name>, <string-name><given-names>J.P.</given-names> <surname>Luzio</surname></string-name>, <string-name><given-names>J.J.C.</given-names> <surname>Neefjes</surname></string-name>, and <string-name><given-names>P.J.</given-names> <surname>Lehner</surname></string-name></person-group>. <year>2020</year>. <article-title>A trimeric Rab7 GEF controls NPC1-dependent lysosomal cholesterol export</article-title>. <source>Nat. Commun</source>. <volume>11</volume>:<fpage>5559</fpage>. <pub-id pub-id-type="doi">10.1038/s41467-020-19032-0</pub-id></mixed-citation></ref>
<ref id="c77"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wang</surname>, <given-names>C.W.</given-names></string-name>, <string-name><given-names>P.E.</given-names> <surname>Stromhaug</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Shima</surname></string-name>, and <string-name><given-names>D.J.</given-names> <surname>Klionsky</surname></string-name></person-group>. <year>2002</year>. <article-title>The Ccz1-Mon1 protein complex is required for the late step of multiple vacuole delivery pathways</article-title>. <source>J. Biol. Chem</source>. <volume>277</volume>:<fpage>47917</fpage>–<lpage>47927</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M208191200</pub-id></mixed-citation></ref>
<ref id="c78"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wegner</surname>, <given-names>C.S.</given-names></string-name>, <string-name><given-names>L.</given-names> <surname>Malerod</surname></string-name>, <string-name><given-names>N.M.</given-names> <surname>Pedersen</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Progida</surname></string-name>, <string-name><given-names>O.</given-names> <surname>Bakke</surname></string-name>, <string-name><given-names>H.</given-names> <surname>Stenmark</surname></string-name>, and <string-name><given-names>A.</given-names> <surname>Brech</surname></string-name></person-group>. <year>2010</year>. <article-title>Ultrastructural characterization of giant endosomes induced by GTPase-deficient Rab5</article-title>. <source>Histochem. Cell Biol</source>. <volume>133</volume>:<fpage>41</fpage>–<lpage>55</lpage>. <pub-id pub-id-type="doi">10.1007/s00418-009-0643-8</pub-id></mixed-citation></ref>
<ref id="c79"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wollert</surname>, <given-names>T.</given-names></string-name>, and <string-name><given-names>J.H.</given-names> <surname>Hurley</surname></string-name></person-group>. <year>2010</year>. <article-title>Molecular mechanism of multivesicular body biogenesis by ESCRT complexes</article-title>. <source>Nature</source>. <volume>464</volume>:<fpage>864</fpage>–<lpage>869</lpage>. <pub-id pub-id-type="doi">10.1038/nature08849</pub-id></mixed-citation></ref>
<ref id="c80"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wright</surname>, <given-names>M.H.</given-names></string-name>, <string-name><given-names>I.</given-names> <surname>Berlin</surname></string-name>, and <string-name><given-names>P.D.</given-names> <surname>Nash</surname></string-name></person-group>. <year>2011</year>. <article-title>Regulation of endocytic sorting by ESCRT-DUB-mediated deubiquitination</article-title>. <source>Cell Biochem. Biophys</source>. <volume>60</volume>:<fpage>39</fpage>–<lpage>46</lpage>. <pub-id pub-id-type="doi">10.1007/s12013-011-9181-9</pub-id></mixed-citation></ref>
<ref id="c81"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wu</surname>, <given-names>Y.C.</given-names></string-name>, <string-name><given-names>G.M.</given-names> <surname>Stanfield</surname></string-name>, and <string-name><given-names>H.R.</given-names> <surname>Horvitz</surname></string-name></person-group>. <year>2000</year>. <article-title>NUC-1, a caenorhabditis elegans DNase II homolog, functions in an intermediate step of DNA degradation during apoptosis</article-title>. <source>Genes Dev</source>. <volume>14</volume>:<fpage>536</fpage>–<lpage>548</lpage>.</mixed-citation></ref>
<ref id="c82"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Xie</surname>, <given-names>F.</given-names></string-name>, <string-name><given-names>X.</given-names> <surname>Zhou</surname></string-name>, <string-name><given-names>H.</given-names> <surname>Li</surname></string-name>, <string-name><given-names>P.</given-names> <surname>Su</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Liu</surname></string-name>, <string-name><given-names>R.</given-names> <surname>Li</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Zou</surname></string-name>, <string-name><given-names>X.</given-names> <surname>Wei</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Pan</surname></string-name>, <string-name><given-names>Z.</given-names> <surname>Zhang</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Zheng</surname></string-name>, <string-name><given-names>Z.</given-names> <surname>Liu</surname></string-name>, <string-name><given-names>X.</given-names> <surname>Meng</surname></string-name>, <string-name><given-names>H.</given-names> <surname>Ovaa</surname></string-name>, <string-name><given-names>P.</given-names> <surname>Ten Dijke</surname></string-name>, <string-name><given-names>F.</given-names> <surname>Zhou</surname></string-name>, and <string-name><given-names>L.</given-names> <surname>Zhang</surname></string-name></person-group>. <year>2022</year>. <article-title>USP8 promotes cancer progression and extracellular vesicle-mediated CD8+ T cell exhaustion by deubiquitinating the TGF-beta receptor TbetaRII</article-title>. <source>EMBO J</source>. <volume>41</volume>:<fpage>e108791</fpage>. <pub-id pub-id-type="doi">10.15252/embj.2021108791</pub-id></mixed-citation></ref>
<ref id="c83"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Xiong</surname>, <given-names>W.</given-names></string-name>, <string-name><given-names>X.</given-names> <surname>Gao</surname></string-name>, <string-name><given-names>T.</given-names> <surname>Zhang</surname></string-name>, <string-name><given-names>B.</given-names> <surname>Jiang</surname></string-name>, <string-name><given-names>M.M.</given-names> <surname>Hu</surname></string-name>, <string-name><given-names>X.</given-names> <surname>Bu</surname></string-name>, <string-name><given-names>Y.</given-names> <surname>Gao</surname></string-name>, <string-name><given-names>L.Z.</given-names> <surname>Zhang</surname></string-name>, <string-name><given-names>B.L.</given-names> <surname>Xiao</surname></string-name>, <string-name><given-names>C.</given-names> <surname>He</surname></string-name>, <string-name><given-names>Y.</given-names> <surname>Sun</surname></string-name>, <string-name><given-names>H.</given-names> <surname>Li</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Shi</surname></string-name>, <string-name><given-names>X.</given-names> <surname>Xiao</surname></string-name>, <string-name><given-names>B.</given-names> <surname>Xiang</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Xie</surname></string-name>, <string-name><given-names>G.</given-names> <surname>Chen</surname></string-name>, <string-name><given-names>H.</given-names> <surname>Zhang</surname></string-name>, <string-name><given-names>W.</given-names> <surname>Wei</surname></string-name>, <string-name><given-names>G.J.</given-names> <surname>Freeman</surname></string-name>, <string-name><given-names>H.B.</given-names> <surname>Shu</surname></string-name>, <string-name><given-names>H.</given-names> <surname>Wang</surname></string-name>, and <string-name><given-names>J.</given-names> <surname>Zhang</surname></string-name></person-group>. <year>2022</year>. <article-title>USP8 inhibition reshapes an inflamed tumor microenvironment that potentiates the immunotherapy</article-title>. <source>Nat. Commun</source>. <volume>13</volume>:<fpage>1700</fpage>. <pub-id pub-id-type="doi">10.1038/s41467-022-29401-6</pub-id></mixed-citation></ref>
<ref id="c84"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yang</surname>, <given-names>C.</given-names></string-name>, and <string-name><given-names>X.</given-names> <surname>Wang</surname></string-name></person-group>. <year>2021</year>. <article-title>Lysosome biogenesis: Regulation and functions</article-title>. <source>J. Cell Biol</source>. <volume>220</volume>:<fpage>e202102001</fpage>. <pub-id pub-id-type="doi">10.1083/jcb.202102001</pub-id></mixed-citation></ref>
<ref id="c85"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yong</surname>, <given-names>X.</given-names></string-name>, <string-name><given-names>G.</given-names> <surname>Jia</surname></string-name>, <string-name><given-names>Z.</given-names> <surname>Liu</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Zhou</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Yi</surname></string-name>, <string-name><given-names>Y.</given-names> <surname>Tang</surname></string-name>, <string-name><given-names>L.</given-names> <surname>Chen</surname></string-name>, <string-name><given-names>L.</given-names> <surname>Chen</surname></string-name>, <string-name><given-names>Y.</given-names> <surname>Wang</surname></string-name>, <string-name><given-names>Q.</given-names> <surname>Sun</surname></string-name>, <string-name><given-names>D.D.</given-names> <surname>Billadeau</surname></string-name>, <string-name><given-names>Z.</given-names> <surname>Su</surname></string-name>, and <string-name><given-names>D.</given-names> <surname>Jia</surname></string-name></person-group>. <year>2023</year>. <article-title>Cryo-EM structure of the Mon1-Ccz1-RMC1 complex reveals molecular basis of metazoan RAB7A activation</article-title>. <source>Proc. Natl. Acad. Sci. USA</source>. <volume>120</volume>:<fpage>e2301725120</fpage>. <pub-id pub-id-type="doi">10.1073/pnas.2301725120</pub-id></mixed-citation></ref>
<ref id="c86"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zeigerer</surname>, <given-names>A.</given-names></string-name>, <string-name><given-names>J.</given-names> <surname>Gilleron</surname></string-name>, <string-name><given-names>R.L.</given-names> <surname>Bogorad</surname></string-name>, <string-name><given-names>G.</given-names> <surname>Marsico</surname></string-name>, <string-name><given-names>H.</given-names> <surname>Nonaka</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Seifert</surname></string-name>, <string-name><given-names>H.</given-names> <surname>Epstein-Barash</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Kuchimanchi</surname></string-name>, <string-name><given-names>C.G.</given-names> <surname>Peng</surname></string-name>, <string-name><given-names>V.M.</given-names> <surname>Ruda</surname></string-name>, <string-name><given-names>P.</given-names> <surname>Del Conte-Zerial</surname></string-name>, <string-name><given-names>J.G.</given-names> <surname>Hengstler</surname></string-name>, <string-name><given-names>Y.</given-names> <surname>Kalaidzidis</surname></string-name>, <string-name><given-names>V.</given-names> <surname>Koteliansky</surname></string-name>, and <string-name><given-names>M.</given-names> <surname>Zerial</surname></string-name></person-group>. <year>2012</year>. <article-title>Rab5 is necessary for the biogenesis of the endolysosomal system in vivo</article-title>. <source>Nature</source>. <volume>485</volume>:<fpage>465</fpage>–<lpage>470</lpage>. <pub-id pub-id-type="doi">10.1038/nature11133</pub-id></mixed-citation></ref>
<ref id="c87"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhang</surname>, <given-names>J.</given-names></string-name>, <string-name><given-names>J.</given-names> <surname>Du</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Lei</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Liu</surname></string-name>, and <string-name><given-names>A.J.</given-names> <surname>Zhu</surname></string-name></person-group>. <year>2014a</year>. <article-title>Ubpy controls the stability of the ESCRT-0 subunit Hrs in development</article-title>. <source>Development</source>. <volume>141</volume>:<fpage>1473</fpage>–<lpage>1479</lpage>. <pub-id pub-id-type="doi">10.1242/dev.099564</pub-id></mixed-citation></ref>
<ref id="c88"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhang</surname>, <given-names>Z.</given-names></string-name>, <string-name><given-names>T.</given-names> <surname>Zhang</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Wang</surname></string-name>, <string-name><given-names>Z.</given-names> <surname>Gong</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Tang</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Chen</surname></string-name>, and <string-name><given-names>J.</given-names> <surname>Ding</surname></string-name></person-group>. <year>2014b</year>. <article-title>Molecular mechanism for Rabex-5 GEF activation by Rabaptin-5</article-title>. <source>Elife</source>. <volume>3</volume>. <pub-id pub-id-type="doi">10.7554/eLife.02687</pub-id></mixed-citation></ref>
<ref id="c89"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhu</surname>, <given-names>H.</given-names></string-name>, <string-name><given-names>G.</given-names> <surname>Zhu</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Liu</surname></string-name>, <string-name><given-names>Z.</given-names> <surname>Liang</surname></string-name>, <string-name><given-names>X.C.</given-names> <surname>Zhang</surname></string-name>, and <string-name><given-names>G.</given-names> <surname>Li</surname></string-name></person-group>. <year>2007</year>. <article-title>Rabaptin-5-independent membrane targeting and Rab5 activation by Rabex-5 in the cell</article-title>. <source>Mol. Biol. Cell</source>. <volume>18</volume>:<fpage>4119</fpage>–<lpage>4128</lpage>. <pub-id pub-id-type="doi">10.1091/mbc.e07-02-0100</pub-id></mixed-citation></ref>
</ref-list>
</back>
<sub-article id="sa0" article-type="editor-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.96353.3.sa4</article-id>
<title-group>
<article-title>eLife Assessment</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Delgui</surname>
<given-names>Laura Ruth</given-names>
</name>
<role specific-use="editor">Reviewing Editor</role>
<aff>
<institution-wrap>
<institution>National Scientific and Technical Research Council</institution>
</institution-wrap>
<city>Mendoza</city>
<country>Argentina</country>
</aff>
</contrib>
</contrib-group>
<kwd-group kwd-group-type="evidence-strength">
<kwd>Convincing</kwd>
</kwd-group>
<kwd-group kwd-group-type="claim-importance">
<kwd>Important</kwd>
</kwd-group>
</front-stub>
<body>
<p>The manuscript presents an <bold>important</bold> model for the field of endosome maturation, providing perspective on the role of the deubiquitinating enzyme UPS-50/USP8 in the process. The evidence presented in the paper is clear, incorporating well-designed experiments that suggest the dual actions of UPS-50 and USP8 in the conversion of early endosomes into late endosomes. Overall, the work is <bold>convincing</bold> and centers on an intriguing subject.</p>
</body>
</sub-article>
<sub-article id="sa1" article-type="referee-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.96353.3.sa3</article-id>
<title-group>
<article-title>Reviewer #1 (Public review):</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<anonymous/>
<role specific-use="referee">Reviewer</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>Summary:</p>
<p>The manuscript focuses on the role of the deubiquitinating enzyme UPS-50/USP8 in endosome maturation. The authors aimed to clarify how this enzyme drives the conversion of early endosomes into late endosomes. Overall, they did achieve their aims in shedding light on the precise mechanisms by which UPS-50/USP8 regulates endosome maturation. The results support their conclusions that UPS-50 acts by disassociating RABX-5 from early endosomes to deactivate RAB-5 and by recruiting SAND-1/Mon1 to activate RAB-7. This work is commendable and will have a significant impact on the field. The methods and data presented here will be useful to the community in advancing our understanding of endosome maturation and identifying potential therapeutic targets for diseases related to endosomal dysfunction. It is worth noting that further investigation is required to fully understand the complexities of endosome maturation. However, the findings presented in this manuscript provide a solid foundation for future studies.</p>
<p>Strengths:</p>
<p>The major strengths of this work lie in the well-designed experiments used to examine the effects of UPS-50 loss. The authors employed confocal imaging to obtain a picture of the aftermath of USP-50 loss. Their findings indicated enlarged early endosomes and MVB-like structures in cells deficient in USP-50/USP8.</p>
<p>Weaknesses:</p>
<p>Specifically, there is a need for further investigation to accurately characterize the anomalous structures detected in the ups-50 mutant. Also, the correlation between the presence of these abnormal structures and ESCRT-0 is yet to be addressed, and the current working model needs to be revised to prevent any confusion between enlarged early endosomes and MVBs.</p>
</body>
</sub-article>
<sub-article id="sa2" article-type="referee-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.96353.3.sa2</article-id>
<title-group>
<article-title>Reviewer #2 (Public review):</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<anonymous/>
<role specific-use="referee">Reviewer</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>Summary:</p>
<p>In this study, the authors study how the deubiquitinase USP8 regulates endosome maturation in C. elegans and mammalian cells. The authors have isolated USP8 mutant alleles in C. elegans and used multiple in vivo reporter lines to demonstrate the impact of USP8 loss-of-function on endosome morphology and maturation. They show that in USP8 mutant cells, the early endosomes and MVB-like structures are enlarged while the late endosomes and lysosomal compartments are reduced. They elucidate that USP8 interacts with Rabx5, a guanine nucleotide exchange factor (GEF) for Rab5, and show that USP8 likely targets specific lysine residue of Rabx5 to dissociate it from early endosomes. They also find that localization of USP8 to early endosomes are disrupted in Rabx5 mutant cells. They observe that in both Rabx5 and USP8 mutant cells, the Rab7 GEF SAND-1 puncta which likely represents late endosomes are diminished, although that Rabex5 are accumulated in USP8 mutant cells. The authors provide evidence that USP8 regulates endosomal maturation in a similar fashion in mammalian cells. Based on their observations they propose that USP8 dissociates Rabex5 from early endosomes and enhances the recruitment of SAND-1 to promote endosome maturation.</p>
<p>Strengths:</p>
<p>The major highlights of this study include the direct visualization of endosome dynamics in a living multi-cellular organism, C. elegans. The high-quality images provide clear in vivo evidences to support the main conclusions. The authors have generated valuable resources to study mechanisms involved in endosome dynamics regulation in both the worm and mammalian cells, which would benefit many members in the cell biology community. The work identifies a fascinating link between USP8 and the Rab5 guanine nucleotide exchange factor Rabx5, which expands the targets and modes of action of USP8. The findings make a solid contribution toward the understanding of how endosomal trafficking is controlled.</p>
<p>Weaknesses:</p>
<p>- The authors utilized multiple fluorescent protein reporters, including those generated by themselves, to label endosomal vesicles. Although these are routine and powerful tools for studying endosomal trafficking, these results cannot tell that whether the endogenous proteins (Rab5, Rabex5, Rab7, etc.) are affected in the same fashion. Note that the authors have provided convincing evidence about the effects on Rab proteins in the revised manuscript.</p>
<p>
- The authors clearly demonstrated a link between USP8 and Rabx5, and they showed that cells deficient of both factors displayed similar defects in late endosomes/lysosomes. But the authors didn't confirm whether and/or to which extent that USP8 regulates endosome maturation through Rabx5. Additional genetic and molecular evidence might be required to better support their working model. Note that the authors have provided convincing evidence about the role of USP8-Rabx5 axis in the revised manuscript.</p>
</body>
</sub-article>
<sub-article id="sa3" article-type="referee-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.96353.3.sa1</article-id>
<title-group>
<article-title>Reviewer #3 (Public review):</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<anonymous/>
<role specific-use="referee">Reviewer</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>Summary:</p>
<p>The authors elucidated the role of USP8 in the endocytic pathway. Using C. elegans epithelial cells as a model, they observed that when USP8 function is lost, the cells have a decreased number and size in lysosomes. Since USP8 was already known to be a protein linked to ESCRT components, they looked into what role USP8 might play in connecting lysosomes and multivesicular bodies (MVB). They observed fewer ESCRT-associated vesicles but an increased number of abnormal enlarged vesicles (aberrant early endosomes) when USP8 function was lost. They showed that USP8 interacts with Rabx5 to dissociate it from early endosomes promoting the recruitment of the Rab7 GEF SAND-1/Mon1 and the maturation of the endosomes. The authors provided evidence that USP8 regulates endosomal maturation in a similar fashion in mammalian cells.</p>
<p>Strengths:</p>
<p>The use of two models, C. elegans and a mammalian cell line to describe a similar mechanism.</p>
</body>
</sub-article>
<sub-article id="sa4" article-type="author-comment">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.96353.3.sa0</article-id>
<title-group>
<article-title>Author response:</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Miao</surname>
<given-names>Yue</given-names>
</name>
<role specific-use="author">Author</role>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-3317-0300</contrib-id></contrib>
<contrib contrib-type="author">
<name>
<surname>Du</surname>
<given-names>Yongtao</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Baolei</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Liang</surname>
<given-names>Jingjing</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Liang</surname>
<given-names>Yu</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Dang</surname>
<given-names>Song</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Liu</surname>
<given-names>Jiahao</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Li</surname>
<given-names>Dong</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>He</surname>
<given-names>Kangmin</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ding</surname>
<given-names>Mei</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>The following is the authors’ response to the previous reviews.</p>
<disp-quote content-type="editor-comment">
<p><bold>Public Reviews:</bold></p>
<p><bold>Reviewer #1 (Public Review):</bold></p>
<p><bold>S</bold>ummary:</p>
<p>The manuscript focuses on the role of the deubiquitinating enzyme UPS-50/USP8 in endosome maturation. The authors aimed to clarify how this enzyme drives the conversion of early endosomes into late endosomes. Overall, they did achieve their aims in shedding light on the precise mechanisms by which UPS-50/USP8 regulates endosome maturation. The results support their conclusions that UPS-50 acts by disassociating RABX-5 from early endosomes to deactivate RAB-5 and by recruiting SAND-1/Mon1 to activate RAB-7. This work is commendable and will have a significant impact on the field. The methods and data presented here will be useful to the community in advancing our understanding of endosome maturation and identifying potential therapeutic targets for diseases related to endosomal dysfunction. It is worth noting that further investigation is required to fully understand the complexities of endosome maturation. However, the findings presented in this manuscript provide a solid foundation for future studies.</p>
</disp-quote>
<p>We thank this reviewer for the instructive suggestions and encouragement.</p>
<disp-quote content-type="editor-comment">
<p>Strengths:</p>
<p>The major strengths of this work lie in the well-designed experiments used to examine the effects of UPS-50 loss. The authors employed confocal imaging to obtain a picture of the aftermath of the USP-50 loss. Their findings indicated enlarged early endosomes and MVB-like structures in cells deficient in USP-50/USP8.</p>
</disp-quote>
<p>We thank this reviewer for the instructive suggestions and encouragement.</p>
<disp-quote content-type="editor-comment">
<p>Weaknesses:</p>
<p>Specifically, there is a need for further investigation to accurately characterize the anomalous structures detected in the <italic>usp-50</italic> mutant. Also, the correlation between the presence of these abnormal structures and ESCRT-0 is yet to be addressed, and the current working model needs to be revised to prevent any confusion between enlarged early endosomes and MVBs.</p>
</disp-quote>
<p>Excellent suggestions. USP8 has been identified as a protein associated with ESCRT components, which are crucial for endosomal membrane deformation and scission, leading to the formation of intraluminal vesicles (ILVs) within multivesicular bodies (MVBs). In <italic>usp-50</italic> mutants, we observed a significant reduction in the punctate signals of HGRS-1::GFP and STAM-1 (Figure 1G and H; and Figure1-figure supplement 1B), indicating a disruption in ESCRT-0 complex localization (Author response image 1). Additionally, lysosomal structures are markedly reduced in these mutants. In contrast, we found that early endosomes, as marked by FYVE, RAB-5, RABEX5, and EEA1, are significantly enlarged in <italic>usp-50</italic> mutants. Electron microscopy (EM) imaging further revealed an increase in large cellular vesicles containing various intraluminal structures. Given the reduction in lysosomal structures and the enlargement of early endosomes in <italic>usp-50</italic> mutants, these enlarged vesicles are likely aberrant early endosomes rather than late endosomal or lysosomal structures. To address potential confusion, we have revised the manuscript according to the reviewer's comments and updated the model to accurately reflect these observations.</p>
<disp-quote content-type="editor-comment">
<p><bold>Reviewer #2 (Public Review):</bold></p>
<p>Summary:</p>
<p>In this study, the authors study how the deubiquitinase USP8 regulates endosome maturation in <italic>C. elegans</italic> and mammalian cells. The authors have isolated USP8 mutant alleles in <italic>C. elegans</italic> and used multiple in vivo reporter lines to demonstrate the impact of USP8 loss-of-function on endosome morphology and maturation. They show that in USP8 mutant cells, the early endosomes and MVB-like structures are enlarged while the late endosomes and lysosomal compartments are reduced. They elucidate that USP8 interacts with Rabx5, a guanine nucleotide exchange factor (GEF) for Rab5, and show that USP8 likely targets specific lysine residue of Rabx5 to dissociate it from early endosomes. They also find that the localization of USP8 to early endosomes is disrupted in Rabx5 mutant cells. They observe that in both Rabx5 and USP8 mutant cells, the Rab7 GEF SAND-1 puncta which likely represents late endosomes are diminished, although Rabex5 is accumulated in USP8 mutant cells. The authors provide evidence that USP8 regulates endosomal maturation in a similar fashion in mammalian cells. Based on their observations they propose that USP8 dissociates Rabex5 from early endosomes and enhances the recruitment of SAND-1 to promote endosome maturation.</p>
</disp-quote>
<p>We thank this reviewer for the instructive suggestions and encouragement.</p>
<disp-quote content-type="editor-comment">
<p>Strengths:</p>
<p>The major highlights of this study include the direct visualization of endosome dynamics in a living multi-cellular organism, C. elegans. The high-quality images provide clear in vivo evidence to support the main conclusions. The authors have generated valuable resources to study mechanisms involved in endosome dynamics regulation in both the worm and mammalian cells, which would benefit many members of the cell biology community. The work identifies a fascinating link between USP8 and the Rab5 guanine nucleotide exchange factor Rabx5, which expands the targets and modes of action of USP8. The findings make a solid contribution toward the understanding of how endosomal trafficking is controlled.</p>
</disp-quote>
<p>We thank this reviewer for the instructive suggestions and encouragement.</p>
<disp-quote content-type="editor-comment">
<p>Weaknesses:</p>
<p>- The authors utilized multiple fluorescent protein reporters, including those generated by themselves, to label endosomal vesicles. Although these are routine and powerful tools for studying endosomal trafficking, these results cannot tell whether the endogenous proteins (Rab5, Rabex5, Rab7, etc.) are affected in the same fashion.</p>
</disp-quote>
<p>Good suggestion. Indeed, to test whether the endogenous proteins (Rab5, Rabex5, Rab7, etc.) are affected in the same fashion as fluorescent protein reporters, we supplemented our approach with the utilization of endogenous markers. These markers, including Rab5, RAB-5, Rabex5, RABX-5, and EEA1 for early endosomes, as well as RAB-7, Mon1a, and Mon1b for late endosomes, were instrumental in our investigations (refer to Figure 3, Figure 6, Figure 5-figure supplement 1, Figure 5-figure supplement 2, and Figure 6-figure supplement 1). Our comprehensive analysis, employing various methodologies such as tissue-specific fused proteins, CRISPR/Cas9 knock-in, and antibody staining, consistently highlights the critical role of USP8 in early-to-late endosome conversion.</p>
<disp-quote content-type="editor-comment">
<p>- The authors clearly demonstrated a link between USP8 and Rabx5, and they showed that cells deficient in both factors displayed similar defects in late endosomes/lysosomes. However, the authors didn't confirm whether and/or to which extent USP8 regulates endosome maturation through Rabx5. Additional genetic and molecular evidence might be required to better support their working model.</p>
</disp-quote>
<p>Excellent point. To test whether USP-50 regulates endosome maturation through RABX-5, we performed additional genetic analyses. In <italic>rabx-5(null)</italic> mutant animals, the morphology of 2xFYVE-labeled early endosomes is comparable to that of wild-type controls (Figure 4H and I). Introducing the <italic>rabx-5(null)</italic> mutation into <italic>usp-50(xd413)</italic> backgrounds resulted in a significant suppression of the enlarged early endosome phenotype characteristic of <italic>usp-50(xd413)</italic> mutants (Figure 4H and I). These findings suggest that USP-50 may modulate the size of early endosomes through its interaction with RABX-5.</p>
<disp-quote content-type="editor-comment">
<p><bold>Reviewer #3 (Public Review):</bold></p>
<p>Summary:</p>
<p>The authors were trying to elucidate the role of USP8 in the endocytic pathway. Using C. elegans epithelial cells as a model, they observed that when USP8 function is lost, the cells have a decreased number and size in lysosomes. Since USP8 was already known to be a protein linked to ESCRT components, they looked into what role USP8 might play in connecting lysosomes and multivesicular bodies (MVB). They observed fewer ESCRT-associated vesicles but an increased number of &quot;abnormal&quot; enlarged vesicles when USP8 function was lost. At this specific point, it's not clear what the objective of the authors was. What would have been their hypothesis addressing whether the reduced lysosomal structures in USP8 (-) animals were linked to MVB formation? Then they observed that the abnormally enlarged vesicles, marked by the PI3P biosensor YFP-2xFYVE, are bigger but in the same number in USP8 (-) compared to wild-type animals, suggesting homotypic fusion. They confirmed this result by knocking down USP8 in a human cell line, and they observed enlarged vesicles marked by YFP-2xFYVE as well. At this point, there is quite an important issue. The use of YFP-2xFYVE to detect early endosomes requires the transfection of the cells, which has already been demonstrated to produce differences in the distribution, number, and size of PI3P-positive vesicles (doi.org/10.1080/15548627.2017.1341465). The enlarged vesicles marked by YFP-2xFYVE would not necessarily be due to the loss of UPS8. In any case, it appears relatively clear that USP8 localizes to early endosomes, and the authors claim that this localization is mediated by Rabex-5 (or Rabx-5). They finally propose that USP8 dissociates Rabx-5 from early endosomes facilitating endosome maturation.</p>
<p>Weaknesses:</p>
<p>The weaknesses of this study are, on one side, that the results are almost exclusively dependent on the overexpression of fusion proteins. While useful in the field, this strategy does not represent the optimal way to dissect a cell biology issue. On the other side, the way the authors construct the rationale for each approximation is somehow difficult to follow. Finally, the use of two models, C. elegans and a mammalian cell line, which would strengthen the observations, contributes to the difficulty in reading the manuscript.</p>
<p>The findings are useful but do not clearly support the idea that USP8 mediates Rab5-Rab7 exchange and endosome maturation, In contrast, they appear to be incomplete and open new questions regarding the complexity of this process and the precise role of USP8 within it.</p>
</disp-quote>
<p>We thank this reviewer for the insightful comments. Fluorescence-fused proteins serve as potent tools for visualizing subcellular organelles both in vivo and in live settings. Specifically, in epidermal cells of worms, the tissue-specific expression of these fused proteins is indispensable for studying organelle dynamics within living organisms. This approach is necessitated by the inherent limitations of endogenously tagged proteins, whose fluorescence signals are often weak and unsuitable for live imaging or genetic screening purposes. Acknowledging concerns raised by the reviewer regarding potential alterations in organelle morphology due to overexpression of certain fused proteins, we supplemented our approach with the utilization of endogenous markers. These markers, including Rab5, RAB-5, Rabex5, RABX-5, and EEA1 for early endosomes, as well as RAB-7, Mon1a, and Mon1b for late endosomes, were instrumental in our investigations (refer to Figure 3, Figure 6, Figure 5-figure supplement 1, Figure 5-figure supplement 2, and Figure 6-figure supplement 1). Our comprehensive analysis, employing various methodologies such as tissue-specific fused proteins, CRISPR/Cas9 knock-in, and antibody staining, consistently highlights the critical role of USP8 in early-to-late endosome conversion. Specifically, we discovered that the recruitment of USP-50/USP8 to early endosomes is depending on Rabex5. However, instead of stabilizing Rabex5, the recruitment of USP-50/USP8 leads to its dissociation from endosomes, concomitantly facilitating the recruitment of the Rab7 GEF SAND-1/Mon1. In cells with loss-of-function mutations in <italic>usp-50/usp8</italic>, we observed enhanced RABX-5/Rabex5 signaling and mis-localization of SAND-1/Mon1 proteins from endosomes. Consequently, this disruption impairs endolysosomal trafficking, resulting in the accumulation of enlarged vesicles containing various intraluminal contents and rudimentary lysosomal structures.</p>
<p>Through an unbiased genetic screen, verified by cultured mammalian cell studies, we observed that loss-of-function mutations in <italic>usp-50</italic>/<italic>usp8</italic> result in diminished lysosome/late endosomes. Electron microscopy (EM) analysis indicated that <italic>usp-50</italic> mutation leads to abnormally enlarged vesicles containing various intraluminal structures in worm epidermal cells. USP8 is known to regulate the endocytic trafficking and stability of numerous transmembrane proteins. Given that lysosomes receive and degrade materials generated by endocytic pathways, we hypothesized that the abnormally enlarged vesicular structures observed in <italic>usp-50</italic> or <italic>usp8</italic> mutant cells correspond to the enlarged vesicles coated by early endosome markers. Indeed, in the absence of <italic>usp8/usp-50</italic>, the endosomal Rab5 signal is enhanced, while early endosomes are significantly enlarged. Given that Rab5 guanine nucleotide exchange factor (GEF), Rabex5, is essential for Rab5 activation, we further investigated its dynamics. Additional analyses conducted in both worm hypodermal cells and cultured mammalian cells revealed an increase of endosomal Rabex5 in response to <italic>usp8/usp-50</italic> loss-of-function. Live imaging studies further demonstrated active recruitment of USP8 to newly formed Rab5-positive vesicles, aligning spatiotemporally with Rabex5 regulation. Through systematic exploration of putative USP-50 binding partners on early endosomes, we identified its interaction with Rabex5. Comprehensive genetics and biochemistry experiments demonstrated that USP8 acts through K323 site de-ubiquitination to dissociate Rabex5 from early endosomes and promotes the recruitment of the Rab7 GEF SAND-1/Mon1. In summary, our study began with an unbiased genetic screen and subsequent examination of established theories, leading to the formulation of our own hypothesis. Through multifaceted approaches, we unveiled a novel function of USP8 in early-to-late endosome conversion.</p>
<disp-quote content-type="editor-comment">
<p><bold>Recommendations for the authors:</bold></p>
<p><bold>Reviewer #1 (Recommendations For The Authors):</bold></p>
<p>(1) Within Figures 1K-N, diverse anomalous structures were detected in the <italic>usp-50</italic> mutant. Further scrutiny is needed to definitively characterize these structures, particularly as the images in Figures 1M and 1L exhibit notable similarities to lamellar bodies.</p>
</disp-quote>
<p>We thank the reviewer for the insightful question regarding the resemblance between the vesicles observed in our study and lamellar bodies (LBs). Lamellar bodies are specialized organelles involved in lipid storage and secretion1, prominently studied in keratinocytes of the skin and alveolar type II (ATII) epithelial cells in the lung2. These organelles contain not only lipids but also cell-type specific proteins and lytic enzymes. Due to their acidic pH and functional similarities, LBs are classified as lysosome-related organelles (LROs) or secretory lysosomes3,4. In <italic>usp-50</italic> mutants, we observed a considerable number of abnormal vesicles, some of which contain threadlike membrane structures and exhibit morphological similarities to LBs (Figure 2O). However, further analysis with a comprehensive panel of lysosome-related markers demonstrated a significant reduction in lysosomal structures within these mutants. In contrast, vesicles marked by early endosome markers, such as FYVE, RAB-5, RABX-5, and EEA1, were notably enlarged. These results suggest that the enlarged vesicles observed in <italic>usp-50</italic> mutants are more likely aberrant early endosomes rather than true lamellar bodies. We have revised the manuscript to reflect these findings and to clearly differentiate between these structures and lysosome-related organelles.</p>
<disp-quote content-type="editor-comment">
<p>(2) The correlation between the presence of these abnormal structures and ESCRT-0 remains unaddressed, thus the assertion that UPS-50 regulates endolysosome trafficking in conjunction with ESCRT-0 lacks empirical support.</p>
</disp-quote>
<p>We thank the reviewer for the valuable suggestions. We apologize for any confusion and appreciate the opportunity to clarify our findings. The ESCRT machinery is essential for driving endosomal membrane deformation and scission, which leads to the formation of intraluminal vesicles (ILVs) within multivesicular bodies (MVBs). Recent research has shown that the absence of ESCRT components results in a reduction of ILVs in worm gut cells5. In wild type animals, the ESCRT-0 components HGRS-1 and STAM-1 display a distinct punctate distribution (Figure 1G and H). However, in <italic>usp-50</italic> mutants, the punctate signals of HGRS-1::GFP and STAM-1::GFP are significantly reduced (Figure 1G and H; and Figure 1-figure supplement 1B), indicating a role for USP-50 in stabilizing the ESCRT-0 complex. Our TEM analysis revealed an accumulation of abnormally enlarged vesicles containing intraluminal structures in <italic>usp-50</italic> mutants. When we examined a panel of early endosome and late endosome/lysosome markers, we found that early endosomes are significantly enlarged, while late endosomal/lysosomal structures are markedly reduced in these mutants. This suggests that the abnormal structures observed in <italic>usp-50</italic> mutants are likely enlarged early endosomes rather than classical MVBs. To further investigate whether the reduction in ESCRT components contributes to the late endosome/lysosome defects, we analyzed <italic>stam-1</italic> mutants. In these mutants, the size of RAB-7-coated vesicles was reduced (Author response image 1C), and the lysosomal marker LAAT-1 indicated a reduction in lysosomal structures (Author response image 1B). These results highlight the importance of the ESCRT complex in late endosome/lysosome formation. However, the morphology of early endosomes, as marked by 2xFYVE, remained similar to that of wild type in <italic>stam-1</italic> mutants (Author response image 1A). Therefore, while reduced ESCRT-0 components may contribute to the late endosome/lysosome defects observed in <italic>usp-50</italic> mutants, the enlargement of early endosomes in these mutants may involve additional mechanisms. We have revised the manuscript to incorporate these insights and to address the reviewer's comments more comprehensively.</p>
<fig id="sa4fig1">
<label>Author response image 1.</label>
<caption>
<title>(A) Confocal fluorescence images of hypodermis expressing YFP::2xFYVE to detect EEs in L4 stage animals in wild type and <italic>stam-1(ok406)</italic> mutants.</title>
<p>Scale bar: 5 μm. (B) Confocal fluorescence images of hypodermal cell 7 (hyp7) expressing the LAAT-1::GFP marker to highlight lysosome structures in 3-day-old adult animals. Compared to wild type, LAAT-1::GFP signal is reduced in <italic>stam-1(ok406)</italic> animals. Scale bar, 5 μm. (C) The reduction of punctate endogenous GFP::RAB-7 signals in <italic>stam-1(ok406)</italic> animals. Scale bar: 10 μm.</p>
</caption>
<graphic mime-subtype="jpg" xlink:href="elife-96353-sa4-fig1.jpg" mimetype="image"/>
</fig>
<disp-quote content-type="editor-comment">
<p>(3) Endosomal dysfunction typically leads to significant alterations in the spatial arrangement of marker proteins across distinct endosomes. In the manuscript, the authors examined the distribution and morphology of early endosomes, multivesicular bodies (MVBs), late endosomes, and lysosomes in a <italic>usp-50</italic> deficient background primarily through single-channel confocal imaging. By employing two color images showing RAB-5 and RAB-7, in conjunction with HGRS-1, a more comprehensive picture of the aftermath of USP-50 loss can be obtained.</p>
</disp-quote>
<p>Good suggestions. We have conducted a double-labeling analysis to examine the distribution of RAB-5 and RAB-7 in conjunction with HGRS-1. In wild type animals, HGRS-1 exhibits a punctate distribution that is partially co-localized with both RAB-5 and RAB-7. In contrast, in <italic>usp-50</italic> mutants, the punctate signal of HGRS-1 is significantly reduced, along with its co-localization with RAB-5 and RAB-7 (Author response image 2). These results suggest that, in the absence of USP-50, the stabilization of ESCRT-0 components on endosomes is compromised.</p>
<fig id="sa4fig2">
<label>Author response image 2.</label>
<caption>
<title>ESCRT-0 is adjacent to both early endosomes and late endosomes.</title>
<p>(A) Confocal fluorescence images of wild-type and <italic>usp-50(xd413)</italic> hypodermis at L4 stage co-expressing HGRS-1::GFP (<italic>hgrs-1</italic> promoter) and endogenous wrmScarlet::RAB-5. (B) HGRS-1 and RAB-5 puncta were analyzed to produce Manders overlap coefficient M1 (HGRS-1/RAB-5) and M2 (RAB-5/HGRS-1) (N=10). (C) Confocal fluorescence images of wild-type and <italic>usp-50(xd413)</italic> hypodermis at L4 stage co-expressing HGRS-1::GFP (<italic>hgrs-1</italic> promoter) and endogenous wrmScarlet::RAB-7. (D) HGRS-1 and RAB-7 puncta were analyzed to produce Manders overlap coefficient M1 (HGRS-1/RAB-7) and M2 (RAB-7/HGRS-1) (N=10). Scale bar: 10 μm for (A) and (C).</p>
</caption>
<graphic mime-subtype="jpg" xlink:href="elife-96353-sa4-fig2.jpg" mimetype="image"/>
</fig>
<disp-quote content-type="editor-comment">
<p>(4) The authors observed enlarged early endosomes in cells depleted of <italic>usp-50</italic>/usp8, along with enlarged MVB-like structures identified through TEM. The potential identity of these structures as the same organelle could be determined using CLEM.</p>
</disp-quote>
<p>We thank the reviewer for the valuable suggestion. Our TEM analysis identified a large number of abnormally enlarged vesicles with various intraluminal structures accumulated in <italic>usp-50</italic> mutants. As the reviewer correctly noted, CLEM (correlative light and electron microscopy) would be an ideal approach to further characterize these structures. We have been attempting to implement CLEM in <italic>C. elegans</italic> for a few years. Given that CLEM relies on fluorescence markers, in this study we focused on two tagged proteins, RAB-5 and RABX-5, which show enlargement in their vesicles in <italic>usp-50</italic> mutants. Unfortunately, we encountered significant challenges with this approach, as the GFP-tagged RAB-5 and RABX-5 signals did not survive the electron microscopy procedure. Attempts to align EM sections with residual GFP signaling yielded results that were not convincing. Consequently, we concentrated our analysis on a panel of molecular markers, including 2xFYVE, RAB-5, RABX-5, RAB-7, and LAAT-1. These markers consistently indicated that early endosomes are specifically enlarged in <italic>usp-50</italic> mutants, while late endosomal/lysosomal structures are notably reduced. Thus, the abnormal structures identified in <italic>usp-50</italic> mutants via TEM are likely to be enlarged early endosomes rather than the classical view of MVBs. We have revised the manuscript to reflect these findings and to clarify this point.</p>
<disp-quote content-type="editor-comment">
<p>(5) The working model depicted in Figure 6 Y (right) requires revision, as it has the potential to mislead authors into mistaking enlarged early endosomes for multivesicular bodies (MVBs).</p>
</disp-quote>
<p>We thank the reviewer for the excellent suggestion. We have revised the model to clarify that it is the enlarged early endosomes, rather than MVBs, that are observed in <italic>usp-50</italic> mutants.</p>
<disp-quote content-type="editor-comment">
<p><bold>Reviewer #2 (Recommendations For The Authors):</bold></p>
<p>(1) Is there any change of Rabx5 protein level in USP8/USP50 mutant cells?</p>
</disp-quote>
<p>Good question. In the absence of <italic>usp-50/usp8</italic>, we indeed observed a noticeable increase in the signal of Rabex5 on endosomes. To determine whether <italic>usp-50/usp8</italic> affects the protein level of Rabex5, we investigated the endogenous levels of RABX-5 using the RABX-5::GFP knock-in line. Compared to wild-type controls, we found an elevated protein level of RABX-5::GFP in the knock-in line (Author response image 3). This suggests that USP-50 may play a role in the destabilization of RABX-5/Rabex5 <italic>in vivo</italic>.</p>
<fig id="sa4fig3">
<label>Author response image 3.</label>
<caption>
<title>The endogenous RABX-5 protein level is increased in <italic>usp-50</italic> mutants.</title>
<p>(A) The RABX-5::GFP KI protein level is increased in <italic>usp-50(xd413)</italic>. (B) Quantification of endogenous RABX-5::GFP protein level in wild type and <italic>usp-50(xd413)</italic> mutant animals.</p>
</caption>
<graphic mime-subtype="jpg" xlink:href="elife-96353-sa4-fig3.jpg" mimetype="image"/>
</fig>
<disp-quote content-type="editor-comment">
<p>(2) It is interesting that &quot;The <italic>rabx-5(null)</italic> animals are healthy and fertile and do not display obvious morphological or behavioral defects.&quot;, which seems contrary to its role in regulating USP8 localization and endosome maturation.</p>
</disp-quote>
<p>It has been previously documented that <italic>rabx-5</italic> functions redundantly with <italic>rme-6</italic>, another RAB-5 GEF in <italic>C. elegans</italic>, to regulate RAB-5 localization in oocytes6. RNA interference (RNAi) targeting <italic>rabx-5</italic> in a <italic>rme-6</italic> mutant background results in synthetic lethality, whereas neither <italic>rabx-5</italic> nor <italic>rme-6</italic> single mutants are essential for worm viability. RME-6 co-localizes with clathrin-coated pits, while Rabex-5 is localized to early endosomes. Rabex-5 forms a stable complex with Rabaptin-5 and is part of a large EEA1-positive complex on early endosomes, whereas RME-6 does not interact with Rabaptin-5 (RABN-5) or EEA-1. These findings suggest that while RME-6 and RABX-5 may function redundantly, they likely play distinct roles in regulating intracellular trafficking processes. In the absence of RABX-5, USP-50 appears to lose its endosomal localization, although the size of the early endosome remains comparable to that of wild type. This observation contrasts with the phenotype associated with USP-50 loss-of-function, in which the early endosome is notably enlarged. These results suggest that residual USP-50 present in the endosomes is sufficient to maintain its role in the endocytic pathway. Conversely, the complete absence of USP-50 likely disrupts the transition of early endosomes to late endosomes, indicating a crucial role of USP-50 in this conversion process. It is also noteworthy that, although loss-of-function of <italic>rabx-5</italic> does not result in obvious changes to early endosomes, increasing the gene expression level of <italic>rabx-5/Rabex-5</italic> alone is sufficient to cause enlargement of early endosomes (Author response image 4) . Indeed, we observed that loss-of-function mutations in u_sp-50/usp_8 lead to abnormally enlarged early endosomes, accompanied by an enhanced signal of endosomal RABX-5. When the <italic>rabx-5(null)</italic> mutation was introduced into <italic>usp-50</italic> mutant animals, the enlarged early endosome phenotype seen in <italic>usp-50</italic> mutants was significantly suppressed (Figure 4H and I). This implies that maintaining a lower level of Rab5 GEF may be crucial for endolysosomal trafficking.</p>
<disp-quote content-type="editor-comment">
<p>(3) Does Rabx5 mutation has any impact on early endosomes?</p>
</disp-quote>
<p>To address the question, we utilized the CRISPR/Cas9 technique to create a molecular null for <italic>rabx</italic>-5 (Figure 4E). In the <italic>rabx-5(null)</italic> mutant animals, we found that the 2xFYVE-labeled early endosomes are indistinguishable from wild type (Figure 4H and 4I). Given that r_abx-5_ functions redundantly with <italic>rme-6</italic>, another RAB-5 GEF in <italic>C. elegans</italic>, it is likely that the regulation of early endosome size involves a cooperative interaction between RABX-5 and RME-6.</p>
<disp-quote content-type="editor-comment">
<p>(4) The authors observed a reduction of ESCRT-0 components in USP8 mutant cells, could this contribute to the late endosome/lysosome defects?</p>
</disp-quote>
<p>Good suggestion. In wild-type animals, the two ESCRT-0 components, HGRS-1 and STAM-1, exhibit a distinct punctate distribution (Figure 1G and H). However, in <italic>usp-50</italic> mutants, the punctate signals of HGRS-1::GFP and STAM-1::GFP are significantly diminished (Figure 1G and H; and Figure 1-figure supplement 1B), which aligns with the role of USP-50 in stabilizing the ESCRT-0 complex. To investigate whether the reduction in ESCRT components might contribute to defects in late endosome/lysosome formation, we examined <italic>stam-1</italic> mutants. In <italic>stam-1</italic> mutants, we observed a reduction in the size of RAB-7-coated vesicles (Author response image 1). Further, when we introduced the lysosomal marker LAAT-1::GFP into <italic>stam-1</italic> mutants, we found a substantial decrease in lysosomal structures compared to wild-type animals (Author response image 1). This suggests that the ESCRT complex is essential for proper late endosome/lysosome formation. In contrast, the morphology of early endosomes, as indicated by the 2xFYVE marker, appeared normal in <italic>stam-1</italic> mutants, similar to wild-type animals (Author response image 1). This implies that while a reduction in ESCRT-0 components may contribute to the late endosome/lysosome defects observed in <italic>usp-50</italic> mutants, the early endosome enlargement phenotype in _usp-5_0 mutants may involve additional mechanisms.</p>
<disp-quote content-type="editor-comment">
<p>(5) Rabx5 is accumulated in USP8 mutant cells, I am very curious about the phenotype of USP8-Rabx5 double mutants. Could over-expression of Rabx5 (wild type or mutant forms) cause any defects?</p>
</disp-quote>
<p>Excellent suggestions. To address the question, we employed the CRISPR/Cas9 technique to create a molecular null for <italic>rabx-5</italic> (Figure 4E). In the <italic>rabx-5(null)</italic> mutant animals, we observed that the punctate USP-50::GFP signal became diffusely distributed (Figure 4F and G). This suggests that <italic>rabx-5</italic> is necessary for the endosomal localization of USP-50. Interestingly, in <italic>rabx-5(null)</italic> mutant animals, the 2xFYVE-labeled early endosomes appeared similar to those in wild-type animals (Figure 4H and I). When <italic>rabx-5(null)</italic> was introduced into <italic>usp-50</italic> mutant animals, the enlarged early endosome phenotype observed in <italic>usp-50</italic> was significantly suppressed (Figure 4H and I). This finding indicates that <italic>usp-50</italic> indeed functions through <italic>rabx-5</italic> to regulate early endosome size. Additionally, we constructed strains overexpressing either wild-type or K323R mutant RABX-5. Our results showed that overexpression of wild-type RABX-5 led to early endosome enlargement (as indicated by YFP::2xFYVE labeling) (Author response image 4A, B and D). In contrast, overexpression of the K323R mutant RABX-5 did not result in noticeable early endosome enlargement (Author response image 4A, C and D). Together, these data are in consistent with our model that USP-50 may regulate RABX-5 by deubiquitinating the K323 site.</p>
<fig id="sa4fig4">
<label>Author response image 4.</label>
<caption>
<title>(A-C) Over-expression wild type RABX-5 causes enlarged EEs (labeled by YFP::2xFYVE) while RABX-5(K323R) mutant form does not.</title>
<p>(D) Quantification of the volume of individual YFP::2xFYVE vesicles. Data are presented as mean ± SEM. ****<italic>P</italic>&lt;0.0001. ns, not significant. One-way ANOVA with Tukey’s test.</p>
</caption>
<graphic mime-subtype="jpg" xlink:href="elife-96353-sa4-fig4.jpg" mimetype="image"/>
</fig>
<disp-quote content-type="editor-comment">
<p>(6) Rabx5 could be ubiquitinated at K88 and K323, and Rabx5-K323R showed different activity when compared with the wild-type protein in USP8 mutant cells. Could the authors provide evidence that USP8 could remove the ubiquitin modification from K323 in Rabx5 protein?</p>
</disp-quote>
<p>We appreciate the reviewer's insightful suggestions. To explore the potential of USP-50 in removing ubiquitin modifications from lysine 323 on the RABX-5 protein, we undertook a series of experiments. Initially, we sought to determine whether USP-50 influences the ubiquitination level of RABX-5 <italic>in vivo</italic>. However, due to the low expression levels of USP-50, we encountered challenges in obtaining adequate amounts of USP-50 protein from worm lysates. To overcome this, we expressed USP-50::4xFLAG in HEK293 cells for subsequent affinity purification. Concurrently, we utilized anti-GFP agarose beads to purify RABX-5::GFP from worms expressing the <italic>rabx-5::gfp</italic> construct. We then incubated RABX-5::GFP with USP-50::4xFLAG for varying durations and performed immunoblotting with an anti-ubiquitin antibody. As shown in Author response image 5A, our results revealed a decrease in the ubiquitination level of RABX-5 in the presence of USP-50, suggesting that USP-50 directly deubiquitinates RABX-5. Previous studies have indicated that only a minor fraction of recombinant RABX-5 undergoes ubiquitination in HeLa cells, which is believed to have functional significance7. Our findings are consistent with this observation, as only a small fraction of RABX-5 in worms is ubiquitinated. Rabex-5 is known to interact with both K63- and K48-linked poly-ubiquitin chains. To further elucidate whether USP-50 specifically targets K48 or K63-linked ubiquitination at the K323 site of RABX-5, we incubated various HA-tagged ubiquitin mutants with either wild-type or K323R mutant RABX-5 protein. Our results indicated that the K323R mutation reduces K63-linked ubiquitination of RABX-5 (Author response image 5). This experiment was repeated multiple times with consistent results. Additionally, while overexpression of wild-type RABX-5 led to an enlargement of early endosomes, as evidenced by YFP::2xFYVE labeling, overexpression of the K323R mutant did not produce a noticeable effect on endosome size (Author response image 4). Collectively, this finding indicates that RABX-5 is subject to ubiquitin modification <italic>in vivo</italic> and that USP-50 plays a significant role in regulating this modification at the K323 site.</p>
<fig id="sa4fig5">
<label>Author response image 5.</label>
<caption>
<title>(A) RABX-5::GFP protein was purified from worm lysates using anti-GFP antibody.</title>
<p>FLAG-tagged USP-50 was purified from HEK293T cells using anti-FLAG antibody. Purified RABX-5::GFP was incubated with USP-50::4FLAG for indicated times (0, 15, 30, 60 mins), followed by immunoblotting using antibody against ubiquitin, FLAG or GFP. In the presence of USP-50::4xFLAG, the ubiquitination level of RABX-5::GFP is decreased. (B) Quantification of RABX-5::GFP ubiquitination level from three independent experiments. (C) HEK293T cells were transfected with HA-Ub or indicated mutants and 4xFLAG tagged RABX-5 or RABX-5 K323R mutant for 48h. The cells were subjected to pull down using the FLAG beads, followed by immunoblotting using antibody against HA or Flag.</p>
</caption>
<graphic mime-subtype="jpg" xlink:href="elife-96353-sa4-fig5.jpg" mimetype="image"/>
</fig>
<disp-quote content-type="editor-comment">
<p>(7) The authors described &quot;the almost identical phenotype of usp-50/usp8 and sand-1/Mon1 mutants&quot;, found protein-protein interaction between USP8 and sand-1, and showed that sand1-GFP signal is diminished in USP8 mutant cells. These observations fit with the possibility that USP8 regulates the stability of sand-1 to promote endosomal maturation. Could this be tested and integrated into the current model?</p>
</disp-quote>
<p>are grateful for the insightful comments provided by the reviewer. Rab5, known to be activated by Rabex-5, plays a crucial role in the homotypic fusion of early endosomes. Rab5 effectors also include the Rab7 GEF SAND-1/Mon1–Ccz1 complex. Rab7 activation by SAND-1/Mon1-Ccz1 complex is essential for the biogenesis and positioning of late endosomes (LEs) and lysosomes, and for the fusion of endosomes and autophagosomes with lysosomes. The Mon1-Ccz1 complex is able to interact with Rabex5, causing dissociation of Rabex5 from the membrane, which probably terminates the positive feedback loop of Rab5 activation and then promotes the recruitment and activation of Rab7 on endosomes. In our study, we identified an interaction between USP-50 and the Rab5 GEF, RABX-5. In the absence of USP-50, we observed an increased endosomal localization of RABX-5 and the formation of abnormally enlarged early endosomes. This phenotype is reminiscent of that seen in <italic>sand-1</italic> loss-of-function mutants, which also exhibit enlarged early endosomes and a concomitant reduction in late endosomes/lysosomes. Notably, USP-50 also interacts with SAND-1, suggesting a potential role in regulating its localization. We could propose several models to elucidate how USP-50 might influence SAND-1 localization, including:</p>
<p>(1) USP-50 may stabilize SAND-1 through direct de-ubiquitination.</p>
<p>(2) In the absence of USP-50, the sustained presence of RABX-5 could lead to continuous Rab5 activation, which might hinder or delay the recruitment of SAND-1.</p>
<p>(3) USP-50 could facilitate SAND-1 recruitment by promoting the dissociation of RABX-5.</p>
<p>We are actively investigating these models in our laboratory. Due to space constraints, a more detailed exploration of how USP-50 regulates SAND-1 stability will be presented in a separate publication.</p>
<p>References:</p>
<p>(1) Schmitz, G., and Müller, G. (1991). Structure and function of lamellar bodies, lipid-protein complexes involved in storage and secretion of cellular lipids. J Lipid Res <italic>32</italic>, 1539-1570.</p>
<p>(2) Dietl, P., and Frick, M. (2021). Channels and Transporters of the Pulmonary Lamellar Body in Health and Disease. Cells-Basel <italic>11</italic>. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3390/cells11010045">https://doi.org/10.3390/cells11010045</ext-link>.</p>
<p>(3) Raposo, G., Marks, M.S., and Cutler, D.F. (2007). Lysosome-related organelles: driving post-Golgi compartments into specialisation. Current opinion in cell biology <italic>19</italic>, 394-401. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.ceb.2007.05.001">https://doi.org/10.1016/j.ceb.2007.05.001</ext-link>.</p>
<p>(4) Weaver, T.E., Na, C.L., and Stahlman, M. (2002). Biogenesis of lamellar bodies, lysosome-related organelles involved in storage and secretion of pulmonary surfactant. Semin Cell Dev Biol <italic>13</italic>, 263-270. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/s1084952102000551">https://doi.org/10.1016/s1084952102000551</ext-link>.</p>
<p>(5) Ott, D.P., Desai, S., Solinger, J.A., Kaech, A., and Spang, A. (2024). Coordination between ESCRT function and Rab conversion during endosome maturation. bioRxiv, 2024.2005.2014.594104. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1101/2024.05.14.594104">https://doi.org/10.1101/2024.05.14.594104</ext-link>.</p>
<p>(6) Sato, M., Sato, K., Fonarev, P., Huang, C.J., Liou, W., and Grant, B.D. (2005). Caenorhabditis elegans RME-6 is a novel regulator of RAB-5 at the clathrin-coated pit. Nature cell biology <italic>7</italic>, 559-569. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/ncb1261">https://doi.org/10.1038/ncb1261</ext-link>.</p>
<p>(7) Mattera, R., Tsai, Y.C., Weissman, A.M., and Bonifacino, J.S. (2006). The Rab5 guanine nucleotide exchange factor Rabex-5 binds ubiquitin (Ub) and functions as a Ub ligase through an atypical Ub-interacting motif and a zinc finger domain. The Journal of biological chemistry <italic>281</italic>, 6874-6883. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1074/jbc.M509939200">https://doi.org/10.1074/jbc.M509939200</ext-link>.</p>
</body>
</sub-article>
</article>